Recent Advances in Transthyretin Evolution, Structure and Biological Functions
Samantha J. Richardson
l
Vivian Cody
Recent Advances in Transthyretin Evolution, Structure and Biological Functions
Dr. Samantha J. Richardson RMIT University School of Medical Sciences Bundoora VIC 3083 Bundoora West Campus Australia
[email protected]
Dr. Vivian Cody Hauptman-Woodward Medical Research Institute 700 Elliott Street Buffalo NY 14203 USA
[email protected]
ISBN 978-3-642-00645-6 e-ISBN 978-3-642-00646-3 DOI: 10.1007/978-3-642-00646-3 Springer Dordrecht Heidelberg London New York Library of Congress Control Number: 2009926025 # Springer-Verlag Berlin Heidelberg 2009 This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilm or in any other way, and storage in data banks. Duplication of this publication or parts thereof is permitted only under the provisions of the German Copyright Law of September 9, 1965, in its current version, and permission for use must always be obtained from Springer. Violations are liable to prosecution under the German Copyright Law. The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. Cover design: WMXDesign GmbH, Heidelberg, Germany Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com)
Preface
Since its first description in 1942 in both serum and cerebrospinal fluid, transthyretin (TTR) has had an eventful history, including changes in name from “prealbumin” to “thyroxine-binding prealbumin” to “transthyretin” as knowledge increased about its functions. TTR is synthesised in a wide range of tissues in humans and other eutherian mammals: the liver, choroid plexus (blood- cerebrospinal fluid barrier), retinal pigment epithelium of the eye, pancreas, intestine and meninges. However, its sites of synthesis are more restricted in other vertebrates. This implies that the number of tissues synthesising TTR during vertebrate evolution has increased, and raises questions about the selection pressures governing TTR synthesis. TTR is most widely known as a distributor of thyroid hormones. In addition, TTR binds retinol-binding protein, which binds retinol. In this way, TTR is also involved with retinoid distribution. More recently, TTR has been demonstrated to bind a wide variety of endocrine disruptors including drugs, pollutants, industrial compounds, heavy metals, and some naturally occurring plant flavonoids. These not only interfere with thyroid hormone delivery in the body, but also transport such endocrine disruptors into the brain, where they have the potential to accumulate. The X-ray crystal structure of TTR from vertebrates (fish, chicken, rat, mouse and human) has not changed in its overall structure. Despite this, TTRs in fish, amphibians, reptiles and birds bind T3 with higher affinity than T4, whereas in mammals, while maintaining the same three-dimensional structure in the binding site, TTR binds T4 with higher affinity than T3. The high conservation of quaternary, tertiary, secondary and primary structure, in combination with the sequencing of many non-vertebrate genomes, has allowed the identification of genes coding for TTR-Like Proteins (TLPs) in microbes, plants and non-vertebrate animals. TLPs studied to date do not bind thyroid hormones, but have 5-hydroxyisourate hydrolase activity. The change in function from 5-HIUase in bacteria to distributor of T3 in fish, amphibians, reptiles and birds, to distributor of T4 in mammals, yet maintaining the same overall three-dimensional structure, renders TLP/TTR an excellent model for the study of protein evolution. The function of TTR is still considered controversial by some researchers, as TTR null mice were originally reported to be without an overt phenotype. There exists the possibility that the lack of phenotype is due to redundancies in thyroid v
vi
Preface
hormone and retinoid metabolism, and also that mice living in animal houses in laboratories are not subjected to the same stresses as those in the wild; thus the phenotype is not seen under laboratory conditions. Intriguingly, there are no reports of humans lacking TTR. However, more recent studies have revealed a variety of phenotypes in TTR null mice, shedding light on previously unknown roles of TTR in development and neurobiology. TTR is also widely implicated in human health and disease. TTR is used as a nutritional marker, and also as an indicator of recovery following some diseases and surgery. Perhaps the most prolific area of TTR research concerns human TTR amyloid formation. There are two main types of TTR amyloid: familial amyloidotic polyneuropathy (FAP) is an autosomal dominant inherited mutation in the TTR gene causing polyneuropathy, whereas senile systemic amyloidosis (SSA; also known as senile cardiac amyloidosis, SCA) is age-dependent and the amyloid fibrils contain wild type TTR. Of the 127 amino acids in the polypeptide, there are at least 100 point mutations that result in FAP. Therefore, there is an urgent need for continued research into the mechanisms of TTR amyloid formation, and for the development of therapeutics including drugs, gene therapy and organ transplants. Thus, progress in medical research into TTR is fundamental to human health. TTR is a fascinating protein from the stand point of protein evolution, and also in medicine. Thus, this is an exciting time for experts in TTR research to come together to write this monograph that covers both the basic and the clinical research in TTR. This monograph describes each of the above-mentioned aspects of TTR and brings the reader up to date on the latest developments and discoveries.
March 2009
Samantha J. Richardson Vivian Cody
Contents
1
2
Mechanisms of Molecular Recognition: Structural Characteristics of Transthyretin Ligand Interactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Vivian Cody and Andrzej Wojtczak
1
Transthyretin Synthesis During Development and Evolution: What the Marsupials Revealed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Samantha J. Richardson
23
3
Evolution of Transthyretin Gene Structure . . . . . . . . . . . . . . . . . . . . . . . . . . . Porntip Prapunpoj
45
4
Evolutionary Insights from Fish Transthyretin . . . . . . . . . . . . . . . . . . . . . . . Deborah M. Power, Isabel Morgado, and Joa˜o C.R. Cardoso
59
5
The Salmonella sp. TLP: A Periplasmic 5-Hydroxyisourate Hydrolase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Sarah Hennebry
6
Vertebrate 5-Hydroxyisourate Hydrolase Identification, Function, Structure, and Evolutionary Relationship with Transthyretin . . . . . . Giuseppe Zanotti, Ileana Ramazzina, Laura Cendron, Claudia Folli, Riccardo Percudani, and Rodolfo Berni
77
95
7
Transthyretin-Related and Transthyretin-like Proteins . . . . . . . . . . . . . . 109 A. Elisabeth Sauer-Eriksson, Anna Linusson, and Erik Lundberg
8
The Transthyretin–Retinol-Binding Protein Complex . . . . . . . . . . . . . . . 123 Hugo L. Monaco
9
Transthyretin and Retinol-Binding Protein: Implications in Fish Physiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143 Sancia Gaetani and Diana Bellovino
vii
viii
Contents
10
Transthyretin and Endocrine Disruptors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 159 Kiyoshi Yamauchi and Akinori Ishihara
11
Genetics: Clinical Implications of Transthyretin Amyloidosis . . . . . . . 173 Merrill D. Benson
12
Molecular Pathogenesis Associated with Familial Amyloidotic Polyneuropathy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 191 Maria Joa˜o Saraiva
13
Histidine 31: The Achilles’ Heel of Human Transthyretin. Microheterogeneity is Not Enough to Understand the Molecular Causes of Amyloidogenicity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201 Klaus Altland and Samantha J. Richardson
14
New Therapeutic Approaches for Familial Amyloidotic Polyneuropathy (FAP) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 215 Yukio Ando, Masaaki Nakamura, Mistuharu Ueda, and Hirofumi Jono
15
Liver Transplantation for Transthyretin Amyloidosis . . . . . . . . . . . . . . . 239 Bo-Goran Ericzon, Erik Lundgren, and Ole B. Suhr
16
Mouse Models of Transthyretin Amyloidosis . . . . . . . . . . . . . . . . . . . . . . . . . 261 Sadahiro Itoand Shuichiro Maeda
17
What Have We Learned from Transthyretin-Null Mice: Novel Functions for Transthyretin? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 281 Joa˜o Carlos Sousa and Joana Almeida Palha
18
Transthyretin Null Mice: Developmental Phenotypes . . . . . . . . . . . . . . . . 297 Julie A. Monk and Samantha J. Richardson
19
Transthyretin Null Mice as a Model to Study the Involvement of Transthyretin in Neurobiology: From Neuropeptide Processing to Nerve Regeneration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 311 Carolina Estima Fleming, Ana Filipa Nunes, Ma´rcia Almeida Liz, and Mo´nica Mendes Sousa
20
Plasma Transthyretin Reflects the Fluctuations of Lean Body Mass in Health and Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 329 Yves Ingenbleek
Index
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 359
Contributors
Klaus Altland Justus-Liebig-University, Institute of Human Genetics Schlangenzahl 14, 35392 Giessen, Germany
[email protected] Yukio Ando Department of Diagnostic Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-0811, Japan
[email protected] Diana Bellovino National Research Institute on Food and Nutrition, Via Ardeatina 546, 00178 Rome, Italy
[email protected] Merrill D. Benson Indiana University School of Medicine, 635 Barnhill Drive, MS-128, Indianapolis, IN 46202-5126, USA
[email protected] Rodolfo Berni Department of Biochemistry and Molecular Biology, University of Parma, Viale delle Scienze 23/A, 43100 Parma, Italy
[email protected] Joa˜o C.R. Cardoso Comparative and Molecular Endocrinology Group, Centre for Marine Sciences (CCMAR), Universidade do Algarve, Campus do Gambelas, 8005139 Faro, Portugal
[email protected] Laura Cendron Department of Chemistry, University of Padua, and ICB-CNR, Section of Padua, Via Marzolo 1, 35131 Padova, Italy and Venetian Institute of Molecular Medicine, Via Orus 2, 35127 Padua, Italy
[email protected] Vivian Cody Structural Biology Department, Hauptman-Woodward Medical Research Institute, 700 Ellicott Street, Buffalo, NY 14203, USA
ix
x
Contributors
Bo-Goran Ericzon Head Division of Transplantation Surgery, CLINTEC, Karolinska Institutet, Karolinska University Hospital Huddinge, F82, 141 86 Stockholm, Sweden
[email protected] Carolina Estima Fleming Nerve Regeneration Group, Instituto de Biologia Molecular e Celular – IBMC, Universidade do Porto, R Campo Alegre 823, 4150 Porto, Portugal
[email protected] Claudia Folli Department of Biochemistry and Molecular Biology, University of Parma, Viale delle Scienze 23/A, 43100 Parma, Italy
[email protected] Sancia Gaetani National Research Institute on Food and Nutrition, Via Ardeatina 546, 00178 Rome, Italy
[email protected] Sarah Hennebry Human Neurotransmitters Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia
[email protected] Yves Ingenbleek Laboratory of Nutrition, Faculty of Pharmacy, University Louis Pasteur, Strasbourg 1, France
[email protected] and 15 bis, rue de la Vise, 34540 Balaruc-le-Vieux, France
[email protected] Akinori Ishihara Department of Biological Science, Faculty of Science, Shizuoka University, Shizuoka, Japan
[email protected] Sadahiro Ito Department of Biochemistry, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi 409-3898, Japan and Center for Life Science Research, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi 409-3898, Japan
[email protected] Hirofumi Jono Department of Diagnostic Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-0811, Japan
[email protected]
Contributors
xi
Anna Linusson Department of Chemistry, Umea˚ University, 90187 Umea˚, Sweden Ma´rcia Almeida Liz Nerve Regeneration Group, Instituto de Biologia Molecular e Celular – IBMC, Universidade do Porto, R Campo Alegre 823, 4150 Porto, Portugal
[email protected] Erik Lundgren Department of Molecular Biology, Umea˚ University, 901 87 Umea˚, Sweden
[email protected] and Department of Chemistry, Umea˚ University, 90187 Umea˚, Sweden Shuichiro Maeda Department of Biochemistry, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi 409-3898, Japan
[email protected] Hugo L. Monaco Biocrystallography Laboratory, Department of Biotechnology, University of Verona, Strada Le Grazie 15, 37134 Verona, Italy
[email protected] Julie A. Monk ProScribe Medical Communications, 481 Gilbert Rd., Preston, VIC 3072, Australia
[email protected], url: www.proscribe.com.au Isabel Morgado Comparative and Molecular Endocrinology Group, Centre for Marine Sciences (CCMAR), Universidade do Algarve, Campus do Gambelas, 8005139 Faro, Portugal and Max Planck Research Unit for Enzymology of Protein Folding, Weinbergweg 22, 06120 Halle (Saale), Germany
[email protected] Masaaki Nakamura Department of Diagnostic Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-0811, Japan
[email protected] Ana Filipa Nunes Nerve Regeneration Group, Instituto de Biologia Molecular e Celular – IBMC, Universidade do Porto, R Campo Alegre 823, 4150 Porto, Portugal
[email protected]
xii
Contributors
Joana Almeida Palha Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal
[email protected] Riccardo Percudani Department of Biochemistry and Molecular Biology, University of Parma, Viale delle Scienze 23/A, 43100 Parma, Italy
[email protected] Deborah M. Power Comparative and Molecular Endocrinology Group, Centre for Marine Sciences (CCMAR), Universidade do Algarve, Campus do Gambelas, 8005-139 Faro, Portugal
[email protected] Porntip Prapunpoj Department of Biochemistry, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90112, Thailand
[email protected] Ileana Ramazzina Department of Biochemistry and Molecular Biology, University of Parma, Viale delle Scienze 23/A, 43100 Parma, Italy
[email protected] Samantha J. Richardson School of Medical Sciences, RMIT University, P.O. Box 71, Bundoora, 3083 VIC, Australia
[email protected] Maria Joa˜o Saraiva Molecular Neurobiology Group, IBMC – Instituto de Biologia Molecular e Celular, R Campo Alegre 823, 4150 Porto, Portugal
[email protected] and ICBAS – Instituto de Cieˆncias Biome´dicas Abel Salazar, Universidade do Porto, Porto, Portugal A. Elisabeth Sauer-Eriksson Department of Chemistry, Umea˚ University, 90187 Umea˚, Sweden
[email protected] Joa˜o Carlos Sousa Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal
[email protected] Mo´nica Mendes Sousa Nerve Regeneration Group, Instituto de Biologia Molecular e Celular – IBMC, Universidade do Porto, R Campo Alegre 823, 4150 Porto, Portugal
[email protected]
Contributors
xiii
Ole B. Suhr Department of Medicine, Section for Gastroenterology and Hepatology, Umea˚ University Hospital, 901 85 Umea˚, Sweden
[email protected] Mistuharu Ueda Department of Diagnostic Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-0811, Japan
[email protected] Andrzej Wojtczak Chemistry Department, N. Copernicus University, Torun, Poland
[email protected] Kiyoshi Yamauchi Department of Biological Science, Faculty of Science, Shizuoka University, Shizuoka, Japan
[email protected] Giuseppe Zanotti Department of Chemistry, University of Padua, and ICB-CNR, Section of Padua, Via Marzolo 1, 35131 Padova, Italy and Venetian Institute of Molecular Medicine, Via Orus 2, 35127 Padua, Italy
[email protected]
Chapter 1
Mechanisms of Molecular Recognition: Structural Characteristics of Transthyretin Ligand Interactions Vivian Cody and Andrzej Wojtczak
Abstract Transthyretin (TTR) is a homotetrameric serum protein responsible for the transport through the general circulation of thyroid hormones and their metabolites, and also binds retinol-binding protein (RBP) that transports retinol. Structure-activity data show that many pharmacological agents can compete for the binding of thyroid hormone to TTR and that this competition can interfere with their normal physiological functions. This review surveys more than 100 TTR crystal structures currently (October 2008) reported in the Protein Data Bank, representing only five species of vertebrates. Despite the highly conserved nature of protein sequences, TTR can bind a wide range of compounds with a high degree of flexibility. TTR is composed of four identical monomeric subunits that assemble around a central channel such that the tetramer possesses molecular 222-symmetry with two hormone-binding sites per tetramer. At physiological conditions, only one domain is occupied; however, negative cooperativity in binding to the second domain causes the second hormone to bind with a lower affinity. To date, more than 100 variants at 67 amino acid sites of the 127 residues of the human TTR monomer have been implicated in amyloid fibril formation that gives rise to familial amyloid polyneuropathy (FAP). Although the mechanism underlying TTR tetramer stability is not well understood, it has been shown that tight binding ligands can reduce the propensity for amyloid fibril formation. Structural data of TTR ligand complexes provide new insight into the design of novel inhibitors that can stabilize specific mutants and thereby delay the onset of fibril formation. Keywords Transthyretin, Conformational flexibility, Active site topology, Proteinprotein interactions
V. Cody (*) Structural Biology Department, Hauptman-Woodward Medical Research Institute, 700 Ellicott Street, Buffalo, New York 14203, USA
S.J. Richardson and V. Cody (eds.), Recent Advances in Transthyretin Evolution, Structure and Biological Functions, DOI: 10.1007/978‐3‐642‐00646‐3_1, # Springer‐Verlag Berlin Heidelberg 2009
1
2
V. Cody and A. Wojtczak
1.1
Introduction
Transthyretin (TTR) is one of the three thyroid hormone-binding proteins found in the blood of vertebrates (Robbins 1996; Cody 2005). Produced in the liver, it binds retinol-binding protein that carries retinol (vitamin A) and thyroxine (3,5,30 ,50 tetraiodo-L-thyronine, T4) and differs from thyroxine-binding globulin (TBG) and serum albumin (SA) that has several nonspecific hormone-binding sites. Human TTR is a 55 kDa homotetramer composed of four identical 127 residue subunits that form an extensive b-sheet structure. The homotetramer assembles to form an internal channel in which two T4 molecules are bound per tetramer (Fig. 1.1). Biochemical data revealed that in the general circulation only one site is filled and that there is negative cooperativity in the binding of the second T4 (Cheng et al. 1977). Structure activity data revealed that the thyroid hormones and their metabolites have different binding affinities for TTR, depending on their substituent patterns, that is, the number of iodine atoms present or the type of side chain (propionic or acetic acid) (Table 1.1) (Cody 1980). In addition, many pharmacologic agents and natural products, such as plant flavonoids, nonsteroidal analgesic drugs, and inotropic bipyridines, are strong competitors for T4 binding to TTR and have binding affinities greater than T4 (Robbins 1996; Cody 2002). Recent studies have shown that TTR is one of about 20 human proteins that form fibrils in vivo, and to date more than 100 point mutations in TTR have been associated with the formation of fibrils, highly organized filamentous structures that form by self assembly of aggregated polypeptides. The propensity of TTR variants to form fibrils is the basis of familial amyloidotic polyneuropathy (FAP), a fatal genetic disease that is characterized by specific organ damage that targets the
a
b
Fig. 1.1 (a) TTR assembles as a tetramer with four identical subunits that form a channel with two hormone binding sites. The tetramer is generated by a twofold symmetry axis along the channel with monomers A-A0 (green, violet) and B-B0 (Cyan, gold). (b) Independent monomers of TTR illustrating forward and reverse binding of T4 acetic acid (T4A, Fig. 1.2)
1 Mechanisms of Molecular Recognition
3
Table 1.1 Relative binding affinities and biologic potencies of selected thyroid hormone analogues (Cody 1980) Compound TGB (%) TTR (%) Membrane (%) Nuclear (%) Potencya (%) L-Thyroxine
100.0
D-Thyroxine
54.0
39.3 0.95
96.6
12.5
63.0
–
18.1 3.0
3.6 76.4 23.0 – 3.0 T4-propionic acid 1.7 100.0 30.3 – 0.25 T4-acetic acid L-T3 (3,5,30 -triiodo) 9.0 1.4 100.0 100.0 100.0 38.0 3.1 67.5 0.1 <0.1 rT3 (3,5,30 -triiodo) a Potency is percentage of L-T3 (triiodothyronine; 30 ,3,5-triiodothyronine) rT3 reverse triiodothyronine, T3 triiodothyronine, T4 thyroxine, TGB thyroxine-binding globulin, TTR transthyretin
Fig. 1.2 TTR bound ligand classes reported in the PDB (October 2008)
heart, liver, brain, and peripheral nerves (Benson and Kincaid 2007; Westermark et al. 2007). The main focus of this review is to analyze TTR structures to determine preferences in ligand-bound conformation and geometry. In this review, a survey of all TTR protein complexes reported in the Protein Data Bank (PDB) (Berman et al. 2000) will be made, along with a comparison of the variants studied in order to understand the criteria for the formation of amyloid fibrils. Interactions between TTR and retinol-binding protein will not be discussed in this chapter as they are detailed in another chapter. Currently (October 2008), there are over 100 reported TTR crystal structures and their variants listed in the PDB (Berman et al. 2000), representing five species of protein (human, rat, mouse, chicken, and fish) with 37 different ligands in nine structure classifications (Fig. 1.2). Sequence analysis shows that TTRs from various species are more than 85% identical to human (Table 1.2). Of the structural data reported for TTR, the human protein has been the most studied.
hTTR rTTR mTTR cTTR sbTTR
EEEFVEGIYK DEKFTEGVYR DEKFVEGVYR EEQFVEGVYR EQQFPAGVYR
61
APL APTPT
VEIDTKSYWK VELDTKSYWK VELDTKSYWK VEFDTSSYWK VEFDTKAYWT
71 ALGISPFHEH ALGISPFHEY TLGISPFHEF GLGLSPFHEY NQSTPFHEVA
81 AEVVFTANDS AEVVFTANDS ADVVFTANDS ADVVFTANDS EVVFDAHPEG
91
LSPYSYSTTA LSPYSYSTTA LSPYSYSTTA LSPFSYSTTA LSPFSYTTTA
111
WEPFASGKTS WEPFASGKTA WEPFASGKTA WQDFATGKTT WTQIATGVTD
GPRRYTIAAL GHRHYTIAAL GHRHYTIAAL GHRHYTIAAL HRHYTILALL
101
HVFRKAADDT KVFKKTADGS KVFKKTSEGS KVFKKAADGT KVSQKTADGG
VVTNPKE VVSNPQN VVSNPQN VVSDPQE VVSSVHE
121
51
RGSPAINVAV RDSPAVDVAV RGSPAVDVAV RGSPAANVAV KGTPAGSVAL
ESGELHGLTT ESGELHGLTT ESGELHGLTT EFGEIHELTT ATGEIHNLIT
PLMVKVLDAV PLMVKVLDAV PLMVKVLDAV PLMVKVLDAV PLMVKILDAV
hTTR rTTR mTTR cTTR sbTTR
GPTGTGESKC GPGGAGESKC GPAGAGESKC VSHGSVDSKC DKHGGSDTRC
Table 1.2 Sequence comparison of human, rat, mouse, chicken, and sea bream TTR for which crystal structures have been determined 1 11 21 31 41
4 V. Cody and A. Wojtczak
1 Mechanisms of Molecular Recognition
1.2
5
TTR Monomer Assembly and Stability
Each monomer of the human TTR homotetramer is defined as a b-barrel built from a single polypeptide chain of 127 amino acids forming eight strands of A-H organized into two anti-parallel b-sheets (Fig. 1.1b). Each barrel contains a short a-helix between strands E and F (Blake et al. 1978). Among the TTR structures in the PDB, majority of the human (h) TTR structures (73/83) crystallize in the orthorhombic space group P21212 with two independent monomers in the asymmetric unit, designated A and B, that form a dimer that assembles into a tetramer (A-A0 , B-B0 ), forming a dimer of dimers by applying the twofold axis along the thyroid hormone-binding channel (Fig. 1.1a) (Blake and Oately 1977). The resulting 222 symmetry in the tetramer results in twofold symmetry for each of the ligandbinding sites formed by pairs of monomers positioned across the channel axis. As TTR ligands reported to date (Fig. 1.2) do not have twofold symmetry, the electron density for the ligand appears as an average of two symmetry-related positions. Thus, for many hTTR complexes, the specific details of ligand binding interactions are obscured by the twofold disorder observed for the ligand orientation. As observed in some TTR ligand complexes, interpretation of the density is further complicated by the presence of alternate binding modes that simultaneously occupy the same binding pocket (Cody et al. 1991; Ghosh et al. 2000; Muziol et al. 2001a, b). A scan of TTR structures deposited in the PDB revealed that other packing arrangements have been observed for human, as well as other species of TTR, which result in an independent tetramer in the asymmetric unit that defines the unique environment for ligand binding. Each of these packing environments results in the assembly of alternating columns of TTR tetramers that may reflect patterns for fibril formation (Fig. 1.3). Interestingly, crystal packing in other space groups has revealed asymmetric units that contain unique dimers, tetramers, and tetramer– dimer combinations. It is of interest to note that the majority of structures from other species (e.g., rat, mouse, fish) tend to crystallize in space groups that have a unique tetramer in the asymmetric unit of the crystal lattice. This variety of packing interactions provides insight into the role of surface residues in the dynamics of monomer assembly. For example, all the structures of rat TTR crystallized in the tetragonal space group P43212 and provided details of the first unique binding environment for T4 in TTR (Wojtczak et al. 2001a; Fig. 1.3b). Similarly, all the structures reported for fish (sea bream) TTR crystallize with a tetramer in the asymmetric unit in the space groups P41 or C2 (Folli et al. 2003; Eneqvist et al. 2004; Fig. 1.3c). Mouse TTR crystallizes with one tetramer and two unique dimers in the asymmetric unit in the space group P3121 (Reixach et al. 2008). On the other hand, chicken TTR crystallizes in the space group P6522 with a unique dimer in the asymmetric unit (Sunde et al. 1996). One example of unusual monomer assembly and TTR binding was observed for the hTTR T4 complex in space group P21. These data showed two independent tetramers in the asymmetric unit. What makes this structure unusual is that the hormone is bound in only one tetramer (Wojtczak et al. 2001b) (Fig. 1.3d).
6
V. Cody and A. Wojtczak
Fig. 1.3 Representative packing diagrams for TTR assemblies: (a) two views of hTTR-T4 P21212 (2rox) packing of the unique homodimers (red) showing lattice packing (green, cyan), (b) two views of rTTR-T4 P43212 (1ie4) packing of the unique tetramer (green, cyan, violet, yellow) showing the lattice packing (green), (c) two views of piscine TTR-T4 P41 (1sn0) packing of the unique tetramer (green, cyan, violet, yellow) showing lattice packing (green), (d) two views of hTTR-T4 P21 (1ict) packing of two unique tetramers (green, cyan, violet, yellow: pink, grey, purple, gold) showing the lattice packing (green). One tetramer has T4 bound in the two binding domains and the other tetramer is empty
The crystal packing is such that there are intermolecular interactions involving the tips of the alpha helices and loops near Arg21, Glu61, and Ser100 of all monomers. The binding of T4 in this structure differs between the two binding domains. In one, T4 is bound in the orientation observed in the orthorhombic P21212 lattice, while in the other, the hormone is bound deeper in the channel, similar to that observed for 30 ,50 -dinitro-N-acetyl-L-thyronine (Wojtczak et al. 1996). The size of the binding channel in the apo tetramer is smaller than that for the T4 bound tetramer. Another unusual monomer assembly was observed for the hTTR diethylstilbestrol (DES) complex (Fig. 1.2) in space group C2, in which there are two sets of unique dimers that form two tetrameric structures (Morais-de-Sa et al. 2004). In this
1 Mechanisms of Molecular Recognition
7
structure, there are two independent conformers of DES bound in the first tetramer and only one DES bound in the second tetramer. This arrangement differs from that observed in the C2 lattice of the Leu55Pro mutant that formed a tetramer and two independent dimers (Sebastiao et al. 1998). In this case, the structure shows that the L55P mutation disrupts the hydrogen bonds between the D and A strands, resulting in different packing contacts. Tetramers of human wild-type TTR or its variants can dissociate at low pH and assemble into amyloid fibrils. Some models for such transformations include the conformational changes of TTR monomers followed by aggregation of such misfolded monomers to build the amyloid fibril (Jiang et al. 2001; Liu et al. 2000; Lai et al. 1996; Lashuel et al. 1998; Palaninathan et al. 2008; Hurshman-Babbes et al. 2008). Recent studies on the denaturation of TTR have addressed the relationship between protein stability and amyloidosis. Characterization of the thermodynamics of dissociation of wild-type human TTR and the disease-associated variants V122I, L55P, V30M, and A25T have revealed a correlation between the quaternary and tertiary structural stability (Hurshman-Babbes et al. 2008). These data showed that the two-step dissociation of tetramers to folded monomers and then to unfolded monomers was more complicated for the more unstable monomers. These stability measures also correlated with the aggressiveness of the clinical manifestations of the amyloid disease. More recent data indicate that long-lived monomers of the non-amyloidogenic T119M variant can be successfully incorporated into heterotetramers that are less amyloidogenic and that these monomers can function as inhibitors of TTR aggregation (Palhano et al. 2009). Other data suggest that TTR amyloid fibrils may assemble from dimers or tetramers of the protein rather than from altered monomers (Ferrao-Gonzales et al. 2000; Eneqvist et al. 2000; Serag et al. 2001, 2002; Olofsson et al. 2001, 2004; Kelly 1998; Hammarstro¨m et al. 2003). On the other hand, the use of small molecule inhibitors has proven to be an efficient way of preventing the formation of TTR-related amyloid fibrils by tetramer stabilization or prevention of conformational changes independent of the particular mechanism of transformation into amyloid filbrils (Johnson et al. 2005, 2008; Miroy et al. 1996; Peterson et al. 1998; Klabunde et al. 2000; Green et al. 2003). Kelly and coworkers observed that TTR can assemble around bivalent inhibitors that span both T4 binding sites of the tetramer simultaneously. The crystal structures of these complexes are isomorphous with the native TTR, although these compounds do not bind to the native TTR, but rather intercept TTR during folding and assembly (Green et al. 2003). Miroy et al. have shown that binding of T4 stabilizes the TTR tetramer and consequently inhibits amyloid formation (Miroy et al. 1996). White and Kelly investigated the amyloid formation from TTR in the presence of holo RBP, T4, and small molecular inhibitors (White and Kelly 2001) and found that T4 significantly inhibited TTR fibril formation in both TTR and its complex with holo RBP. They observed synergism in the RBP and in the small molecule inhibitor actions against the formation of fibrils of the most amyloidogenic L55P TTR variant.
8
1.3
V. Cody and A. Wojtczak
Negative Cooperativity in TTR Binding
Thyroxine (T4), its analogues, and derivatives can be bound to both binding sites inside the central channel of the TTR tetramer. However, binding of the second ligand is much weaker than that of the first molecule. Equilibrium dialysis experiments had shown that TTR binding affinity for T4, measured by the K1 and K2 association constants for the first and the second T4 molecule bound to TTR, differed by a factor of 100 (K1 = 1.0 108 M1 and K2 = 9.5 105 M1). This difference is explained by the negative cooperativity (NC) effect and has been described for several iodinated T4 analogues with similar binding constants (Cheng et al. 1977; Ferguson et al. 1975). However, the fluorescent probe 8-anilino-1-naphtalenesulfonic acid (ANS) revealed a much smaller difference between the first and the second binding constants, with the K1/K2 ratio of 4.5–3.0 (Cheng et al. 1977; Ferguson et al. 1975). An increase in the difference between the two binding constants with the decreasing pH was observed for 3-(4-hydroxy-3,5-diiodophenyl)-propionic acid (DIPA) (Cheng et al. 1977). This change was caused by a decrease of K2, while K1 remained almost unchanged. This observation was explained by the pH dependence of ionization of the DIPA phenolic hydroxyl group. These data suggest that electrostatic interactions may contribute to the NC effect. A general mechanism can be introduced that involves conformational changes upon binding of a ligand to one subunit, which alter the interactions between the TTR subunits and consequently affects the binding affinity of the second ligand molecule. Studies by ultraviolet difference spectroscopy and ultraviolet fluorescence methods (Peterson et al. 1998; Gonzalez and Tapia 1992; Gonzalez 1989; Irace and Edelhoch 1978) have suggested minor conformational changes of the protein or alteration of the H-bond network linking the two sites upon binding of T4 in the first site. The changes are coupled with the reported quenching of the Trp-79 signal (Irace and Edelhoch 1978). Such changes should also induce conformational restrictions on the protein, making the second site more rigid, so that transport of a second hormone molecule into the channel might be obstructed. Analysis of the crystal structure of monoclinic hTTR provided a unique opportunity to compare the structure of apo hTTR and of its T4 complex at the same level of accuracy as the two forms co-exist in one crystal (Wojtczak et al. 2001b) and permitted examination of the conformational changes caused by T4 binding in the hTTR tetramers. The detailed comparison of several structures of native TTR and TTR complexes with small molecule ligands provided insights into the mechanism of ligand-induced conformational changes on ligand binding (Neumann et al. 2001). The comparison was performed for the TTR channel diameter for the apo protein structures and for different complexes. The channel diameter was calculated in each binding site as the Ca–Ca distances between equivalent amino acids from ˚ and larger than the two monomers. Many of these differences were larger than 0.5 A three times the Luzzati error. In all cases, similar trends were found, although the magnitude of the changes varied.
1 Mechanisms of Molecular Recognition
9
A model of the ligand-induced changes in the TTR binding channel was based on the apo TTR and complex structures (Muziol et al. 2001a; Wojtczak et al., 1992 1993, 1996, 2001a, b; Sunde et al. 1996; Kelly and Lansbury 1994; Ciszak et al. 1992; Hamilton et al. 1993; Wojtczak 1997; Neumann et al. 2005). Comparison of the diameter of the TTR channel revealed that the two hormone-binding sites are not identical. The primary site has a slightly larger channel diameter when measured between equivalent amino acids belonging to b-strands D, A, and H, while the diameter for residue pairs 105–109 of strands G is smaller. The secondary binding site has the opposite characteristics and is narrower at both the outer and the inner part of the channel, while the middle of this binding site is wider. The first hormone molecule binds to the site with a larger diameter near the channel entrance (strands D and A). Binding interactions at the primary site of the first hormone molecule cause an increase in the diameter of the primary site measured at strand G (residues 105–109) and slight collapse of the channel entrance (strands D and A) and the inner part of the binding site (strand H) (Fig. 1.1b). The conformational changes caused by the binding of the first ligand molecule in the primary site trigger the changes in the secondary site, transmitted by the relatively rigid antiparallel b-sheet structure of the channel. The second binding site becomes wider in both the outer and the inner parts of the channel (strands D, A, and H), while the middle part (strand G) collapses. The resulting characteristics of the second binding site are similar to that of an empty primary binding site. Binding of the second ligand reverses the alterations described in both the sites, but the amplitude of the changes is relatively small because of the binding interactions that are already formed by the first ligand. Therefore, the collapse of the second site is not as significant as that of the first site, and the second hormone molecule is bound less tightly. The mechanism of negative cooperativity in TTR based on structural data is consistent with fluorescence spectroscopy studies (Irace and Edelhoch 1978), showing that quenching of tryptophanyl emission is caused mostly by the first ligand molecule bound to the hTTR tetramer. Similar results have been obtained with molecular dynamics simulations by Wang et al. (Wang et al. 2007). They investigated the influence of different ligands on the conformational flexibility of the TTR channel by exploring their interactions with human TTR complexes with flufenamic acid (FLU) and 10-(m-trifluoromethylphenyl)-phenoxazine-4,6-dicarboxylate (BPD). The FLU complex revealed a pattern change similar to that reported for the NC effect (Neumann et al. 2001). However, BPD exhibited a different pattern of channel alterations, with both binding sites slightly collapsed. This was attributed to the independent (positive) cooperativity of that ligand. These results were also supported by an all-atom molecular dynamics simulation study associated with tetramer dissociation, which showed that only the dimeric form of TTR can undergo initial fibril formation (Sorensen et al. 2007). More recently, molecular dynamics simulations carried out on wild-type monomer and amyloidogenic variants at neutral and low pH revealed that the D strand dissociated from the b-sheet to expose the A strand, in agreement with the structural data (Steward et al. 2008). These calculations further showed that the T119M protective variant suppressed a-sheet formation by changing
10
V. Cody and A. Wojtczak
the local conformation at this site, in contrast to the other variants that had a negative cooperative conformational change that was influenced by specific variants.
1.4
Ligand Binding Architecture
Biochemical studies revealed that the two thyroid hormone-binding domains of the TTR tetramer, although chemically equivalent, are biochemically different as indicated by the negative cooperativity observed for binding the second site (Cheng et al. 1977). Also, analysis of structural data for TTR complexes with T4 and its analogues showed that there are three pairs of halogen binding pockets (P1-P10 , P2-P20 , and P3-P30 ) in each binding domain (Fig. 1.4a) (Blake and Oately 1977; Cody et al. 1991). The pair of pockets positioned near the center of the TTR tetramer (P3 and its twofold-related P30 ) is defined by the hydroxyl groups of the side chains of Ser112, Ser115, Ser117, and Thr119. The central P2 and P20 pockets are hydrophobic and are formed between the side chains of Leu17, Thr106, Ala108, Leu110, as well as the methylene carbons of the Lys15 side chain. The outermost P1 and P10 pockets near the channel entrance are defined by Glu54, His56, Lys15 and the hydrophobic groups of the Lys15, Ala108, and Thr106 side chains. Structural data for thyroid hormone-binding complexes with hTTR revealed that T4 binds in a ‘‘forward’’ mode, with its 40 -hydroxyl bound deep within the channel
Fig. 1.4 (a) Superposition of 3,30 -diiodothyronine (red) on that of T4 (green) in hTTR dimer A-A0 (green and violet). The halogen binding pockets P1, P2, P3, and their symmetry-related pairs are highlighted. (b) Superposition of T4 in h (green), h in P21 lattice (cyan), piscine (violet), and rat (yellow) TTR complexes. (c) Superposition of T4A in the forward and reverse orientation for h (green) and rat (cyan) TTR. (d) Flavone EMD21388 in forward and reverse binding mode in domain A for hTTR. (e) Two alternative forward binding modes for EMD21388 in domain A for rTTR. (f) Superposition of EMD21388 (green and cyan) with T4A (violet) in hTTR
1 Mechanisms of Molecular Recognition
11
near the tetramer interface and the phenolic ring iodine atoms positioned in the P2 and P30 pockets of the two monomers forming the binding site. The tyrosyl ring iodine atoms occupy the P1 and P10 pockets and the amino side chain that binds near the channel entrance interacts with Lys15 and Glu54. The presence of a twofold symmetry axis along the dimer interface of the P21212 space group found for most hTTR crystal structures requires the ligand to either have twofold symmetry or have a 50% statistical disorder in its binding orientation (Blake and Oately 1977). The orientation of T4 in the second binding site is different, as the phenolic ring iodine atoms occupy both the P3 and P30 pockets, the tyrosyl ring iodine atoms occupy the P1 and P10 pockets, and the two P2 pockets contain water molecules. The observed position of T4 deep in the channel results in the involvement of Ser117 hydroxyl in the binding interactions with the hormone’s 40 -OH group (Fig. 1.4a). The structural data suggest that changes in thyroxine’s position in the binding channel of TTR are coupled with the replacement of water molecules in the binding pockets. This picture is consistent with the presence of strongly bound water molecules stabilizing the TTR tetramer as was shown by the molecular dynamics investigation of TTR binding (Wang et al. 2007; Sorensen et al. 2007). ˚ between phenolic Analysis also revealed a short contact of approximately 3.0 A ring iodines and the Ala109 carbonyl. Similar interactions have been found in the small molecular crystal structures deposited in the Cambridge Structure Database (Cody and Murray-Rust 1984). A survey of TTR structural data revealed significant flexibility in the orientation of many ligands. Comparison of the seven TTR–T4 complexes from human, rat, mouse, and fish TTR revealed that there is variability in the orientation of hormonebinding that depends on the pH of the crystallization conditions and the species of TTR. As illustrated in Fig. 1.4b, the superposition of T4 complexes indicates that the T4 binding mode observed in the fish TTR complex (Eneqvist et al. 2004) differs from that reported for rat TTR and monoclinic human TTR (Wojtczak et al. ˚ closer to the channel entrance 2001a, b). The hormone molecule is bound about 1 A 0 0 and iodine atoms occupy the P2/P2 and P1/P1 pockets. Because of the differences in the orientation of the hormone, no significant interaction between the iodine atoms of T4 and the nucleophilic groups of the protein main chain was observed. The T3 complex of the sea bream TTR (Eneqvist et al. 2004) revealed another binding mode of the hormone. The steric restrictions are smaller than those for T4 and permit the ligand to adopt a slightly different conformation of the T3 ether bridge. The single phenolic iodine atom of T3 is positioned near the channel axis between the pair of P3 pockets, while the hydroxyl group penetrates deep into the P3 pocket and interacts with the main chain polar groups of Leu109 and Leu110. The two tyrosyl iodine atoms are positioned in the P1 and P10 binding pockets. Data for T4 metabolites revealed novel binding orientations. The structure analysis of 3,30 -T2 (3,30 -diiodo-L-thyronine) (Fig. 1.4a) placed the weak binding metabolite deeper in the channel with a shift in orientation that showed the iodine atoms bound in the P3 and P10 pockets (Wojtczak et al. 1992). In the structure of the 30 ,50 -dinitro-N-acetyl-L-thyronine complex, the nitro groups bind in the P3 and P30 pockets, while the 40 -OH forms almost identical H-bonds to Ser117 of two
12
V. Cody and A. Wojtczak
monomers constituting each binding site of TTR (Wojtczak et al. 2001a). Comparison of the H-bond network in the P3 pockets of both binding sites as well as those found at the interface between the two sites revealed that ligand binding disrupts the H-bond link between these sites across the tetramer interface (Wojtczak et al. 2001b). This appears to be an element of the mechanism of signal transmission between the two binding sites of TTR and could be coupled with both the molecular mechanism of the tetramer stabilization and negative cooperativity observed in the binding of the second domain. In both cases, T4 or other tightly binding analogues should prevent the destabilization of the TTR tetramer and its conversion into amyloid fibrils. The tightly binding metabolite, tetraiodothyroacetic acid (T4A) (Fig. 1.2), turned out to be unique in its binding. The structures of its complexes with both rat and human TTRs (Muzioł et al. 2001a; Neumann et al. 2005) revealed that it can bind in both the forward and the reverse orientations (Figs. 1.1b, 1.4c). In the forward mode, the position of the ring system with iodine atoms is similar to that observed for T4. It was found that in the forward mode the iodine atoms are positioned in the P3, P20 , P1, and P10 pockets, while the carboxylic group interacts with Lys15 ammonium group in P1 pocket. In the reverse mode, the iodine atoms are positioned in both the P2/P20 and the P1/P10 pockets and form several polar interactions with the main-chain nucleophilic groups of Ala109 and Leu110. In each binding site, the carboxylic group of T4A bound in the reverse mode is positioned deep in the channel in the P3 pocket. It forms polar interactions with the Ser117 residues of two monomers forming the binding site and with Ser115 of the second binding site across the dimer–dimer interface. Such penetration of the interface between two binding sites is unique for T4A and has not been found for any other T4 derivative in TTR. The reverse mode of T4A binding is exceptional, as it is the first report on the ligand bridging two halves of its binding site and simultaneously penetrating the interface between the two sites (Neumann et al. 2005). This ability seems to be coupled with the replacement of the nonplanar alanyl moiety of T4 or its analogues with relatively smaller and flat carboxylic group capable of forming numerous polar interactions with the hydroxyl groups of amino acids present at the interface between the two thyroid hormone-binding sites of TTR. The lack of bulky groups in TTR ligand inhibitors allows penetration of the narrow space between two binding sites at the tetramer center, as found for the first time for T4A (Wojtczak et al. 2001a; Neumann et al. 2005). The network of hydrophobic interactions is formed between each ligand and the surrounding side chains in the central P2 pockets. All these interactions bridge either two monomeric barrels forming each binding site of TTR or even link two dimers to stabilize the tetramer, as found for T4A. Also, the significance of ligand interactions with Glu54 and Lys15 at the channel entrance cannot be overestimated, as there are reports of the D strand destabilization leading to the TTR transformation into amyloid (Peterson et al. 1998; Armen et al. 2004; Laidman et al. 2006). These conclusions constituted the basis for the design of different groups of ligands that should prevent the TTR transformation into amyloid and might be efficient drugs in TTR-related amyloidosis.
1 Mechanisms of Molecular Recognition
13
Biochemical data also showed that other agents can be competitive inhibitors of hormone binding and showed that the inotropic bipyridine milrinone has an affinity of 59% that of T4 (Davis et al. 1987). Structural data revealed that milrinone was bound with the cyano substituent positioned deep in the P3 pocket, and the carbonyl group formed the H-bond to the Ser117 side chain at the center of the TTR tetramer (Wojtczak et al. 1993). Another cardiac sparing analogue, SKF94901, was designed with liver-sensitive, cardiac-sparing properties, with the potential to reduce cholesterol. Structural data showed that the 3,5-bromine atoms occupy the same positions as the tyrosyl ring iodines of T4, and the 30 -methyl-pyridazinone group interacts in a hydrophobic pocket with contacts to Thr118 and Thr119 (Cody 2005). Plant flavonoids are another class of molecules that was shown to competitively bind to TTR (Cody 2005). Biochemical data revealed that dibromoaurones and bromoflavones are the strongest competitors for T4 binding to TTR. Structural data revealed that the dibromoaurone binds in the forward mode (Ciszak et al. 1992) while the dibromoflavone EMD21388 binds in both the forward and the reverse modes to both human and rat TTR (Muzioł et al. 2001a, b). As illustrated in Figs. 1.4d–f, in the human structure, EMD21388 binds simultaneously in a forward and reverse mode in domain A, while it was observed only in the forward mode in domain B (Cody 2005). This is in contrast to the observation of two alternative binding positions in the forward mode of the bromoflavone in domain A of rat TTR (Muzioł et al. 2001a). The increasing exposure of the halogenated organic compounds, among them polychlorinated phenols, might affect the TTR transport of T4. The structures of 2,4,6-tribromophenol and pentabromophenol complexes of human TTR revealed that these relatively small ligands bind along the channel axis and not as deep as T4 (Ghosh et al. 2000). Both bromophenol ligands were found to bind exclusively in the reverse mode, similar to that reported for T4A, which means the hydroxyl group oriented towards the channel entrance and interacted with Lys15 ammonium group. The core of both ligands participated in the hydrophobic interactions with Lys15, Leu17, Ala108, and Leu110. The results of the TTR-tribromophenol complex structure determination suggest that the outer P1 pockets are preferred for halogen binding (at least for bromine substituents). Their binding interactions are also assisted by the H-bonds formed between the phenolic OH and Lys15 in the reverse mode of binding. It is well known that the halides bind nonspecifically to proteins, interacting with the positively charged ammonium groups or hydroxyl groups. The binding pockets in the TTR channel have been tested for their ability to bind not only halogenated organic compounds but also iodide and chloride ions that have been found to stabilize the tetramers (Hornberg et al. 2005). Such effects were much less pronounced for chloride binding, despite similarity of binding interactions for both ions. These results had shown that the P1 and P3 pockets of each monomeric barrel bind I or Cl ions. One nonspecific site of halogen binding was also found for each monomer between Lys35 and His90 on the surface of the cylindrical cavity of the TTR tetramer.
14
V. Cody and A. Wojtczak
Fig. 1.5 (a) Monomer of TTR highlighting locations of variants (violet) that give rise to amyloid fibril formation. (b) Superposition of the binding orientation of T4A (green), Phenox (gold) of hTTR. (c) Superposition of T4A (yellow), DES (cyan), and DNNAT (gold) in hTTR
1.5
TTR Variants and Amyloid Disease
There are two types of inherited variations in human TTR: those associated with amyloidosis and those associated with hyperthyroxinemia (Cody 1980). TTR amyloidosis, known more commonly as familial amyloidotic polyneuropathy, is an autosomal dominant disorder that results from a mutation in the gene encoding plasma TTR, which results in weaker hormone binding and destabilization of the tetramers. Distinct clinical presentations of the disease have been related to different point mutations (Benson and Kincaid 2007; Westermark et al. 2007). In hyperthyroxinemia, the mutations result in tighter binding of the hormone. To date, more than 100 point mutations at 67 sites within the 127 residue monomer of human TTR have been implicated in FAP disease (Kelly 1998; Hammarstro¨m et al. 2003). As illustrated in Fig. 1.5a, these variants are located throughout the length of the monomer. The crystal structures of 29 variants have been reported for 21 single mutants, six double mutants, and two structures of a triple mutant. Of these, only the T119M and A109T variants are protective, in that they enhance T4 affinity and counter the dissociative effects of V30M, the most prevalent variant found in patients. Structural data for the T4 complex with these variants revealed enhanced monomer–monomer and dimer–dimer contacts and a shift in the water hydrogen bonding network in the binding channel that increases T4 binding (Sebastiao et al. 2001; Steinrauf et al. 1993; Schormann et al. 1996). Data for the V30M variant also revealed a distortion of the b-sheets that causes a distortion of the T4 binding channel that weakens the hormone interactions (Hamilton et al. 1993). The structure of the most amyloidogenic mutant Leu55Pro reveals a disruption of the hydrogen bonds between strands D and A that produces different interface contacts and, as mentioned previously, results in eight monomers that have a different packing arrangement than described for the wild-type human TTR (Fig. 1.3d; Sebastiao et al. 1998; Morais-de-Sa et al. 2006). Structural data for the amyloidogenic variants I84S and I84A were determined at low and neutral pH and revealed significant differences in conformation; at low pH, there was an unwinding
1 Mechanisms of Molecular Recognition
15
of the helix and a change in the loop connecting the helix to strand F that was not observed at neutral pH (Pasquato et al. 2007). The highly amyloidogenic triple mutant G53S/E54D/L55S revealed a new conformation with a novel b-slip conformation, which results in a three-residue shift in strand D that places Leu58 at the position occupied by Leu55. This new conformation impacts the binding interactions with retinol-binding protein. This unique interaction shows the TTR helices to pack as a double helix (Eneqvist et al. 2000). Several hypotheses have been proposed based on monomeric or dimeric amyloidogenic intermediates to explain fibril formation from TTR monomers. One model proposes head-to-tail polymerization of monomeric intermediates (Quintas et al. 1997). Another model is based on the formation of linear aggregates of TTR molecules, each linked by a pair of disulfide bonds involving Cys-10 (Blake and Serpell 1996; Gales et al. 2007). Data for the Y114C variant revealed three forms for the mutant, which suggests that TTR aggregation follows two pathways: amyloid fibril formation or disulfide-bonded polymerization that prevents fibril formation (Eneqvist et al. 2002; Karlsson et al. 2005). Another model is based on the data from two engineered amyloidogenic mutants and requires dimers that are associated by antiparallel organization of the F and H strands of the native protein. This model requires the destabilization of the tetramer prior to fibril formation (Klabunde et al. 2000; Adamski-Werner et al. 2004). Yet another model invokes proteolytic cleavage as the initiation step in fibril formation (Pasquato et al. 2007). Although the mechanism of tetramer stabilization is still unclear, it has been shown that ligand binding stabilizes tetramer formation in all variant human TTRs. Therefore, one means of intervention for disease treatment could involve binding of non-thyromimetic analogues that can stabilize the TTR tetramer and possibly delay the onset of fibril formation. To this end, numerous compounds have been screened (Klabunde et al. 2000; Adamski-Werner et al. 2004; Oza et al. 2002; Petrassi et al. 2000, 2005). Structural data for the TTR complexes with flufenamic acid and diflunisal show that they mediate inter-subunit hydrophobic interactions and inter-subunit hydrogen bonds that stabilize the normal tetrameric fold (Klabunde et al. 2000; Adamski-Werner et al. 2004). Data for the TTR complex with another analgesic analogue, VCP-6, that has 628% the affinity of T4, show that the molecule forms strong hydrogen bond interactions of its 2-carboxylate with Lys-15 and with the 3,5-dichloro atoms in symmetric hydrophobic pockets near the tetramer interface (Cody 2005). These results suggest that the strategy of stabilization by strong competitors may prove fruitful. Optimization of the inhibitor molecules was performed with the ring system and the bridging linker (Johnson et al. 2008). One aryl ring usually has a polar substituent, capable of interacting with Ser117 or Thr119 at the tetramer center or with Lys15 and Glu54 in P1 pockets. Several groups of ligands were design to investigate the components of the molecule responsible for efficient inhibition. The important group among those investigated was the nonsteroidal anti-inflammatory drugs (NSAIDs) and their derivatives (Klabunde et al. 2000), which increased the kinetic barrier of TTR tetramer dissociation (Oza et al. 2002). These competitors possessed polar interactions with Lys15 in the P1 pockets, while the hydrophobic core was
16
V. Cody and A. Wojtczak
involved in the interactions with amino acids constituting the central P2 pockets. In particular, the commonly used drugs diclofenac and flurbiprofen were competitive based on their ability to form the polar interactions at the channel entrance and fill the P3 pockets with their hydrophobic ring moieties. The carboxylate of diclofenac that binds in the P3 pockets corresponds to the reverse mode of binding found for T4A (Muziol et al. 2001b; Neumann et al. 2005). Diclofenac and diflunisal were selected for optimization as the promising inhibitors of amyloid fibril formation (Adamski-Werner et al. 2004; Oza et al. 2002) against wild-type TTR (senile systemic amyloidoses; SSA) and V30M and L55P (familial amyloid polyneuropathy and familial amyloidotic cardiomyopathy, respectively). Compounds derived from diclofenac showed binding in the reverse mode analogous to that of diclofenac (Oza et al. 2002). The molecular architecture of these compounds is analogous to the structure of T4A. Diflunisal analogs are linear molecules derived from biphenyl. Investigation of these compounds suggested that the para-carboxylic group is required for high affinity, because of its interactions with Lys15 or Ser117 in the forward and reverse binding, respectively, while the hydroxyl is not crucial for inhibition (Oza et al. 2002). The presence of halogen substituents is required, but their exact positions are not vital for the efficiency of inhibition, probably due to the alternative positions able to be adopted in the halogen binding pockets. The series of N-phenyl phenoxazine derivatives has been designed to bind simultaneously to the pockets across the TTR channel axis exploiting its twofold symmetry (Petrassi et al. 2000). These compounds proved to be good FAP inhibitors. The phenoxazine moiety was complementary to the space available at the entrance to the TTR channel (P1 pockets) (Fig. 1.5b). Ligands substituted with two carboxylic groups in positions 4 and 6 of the ring system increased the binding affinity by interacting with the symmetry-related pair of Lys15 residues. The metasubstituted phenyl moieties were positioned in the inner part of the binding site. The m-CF3-substituted phenyl filled the innermost P3 pocket, similar to what was found for flufenamic acid (Klabunde et al. 2000). Promising dibenzofuran inhibitors of TTR amyloidogenesis were also investigated for a kinetic stabilization of the TTR native state (Petrassi et al. 2000; 2005). These compounds presumably bind with the ring system positioned in two P1 pockets analogous to their parent compound investigated earlier (Klabunde et al. 2000). The C1-substituted compounds are excellent inhibitors of wild-type TTR acid-mediated fibril formation and revealed high binding selectivity. Their molecular architecture also includes the two polar groups interacting with the pair of Lys15 at the P1 pockets and one or two fluorine/chlorine substituents of C1-phenyl to be bound in the inner pockets.
1.6
Summary
This review of TTR structures was based on the three-dimensional coordinates reported in the PDB (October 2008) for more than 100 listings representing X-ray crystallography from five species and one solution NMR data from a TTR fragment.
1 Mechanisms of Molecular Recognition
17
Structures from human TTR have been studied the most, as they represent direct concern for treatment of genetic disorders resulting in amyloid fibril formation. Despite the highly conserved nature of the ligand binding sites, TTR can bind highly flexible ligands that can adopt alternative conformations as shown by the positional disorder reflecting different occupancies. The observation of ligandinduced conformational changes between the two domains has provided insight into the mechanism of negative cooperativity in the binding affinity of the second ligand. In addition, the fact that a ligand can bind in multiple orientations, for example, forward or reverse, as well as at different depths within the channel, has provided insight into the design of new ligands that target interactions with specific residues, in particular those variants resulting in FAP that could stabilize TTR to prevent amyloid fibril formation.
Acknowledgement
We thank Melda Tugac for her help with the schematic figures.
References Adamski-Werner SL, Palaninathan SK, Sacchettini JC, Kelly JW (2004) Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis. J. Med. Chem. 47:355–374 Armen RS, DeMarco ML, Alonso DOV, Daggett V (2004) Pauling and Cory’s alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease. Proc. Natl. Acad. Sci. USA 101:11622–11627 Benson MD, Kincaid JC (2007) The molecular biology and clinical features of amylobid neuropathy. Muscle Nerve 36:411–423 Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res. 28:235–242 Blake CCF, Geisow MJ, Oatley SJ, Rerat C, Rerat B (1978) Structure of prealbumin: secondary, ´˚ tertiary and quaternary interactions determined by fourier refinement at 1.8A . J. Mol. Biol. 121:339–356 Blake CCF, Oately SJ (1977) Protein-DNA and protein-hormone interactions in prealbumin: a model of the thyroid hormone nuclear receptor? Nature 268:115–129 Blake CCF, Serpell L (1996) Synchrotron X-ray studies suggest that the core of the transthyretin fibril is a continuous b-sheet helix. Structure 4:989–998 Cheng S-Y, Pages RA, Saroff HA, Edelhock H, Robbins J (1977) Analysis of thyroid hormone binding to human serum prealbumin by 8-anilinonapthalene-1-sulfonate fluorescence. Biochemistry 16:3707–3713 ˚ resolution of human Ciszak E, Luft J, Cody V (1992) Crystal structure determination at 2.3-A transthyretin-30 ,50 -dibromo-20 ,4,40 ,6- tetrahydroxyaurone complex. Proc. Natl. Acad. Sci. USA. 89:6644–6648 Cody V (1980) Thyroid–hormone interactions: molecular conformation, protein binding, and hormone action. Endocr. Rev. 1:140–166 Cody V (2002) Mechanisms of molecular recognition: crystal structure analysis of human and rat transthyretin inhibitor complexes. Clin. Chem. Lab. Med. 40:1237–1243
18
V. Cody and A. Wojtczak
Cody V (2005) Thyroid hormone structure-function relationships. In: Braverman LE and Utiger RD (eds) Werner & Ingbar’s The Thyroid: a fundamental and clinical text, 9th edn. Lippincott Williams & Wilkins, Philadelphia, pp 151–157 Cody V, Murray-Rust P (1984) Iodine . . . X(O,N,S) intermolecular contacts: models of thyroid hormone-protein binding interactions using information from the Cambridge Crystallographic Data Files. J. Mol. Struct. 112:189–199 Cody V, Wojtczak A, Ciszak E, Luft JR (1991) Differences in inhibitor and stubstrate binding in transthyretin crystal complexes. In: Gordon A, Gross J, Hennemann G (eds) Progress in thyroid research, Balema, Rotterdam, pp. 793–796 Davis PJ, Cody V, Davis FB, Warnick PR, Schoenl M, Edwards L (1987) Milrinone, a noniodinated bipyridine, competes with thyroid hormone for binding sites on human serum prealbumin (TBPA). Biochem. Pharmacol. 36:3635–3640 Eneqvist T, Andersson K, Olofsson A, Lundgren E, Sauer-Eriksson AE (2000) The b-slip: a novel concept in transthyretin amyloidosis. Mol. Cell 6:1207–1218 Eneqvist T, Lundberg E, Karlsson A, Huang S, Santos CRA, Power DM, Sauer-Eriksson AE (2004) High resolution crystal structures of piscine transthyretin reveal different binding modes for triiodothyronine and thyroxine. J. Biol. Chem. 279:26411–26416 Eneqvist T, Olofsson A, Ando Y, Miyakawa T, Katsuragi S, Jass J, Lundgren E, Sauer-Eriksson AE (2002) Disulfide-bond formation in the transthyretin mutant Y114C prevents amyloid fibril formation in vivo and in vitro. Biochemistry 41:13143–13151 Ferguson RN, Edeldoch H, Saroff HA, Robbins J (1975) Negative cooperativity in the binding of thyroxine to human serum transthyretin. Biochemistry 14:282–289 Ferrao-Gonzales AD, Souto SO, Silva JL, Foguel D (2000) The preaggregated state of an amyloidogenic protein: hydrostatic pressure converts native transthyretin into the amyloidogenic state. Proc. Natl. Acad. Sci. USA. 97:6445–6450 Folli C, Pasquato N, Ramazzina I, Battistutta R, Zanotti G, Berni R (2003) Distinctive binding and structural properties of piscine transthyretin. FEBS Lett. 555:279–284 Gales L, Saraiva MJ, Damas AM (2007) Structural basis for the protective effect of sulfite against transthyretin amyloid formation. Biochim. Biophys. Acta 1774:59–61 Ghosh M, Meerts IATM, Cook A, Bergman A, Brouwer A, Johnson LN (2000) Structure of human transthyretin complexed with bromophenols: a new mode of binding. Acta Cryst. D56:1085–1095 Gonzalez G (1989) Fluorescent derivative of cysteine-10 reveals thyroxine-dependent conformational modifications in human serum prealbumin. Arch. Biochem. Biophys. 271:200–205 Gonzalez G, Tapia G (1992) Fluorescence study of the thyroxine-dependent conformational changes in human serum transthyretin. FEBS Lett. 297:253–256 Green NS, Palaninathan SK, Sacchettini JC, Kelly JW (2003) Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization. J. Am. Chem. Soc. 125:13404–13414 Hamilton JA, Steinrauf LK, Braden BC, Liepniks J, Benson MD, Holmgren G, Sandgren O, Steen L (1993) The X-ray crystal structure refinements of normal human transthyretin and the amyloi˚ resolution. J. Biol. Chem. 268:2416–2424 dogenic Val30Met variant to 1.7 A Hammarstro¨m P, Wiseman RL, Powers ET, Kelly JW (2003) Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science 299:713–716 Ho¨rnberg A, Hultdin UW, Olofsson A, Sauer-Eriksson AE (2005) The effect of iodide and chloride on transthyretin structure and stability. Biochemistry 44:9290–9299 Hurshman-Babbes AR, Powers ET, Kelly JW (2008) Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis. Biochemistry 47:6969–6984. Irace G, Edelhoch H (1978) Thyroxine-induced conformational changes in prealbumin. Biochemistry 17:5729–5733 Jiang X, Smith CS, Petrassi HM, Hammarstrom P, White JT, Sacchettini JC, Kelly JW (2001) An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry 40:11442–11452
1 Mechanisms of Molecular Recognition
19
Johnson SM, Connelly S, Wilson IA, Kelly JW (2008) Toward optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies. J. Med. Chem. 51:6348–6358 Johnson SM, Wiseman RL, Sekijima Y, Green NS, Adamski-Werner SL, Kelly JW (2005) Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses. Acc. Chem. Res. 38:911–921 Karlsson A, Oloffson A, Eneqvist T, Sauer-Eriksson AE (2005) Cys-114-linked dimers of transthyretin are compatible with amyloid formation. Biochemistry 44:13063–13070 Kelly JW (1998) The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struc. Biol. 8:101–106 Kelly JW, Lansbury PTJ (1994) A chemical approach to elucidate the mechanism of transthyretin and beta-protein amyloid fibril formation. Amyloid 1:186–205 Klabunde T, Petrassi HM, Oza VB, Raman P, Kelly JW, Sacchettini JC (2000) Rational design of potent human transthyretin amyloid disease inhibitors. Nat. Struct. Biol. 7:312–321 Lai Z, Colon W, Kelly JW (1996) The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35:6470–6482 Laidman J, Forse GJ, Todd O, Yeates TO (2006) Conformational change and assembly through edge beta strands in transthyretin and other amyloid proteins. Acc. Chem. Res. 39:576–583 Lashuel HA, Lai Z, Kelly JW (1998) Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation. Biochemistry 37:17851–17864 Liu K, Cho HS, Lashuel HA, Kelly JW, Wemmer DE (2000) A glimpse of a possible amyloidogenic intermediate of transthyretin. Nat. Struct. Biol. 7:754–757 Miroy GJ, Lai Z, Lashuel HA, Peterson SA, Strang C, Kelly JW (1996) Inhibiting transthyretin amyloid fibril formation via protein stabilization. Proc. Natl. Acad. Sci. USA. 93:15051–15056 Morais-de-Sa E, Neto-Silva RM, Bereira PJB, Saraiva MJ, Damas AM (2006) The binding of 2,4dinitrophenol to wild-type and amyloidogenic transthyretin. Acta Cryst. D62:512–519 Morais-de-Sa E, Pereira PJB, Saraiva MJ, Damas AM (2004) The crystal structure of transthyretin in complex with diethylstilbestrol. J. Biol. Chem. 279:53483–53490 Muzioł T, Cody V, Luft JR, Pangborn W, Wojtczak A (2001a) Complex of rat transthyretin with ´˚ tetraiodothyroacetic acid refined at 2.1 and 1.8A resolution. Acta Biochim. Polonica 48:877–884 Muzioł T, Cody V, Wojtczak A (2001b) Comparison of binding interactions of dibromoflavonoids with transthyretin. Acta Biochim. Polonica 48:885–892 Neumann P, Cody V, Wojtczak A (2001) Structural basis of negative cooperativity in transthyretin. Acta Biochim. Polonica 48:867–875 Neumann P, Cody V, Wojtczak A (2005) Ligand binding at the transthyretin dimer-dimer ˚ resolution. Acta interface: crystal structure of the transthyretin-T4Ac complex at 2.2 A Cryst. D61:1313–1319 Olofsson A, Ippel HJ, Baranov V, Horstedt P, Wijmenga S, Lundgren E (2001) Capture of a dimeric intermediate during transthyretin amyloid formation. J. Biol. Chem. 276:39592–39599 Olofsson A, Ippel JH, Wijmenga SS, Lundgren E, Ohman A (2004) Probing solvent accessibility of transthyretin amyloid by solution NMR spectroscopy. J. Biol. Chem. 279:5699–5707 Oza VB, Smith C, Raman P, Koepf EK, Lashuel HA, Petrassi HM, Chiang KP, Powers ET, Sachettinni J, Kelly JW (2002) Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors. J. Med. Chem. 45:321–332 Palaninathan SK, Mohamedmohaideen NN, Snee QC, Kelly JW, Sacchettini JC (2008) Structural insight into pH-induced conformational changes within the native human transthyretin tetramer. J. Mol. Biol. 382:1157–1167 Palhano FL, Leme LP, Gusnardo RG, Foguel D (2009) Trapping the monomer of a non-amyloidogenic variant of transthyretin: exploring its possible use as a therapeutic strategy against transthyretin amyloidogenic diseases. J. Biol. Chem. 284:1443–1453 Pasquato N, Berni R, Folli C, Alfieri B, Cendron L, Zanotti G (2007) Acidic pH-induced conformational changes in amyloidogenic mutant transthyretin. J. Mol. Biol. 366:711–719
20
V. Cody and A. Wojtczak
Peterson SA, Klabunde T, Lashuel HA, Purkey H, Sacchettini JC, Kelly JW (1998) Inhibiting transthyretin conformational changes that lead to amyloid fibril formation. Proc. Natl. Acad. Sci. USA. 95:12956–12960 Petrassi HM, Johnson SM, Purkey H, Chiang KP, Walkup T, Jiang X, Powers ET, Kelly JW (2005) Potent and selective structure-based dibenzofuran inhibitors of transthyretin amyloidogenesis: kinetic stabilization of the native state. J. Am. Chem. Soc. 127:6662–6671 Petrassi HM, Klabunde T, Sacchettini JC, Kelly JW (2000) Structure-based design of N-phenyl phenoxazine transthyretin amyloid fibril inhibitors. J. Am. Chem. Soc. 122:2178–2192 Quintas A, Saraiva MJM, Brito RMM (1997) The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution. FEBS Lett. 418:297–300 Reixach N, Foss TR, Santelli E, Pascual J, Kelly JW, Buxbaum JN (2008) Human-murine transthyretin heterotetramers are kinetically stable and non-amyloidogenic. J. Biol. Chem. 283:2098–2107 Robbins J (1996) Thyroid hormone transport proteins and the physiology of hormone binding. In: Braverman LE, Utidger RD (eds) Werner & Ingbar’s The Thyroid: a fundamental and clinical text, 7th edn. Lippincott Williams & Wilkins, Philadelphia, pp. 96–110 Schormann N, Murrell JR, Benson MD (1996) Tertiary structures of amyloidogenic and non-amyloidogenic transthyretin variants: new model for amyloid fibril formation. Amyloid 5:175–187 Sebastiao MP, Lamzin V, Saraiva MJ, Damas AM (2001) Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution. J. Mol. Biol. 306:733–744 Sebastiao MP, Saraiva MJ, Damas AM (1998) The crystal structure of amyloidogenic Leu55Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils. J. Biol. Chem. 273:24715–24722 Serag AA, Altenbach C, Gingery M, Hubbell WL, Yeates TO (2001) Identification of a subunit interface in transthyretin amyloid fibrils: evidence for self-assembly from oligomeric building blocks. Biochemistry 40:9089–9096 Serag AA, Altenbach C, Gingery M, Hubbell WL, Yeates TO (2002) Arrangement of subunits and ordering of beta-strands in an amyloid sheet. Nat. Struct. Biol. 9:734–739 Steinrauf LK, Hamilton JA, Braden BC, Murrell JR, Bensen MD (1993) X-ray crystal structure of the Ala-109-Thr variant of human transthyretin which produces euthyroid hyperthyroxinemia. J. Biol. Chem. 268:2425–2430 Steward RE, Armen RS, Daggett V (2008) Different disease-causing mutations in transthyretin trigger the same conformational conversion. Prot. Eng. Design Selec. 21:187–195 Sorensen J, Hamelberg D, Schiott B, McCammon JA (2007) Comparative MD analysis of the stability of transthyretin providing insight into the fibrillation mechanism. Biopolymers 86:73–82 Sunde M, Richardson SJ, Chang L, Pettersson TM, Schreiber G, Blake CCF (1996) The Crystal structure of transthyretin from chicken. Eur. J. Biochem. 236:491–499 Wang H, Tang Y, Ming Lei M (2007) Models for binding cooperativities of inhibitors with transthyretin. Arch. Biochem. Biophys. 466:85–97 Westermark P, Benson MD, Buxbaum JN, Cohen AS, Brangione B, Ikeda S-I, Masters CL, Merlini G, Saraiva MJ, Sipe JD (2007) A primer of amyloid nonmenclature. Amyloid 14:179–1834 White JT, Kelly JW (2001) Support for the multigenic hypothesis of amyloidosis: the binding stoichiometry of retinol-binding protein, vitamin A, and thyroid hormone influences transthyretin amyloidogenicity in vitro. Proc. Natl. Acad. Sci. USA 98:13019–13024 ˚ resolution: First report on a Wojtczak A (1997) Crystal structure of rat transthyretin at 2.5 A unique tetrameric structure. Acta Biochim. Polon. 44:505–518 Wojtczak A, Luft JR, Cody V (1992) Mechanism of molecular recognition: Structural aspects of 3, 30 -diiodo-L-thyronine binding to human serum transthyretin. J. Biol. Chem. 267:353–357
1 Mechanisms of Molecular Recognition
21
Wojtczak A, Luft JR, Cody V (1993) Structural aspects of inotropic bipyridine binding: crystal ˚ of the human serum transthyretin–milrinone complex. J. Biol. structure determination to 1.9 A Chem. 268:6202–6206 Wojtczak A, Cody V, Luft JR, Pangborn W (1996) Structures of human transthyretin complexed ˚´ resolution. ˚´ resolution and 30 ,50 -dinitro-N-acetyl-L-thyronine at 2.2A with thyroxine at 2.0A Acta Cryst. D52:758–765 Wojtczak A, Cody V, Luft J, Pangborn W (2001a) Structure of rat transthyretin (rTTR) complex ´˚ with thyroxine at 2.5A resolution: first non-biased insight into thyroxine binding reveals different hormone orientation in two binding sites. Acta Cryst. D57:1061–1070 Wojtczak A, Neumann P, Cody V (2001b) Structure of a new polymorphic monoclinic form ˚´ resolution reveals a mixed complex between unliganded and of human transthyretin at 3A T4-bound tetramers of TTR. Acta Crsyt. B57:957–967
Chapter 2
TTR Synthesis During Development and Evolution: What the Marsupials Revealed Samantha J. Richardson
Abstract Many of our current concepts about biological systems are based on the data from eutherian mammals. Taking the comparative approach gives a broader evolutionary perspective. By analysing the situation also in fish, amphibians, reptiles, birds, monotremes and marsupials, we are forced to consider the differences in physiology (e.g. poikilothermic vs. endothermic, aquatic vs. terrestrial, carnivore vs. herbivore vs. omnivore, modes of reproduction and development, etc.) and we are forced to consider the selection pressures involved. This results in a greater understanding of the biological system in question. In the case of transthyretin (TTR), investigation into tissue specificity of synthesis during both development and evolution revealed that not only are the mammalian TTRs the exception (all other TTRs preferentially bind T3, not T4), but that TTR synthesis appears spatially and temporally where greater thyroid hormone (TH) distribution is required. In the case of TTR evolution, the study of marsupials provided several ‘missing links’, even regarding the structure–function relationships. Thus, we can now see a sequential change in the structure of the N-terminal regions of the TTR subunits, sequential change in affinity of TTRs for THs, and a sequential increase in affinity of TTR for THs from amphibians to mammals. Studying marsupials also allowed us to understand the evolution of TTR synthesis during ontogeny. By elucidating the evolutionary history of a protein in terms of its structure, function and sites of synthesis and timing of gene expression, this allowed us to obtain a comprehensive picture of its biological roles. Keywords Evolution, Eutherians, Marsupials, Monotremes, Birds, Reptiles, Amphibians, Fish, Thyroid hormones, Development, Blood, Cerebrospinal fluid, Liver, Choroid plexus, Gene expression, Albumin, Thyroxine-binding globulin, Amyloid
S.J. Richardson School of Medical Sciences, RMIT University, PO box 71, Bundoora, 3083, Victoria, Australia e-mail:
[email protected]
S.J. Richardson and V. Cody (eds.), Recent Advances in Transthyretin Evolution, Structure and Biological Functions, DOI: 10.1007/978‐3‐642‐00646‐3_2, # Springer‐Verlag Berlin Heidelberg 2009
23
24
2.1 2.1.1
S.J. Richardson
Marsupials and Other Mammals Eutherians, Marsupials and Monotremes
Mammals (Class Mammalia) can be divided into three subclasses: Eutheria (often erroneously referred to as ‘placental mammals’), Metatheria (marsupials) and Prototheria (monotremes). In brief, all mammals suckle their young. Eutherian mammals (e.g. humans, mice, bats, whales) are the predominant mammalian subclass and are found on all continents. Marsupials (e.g. kangaroos, koalas, opossums) are born at a very early stage in development compared with other mammals; some females have pouches where the young live for most of their development, and there is no corpus callosum in the brain (only the anterior commissure joins the two hemispheres). Marsupials live in the United States and in Australia. Monotremes (echidnas, platypus and zaglossus) are mammals that lay eggs, and live in Australia.
2.1.2
Evolutionary History of the Marsupials
The mammalian lineage probably diverged from the avian/reptilian lineage around 300 million years ago (MYA). The monotremes probably diverged from the marsupial/eutherian lineage about 200 MYA (van Rheede et al. 2006), and the marsupials probably diverged from the eutherian lineage about 90 MYA (Meredith et al. 2007) (Fig. 2.1). 400
300
200
100
0 Eutherians
+
Diprotodont Marsupials Polyprotodont Marsupials
+ Stem Reptiles LD
++
Monotremes
?LD
Reptiles
LD
Birds
+
400
300
200
100
LD
Amphibians
LD
Fish 0
MYA
Fig. 2.1 Evolutionary/developmental tree for hepatic and choroid plexus synthesis of TTR. Double plus, onset of TTR synthesis in the choroid plexus; LD, hepatic TTR synthesis during development only; Plus, hepatic TTR synthesis throughout life; MYA, million years ago (from Richardson et al. 2005)
2 TTR Synthesis During Development and Evolution: What the Marsupials Revealed
25
Today, marsupials are found in North America, South America and Australia. There are many classification systems for marsupials (see Meredith et al. 2007 and references therein). One of the simplest (but not necessarily most accurate) classifications of marsupials is based on dentition. This classification divides marsupials into two Orders: Polyprotodonta and Diprotodonta. Diprotodont marsupials (e.g. kangaroos and wombats) have two procumbent incisors in the lower jaw. The upper jaw has the normal number of incisors facing in the usual direction. Coupled with diastema and well-developed premolars and molars, this tooth arrangement makes them very effective herbivores. Polyprotodont marsupials (e.g. Tasmanian devils and dunnarts) have many teeth on their upper and lower jaws and are carnivores or omnivores. The polyprotodont/diprotodont classification is used in this review because it fits exactly with patterns of hepatic transthyretin (TTR) synthesis in marsupials. According to the fossil record, marsupials originated in Laurasia (now North America) and were polyprotodont (Tyndale-Biscoe 1973). They then migrated to what is now South America and those in the north died out. From South America, some marsupials migrated back to (what is now) North America and others migrated across Gondwanaland. About 45 million years ago, Gondwanaland separated into South America, Antarctica and Australia (Talent 1984). Fossils of marsupials have been found in Antarctica, e.g. on Seymour Island (Woodburne and Zinsmeister 1982), and some marsupials were isolated on the Australian continent after the land masses drifted too far apart for terrestrial animals to traverse. Soon after Gondwanaland broke up, there was a radiation of marsupials in Australia, which included the divergence of diprotodont marsupials from polyprotodont marsupials (Tyndale-Biscoe 1973; Fig. 2.2).
N.A. 1
Fig. 2.2 Migration of marsupials during evolution. Landmasses currently known as North America (N.A.), South America (S. A.), Africa (Afr), India (Ind), Antarctica (Ant) and Australia (Aus) are shown as they were in relation to each other about 150 million years ago. Major marsupial migration patterns are indicated by arrows: (1) North America to South America; (2) South America to North America and South America via Antarctica to Australia; (3) marsupial radiation throughout Australia (from Richardson 2007)
2
Afr
S.A.
Ind Aus Ant 3
26
2.1.3
S.J. Richardson
Development of Marsupials
Marsupials are born at a much earlier developmental stage than eutherian mammals. For example, the South American grey short-tailed opossum Monodelphis domestica is born 14 days after conception. At birth, it is comparable to an E14 rat embryo or 6 week human embryo with respect to brain development (Saunders et al. 1989). Many marsupials have a pouch in which the new born live during the time they are attached to the teat. The majority of differentiation and organ development occurs during pouch life (Tyndale-Biscoe and Janssens 1988). At the time of pouch exit, many marsupials are at a similar developmental stage to that of many eutherian species at the time of birth (Setchell 1974; TyndaleBiscoe and Janssens 1988). Thus, much of the development that occurs in utero for eutherians occurs postnatally in marsupials. Therefore, marsupials are an ideal model for developmental studies as the young are easily accessible and the mothers do not need to be sacrificed.
2.2
TTR as a Thyroid Hormone Distributor Protein (THDP)
The major thyroid hormone distributor proteins (THDPs) in human blood are albumin, TTR and thyroxine-binding globulin (TBG). THs are extremely lipophilic, having a partition coefficient of 20,000:1 between lipid and aqueous environments (Dickson et al. 1987). In human blood, 99.97% of T4 and 99.70% of T3 are bound to the THDPs (Mendel et al. 1989). Of these, TBG has the highest affinity for T4 and T3 (1.0 1010 M1 and 4.6 108 M1, respectively), TTR has intermediate affinity (7.0 107 M1 and 1.4 107 M1, respectively) and albumin has the lowest affinity (7.0 105 M1 and 1.0 105 M1, respectively). Together, these three THDPs form a buffering network for free T4 in blood, which could help to protect against hypothyroidism (abnormally low levels of free TH in blood) or hyperthyroidism (abnormally high levels of free TH in blood) (Schreiber and Richardson 1997). The older literature and some modern text books (e.g. Alberts et al. 2002) state that the role of THDPs in blood is to overcome low TH solubility. However, the concentration of free T4 in human blood is about 25 pM and the maximum solubility of T4 in physiological saline is 2.3 mM, that is about 100,000 times the concentration of free T4 (Schreiber and Richardson 1997). Therefore, THDPs must play a role other than to aid the solubility of THs in the blood and cerebrospinal fluid (CSF).
2.2.1
The Role of THDPs in Blood
The function of THDPs in the blood was demonstrated using perfused rat livers. When the livers were perfused with medium containing 125I-T4 in the absence of THDPs, all the 125I-T4 partitioned into the first cells it came into contact with.
2 TTR Synthesis During Development and Evolution: What the Marsupials Revealed
*** Mean of Tunel positive cells per section
untreated PTU treated
15
Fig. 2.3 Absence of TTR in the CSF of adult mice results in a hypothyroid phenotype in the subventricular zone of the brain. Wildtype mice (left bars) and TTR null (TTR KO; right bars) mice were either untreated (open bars) or treated with propylthiouracil (PTU) to induce hypothyroidism (filled bars). Untreated TTR null mice had the same level of apoptosis in neural stem cells and progenitor cells as the hypothyroid wildtype mice. Means S.E.M. ***p < 0.001 (from Richardson et al. 2007)
27
10
5
0 Wild–type
TTR KO
When the livers were perfused with medium containing 125I-T4 and THDPs, the 125 I-T4 was evenly distributed throughout the liver lobule and was present in the perfusate (Mendel et al. 1987).
2.2.2
TTR as a THDP in the CSF
The role of TTR as a THDP in the CSF was demonstrated by the analysis of adult TTR null mice. Compared to wild-type mice, TTR null mice were found to have reduced delivery of TH to the stem cells and progenitor cells in the subventricular zone (SVZ) of their brains. The main fate of stem and progenitor cells in the SVZ of adult mammals is apoptosis. The cell cycle of these cells is regulated by TH and apoptosis is reduced during hypothyroidism (Lemkine et al. 2005). The level of apoptosis in the SVZ of TTR null mice was equivalent to that in the SVZ of hypothyroid wild-type mice (Richardson et al. 2007; Fig. 2.3). Thus, the function of THDPs is to ensure an even distribution of TH throughout tissues and to maintain a circulating TH pool of sufficient size in the blood and CSF.
2.2.3
THDPs Differ Between Species: Mammalian TTR is the Exception, not the Rule
In mammals, TTR, albumin and TBG have higher affinity for T4 than T3, and as the concentration of T4 is higher than that of T3 in mammalian blood, T4 is often referred to as the ‘transport form’ of TH. As T3 has higher affinity for the TH
28
S.J. Richardson
nuclear receptors than T4 (Sandler et al. 2004), T3 is often referred to as the ‘active form’ of TH. However, fish, amphibians, reptiles and birds do not have TBG in their blood (see below) and TTR is the major THDP in their blood. Moreover, TTR in fish, amphibians, reptiles and birds has higher affinity for T3 than for T4 (see below). Thus, mammalian TTRs are the exception in binding T4 rather than T3! The function of TTR has changed from binding T3 to binding T4. This is one example of the importance of studying species other than mammals in order to understand the function of a protein. This raises the question as to why TTR changed from distributing T3 to distributing T4.
2.3 2.3.1
Sites of TTR Synthesis in Eutherian Mammals Liver
As with all plasma proteins, TTR is synthesised by the liver and secreted into the blood (see Schreiber 1987). In the blood, TTR binds TH and up to two molecules of retinol-binding protein/retinol complex (for more details see chapters ‘The Transthyretin–Retinol-Binding Protein Complex’ and ‘TTR and RBP: Implications in Fish Physiology’). Thus, hepatic TTR is involved in the distribution of THs and retinol throughout the body via the blood.
2.3.2
Choroid Plexus
TTR is synthesised by the choroid plexus (Dickson et al. 1987) epithelial cells (Stauder et al. 1986) and secreted into the CSF (Schreiber et al. 1990). In rats, this TTR is involved in the movement of T4 (but not T3) from the blood into and within the brain (Chanoine et al. 1992; Dickson et al. 1987; Southwell et al. 1993); for review see Richardson (2005). TTR in the CSF and interstitial fluid is involved in the delivery of TH to stem cells and progenitor cells within the brain (Richardson et al. 2007), which require TH for regulation of cell cycle (Lemkine et al. 2005).
2.3.3
Visceral Yolk Sac and Placenta
Synthesis of TTR and retinol-binding protein (RBP) in the visceral yolk sac (VYS) of rats and placenta of humans is involved in the transport of TH and retinol from the maternal circulation to the developing fetus (McKinnon et al. 2005; Sklan and Ross 1987; Soprano et al. 1986). In rats, TTR and RBP are secreted across the basolateral membrane towards the fetal circulation and could be the source of plasma proteins for the fetus prior to functioning of the fetal liver (Thomas et al. 1990).
2 TTR Synthesis During Development and Evolution: What the Marsupials Revealed
2.3.4
29
Retinal and Ciliary Pigment Epithelia
TTR synthesised by the retinal pigment epithelium (RPE) (Cavallaro et al. 1990) is secreted across the apical membrane into the extracellular matrix together with RBP (Ong et al. 1994). This TTR and RBP is involved in the delivery of retinol to Mu¨ller and amacrine cells (Ong et al. 1994), where it is converted to retinal, which is required for photoreceptor function (Bridges et al. 1984). More recently, TTR synthesis by the ciliary pigment epithelium (CPE) was identified as a result of amyloid deposits (Kawaji et al. 2005), but no function for this TTR has been ascribed. Although TTR synthesis has been described in the RPE of several mammalian species, it has been described only in the CPE of rabbits.
2.3.5
Intestine, Pancreas and Meninges
TTR synthesis has been described in human intestines during fetal development (Loughna et al. 1995), but not in the intestine of adult rats (Dickson et al. 1985). TTR synthesis in the islets of Langerhans in the pancreas has been described in several studies (e.g. Kato et al. 1985). More recently, Refai et al. (2005) described a role for TTR in promoting glucose-induced increases in cytoplasmic calcium ion concentration and insulin release in pancreatic beta cells. A role for TTR in protection against beta cell apoptosis was also proposed, having implications for type 1 diabetes. Blay et al. (1993) described extremely low levels of TTR synthesis by the meninges. However, a function for TTR synthesised by the intestine, pancreas and meninges has not yet been proposed.
2.4 2.4.1
Sites of TTR Synthesis During Development in Vertebrates Liver
Fish, amphibians, reptiles and polyprotodont marsupials do not have TTR in their blood as adults (see below). However, during specific stages of development, i.e. when there is a rise in TH levels in blood, the TTR gene is turned on in the liver of these animals. In fish, this is during early development while they are still absorbing the yolk (Funkenstein et al. 1999; Santos and Power 1999) and during smoltification in salmonids (Richardson et al. 2005; Yamauchi et al. 1999). In amphibians, TTR is synthesised by the liver just prior to or at the climax of metamorphosis (Prapunpoj et al. 2000a; Yamauchi et al. 1998), which involves a sharp rise in TH levels in blood. In the only species of reptiles and polyprotodont marsupials investigated, hepatic TTR synthesis was detected during early development at the time of organ
30
S.J. Richardson
Table 2.1 Vertebrate species with an additional THDP with higher affinity for TH in blood during development Development Adult Reference (for each species) S. aurata
Fish
O. masou
Amphibians
Reptile
Mammals Marsupials –Polyprotodonta –Diprotodonta
Eutherians –Rodentia
S. salar
TTR
O. tshawytscha
Albumin
X. laevis
TTR
R. catesbeiana
Albumin
C. porosus
TTR
S. crassicaudata M. eugenii
R. norvegicus M. musculus
Albumin
Albumin
Prapunpoj et al. (2000) Yamauchi et al. (1993) Richardson et al. (2005)
Albumin
Albumin
TTR Albumin
Albumin
TBG TTR Albumin
TTR Albumin
TBG
TTR Albumin Modified from Richardson et al. 2005. From Richardson 2007
Funkenstein et al. (1999); Santos et al. (1999) Yamauchi et al. (1999) Richardson et al. (2005) Richardson et al. (2005)
TTR Albumin
Richardson et al. (2005) Richardson et al. (2002); Richardson et al. (2005) Vranckx et al. (1990a) Vrancks et al. (1990b)
maturation (Richardson et al. 2005). TH levels in blood during development have not yet been characterised in these animals. TTR is synthesised in the livers of adult eutherians, diprotodont marsupials and birds (see below). The ontogeny of TTR gene expression in the liver has been studied in eutherians (rat, mouse), birds (chicken, pigeon, quail) and a diprotodont marsupial (tammar wallaby). Hepatic TTR synthesis was identified in all species from the earliest time points investigated (Fung et al. 1988; Richardson et al. 2002; Southwell et al. 1991). Thus, in these animals, hepatic TTR synthesis appears not to be regulated by fluctuations in TH distribution requirements. By contrast, some eutherians and diprotodont marsupials synthesise TBG in times of increased TH distribution requirements (Richardson et al. 2005 and references therein). (Table 2.1).
2 TTR Synthesis During Development and Evolution: What the Marsupials Revealed
2.4.2
31
Onset of Hepatic TTR Synthesis in Juveniles Only Could be Related to the Developmental Surge of Thyroid Hormones in Blood at this Time
In all vertebrates studied to date, there is a characteristic rise in TH levels in blood during critical periods of TH-regulated development. As THs are lipophilic and >99% is bound to THDPs, this increase in TH concentration would require additional TH distribution capacity. This could be the selection pressure for the developmentally regulated hepatic synthesis of TTR in species where TTR is not synthesised by adult liver. In these species, albumin is the only THDP in adult blood. TTR has higher affinity for THs than for albumin, and would contribute to the distribution of elevated TH levels in blood during these crucial stages of TH-regulated development. Investigations into marsupials were fundamental in developing the hypothesis that an augmented THDP network is required at the time of elevated TH levels in blood during development: (1) Polyprotodont marsupials only synthesise TTR in the liver during development, probably during the elevated TH levels in blood (Richardson et al. 2005). (2) Diprotodont marsupials only synthesise TBG in liver when there are elevated levels of TH in the blood, which boosts their capacity for TH distribution (above that of albumin and TTR, which are synthesised in the liver throughout life) (Richardson et al. 2002, 2005).
2.4.3
Choroid Plexus
The choroid plexus has the highest concentration of TTR mRNA per gram tissue weight in the body. The adult rat choroid plexus has 4.4 mg TTR mRNA per gram wet weight tissue compared to only 0.39 mg TTR mRNA per gram wet weight liver (Schreiber et al. 1990). In chickens, the adult choroid plexus has 7.2 mg TTR mRNA per gram wet weight, while the liver has only 0.33 mg TTR mRNA per gram wet weight (Duan et al. 1991). The pattern of TTR synthesis by the choroid plexus during development differs between precocial (relatively independent soon after birth) and altricial (very dependent on their mothers after birth) animals. At the time of birth, the brain of precocial animals (e.g. sheep) is significantly further developed compared with the brains of altricial animals (e.g. rats). Therefore, it was of interest to compare TTR gene expression in the choroid plexus of altricial with precocial animals. In rats (altricial), TTR mRNA was detected in the choroid plexus primordia from E12.5 (i.e. 12.5 days post conception). The proportion of TTR mRNA in total RNA increased 40-fold from E12.5 until birth. The maximum of TTR mRNA as a proportion of total brain mRNA (about 140% level in adults) occurred 2 days before birth, just prior to the period of fastest brain growth. By 8 days after birth, TTR mRNA levels had decreased to adult levels (Fung et al. 1988).
32
S.J. Richardson
In sheep (precocial), TTR mRNA was detected in choroid plexus from embryos just a couple of days after gestation. At E40 (40 days post conception), the proportion of TTR mRNA in total mRNA was 34% of that for adult choroid plexus. By E90, this had increased to 70% of the adult value and remained constant throughout the rest of gestation (Tu et al. 1990). In sheep (precocial), the maximal increase in brain weight occurred 50 days before birth (Tu et al. 1990), while in rats (altricial), the maximum increase in brain weight occurred about 9 days after birth (Fung et al. 1988). For both species, the choroid plexus had its maximal growth rate prior to that of the rest of the brain. The critical period of brain development that is dependent on the THs is earlier for precocial animals than for altricial animals (Fisher and Polk 1989). The maximum TTR mRNA level in the choroid plexus of sheep occurs during the first half of gestation, while in rats, it occurs 2 days prior to birth. If TTR is involved in transporting THs across the blood–CSF barrier into the brain and acts as a THDP in the CSF, in each of these species, the timing of the maximal expression of the TTR gene is highly appropriate. Given that (1) THs have a profound effects on brain development; (2) the blood– brain barrier starts to develop as soon as the first blood vessel grows into the brain (Saunders et al. 1999); (3) the choroid plexus develops more rapidly than other parts of the brain; (4) the choroid plexus has an important role in regulating the composition of the CSF; (5) the timing of maximal TTR mRNA in the choroid plexus of altricial and precocial animals is just prior to the maximal growth rate of the brain and (6) TTR null mice have reduced TH levels in the subventricular zone (Richardson et al. 2007), it would follow that the synthesis of TTR from the stage of the choroid plexus primordia would appear to have an important regulatory role in determining the delivery of THs to the brain.
2.4.4
Visceral Yolk Sac and Placenta
TTR synthesis has been documented in both the placenta and VYS of the rat. Levels of TTR mRNA in the VYS were higher than those in the fetal liver throughout gestation. As stated previously, TTR synthesised by the VYS is involved in the transfer of THs from the maternal circulation to fetus, and also provides TTR to the fetal circulation before the fetal liver has reached full TTR synthesis rates. TTRRBP secreted by the VYS facilitates retinol transport to the fetus. More recent papers have confirmed these findings, added quantitative data and implicated specific transcription factors in the regulation of TTR gene expression in rodents (see Richardson 2007). A recent study reported the synthesis of TTR by trophoblasts in 38–40 weeks gestation in human placentas (McKinnon et al. 2005). However, earlier time points, including those where sufficient TH levels are crucial for normal fetal development, particularly during first trimester, have not been reported.
2 TTR Synthesis During Development and Evolution: What the Marsupials Revealed
2.4.5
33
Other Tissues
Scant data are available on TTR or its mRNA levels in other tissues during development. TTR mRNA in the RPE of rats was first detected at E16 and increased gradually until E21. There was a surge in TTR mRNA levels in the RPE at P0 followed by an increase to adult levels by P7. This surge was suggested to be a consequence of an external stimulus response, such as incident light (Mizuno et al. 1992). TTR mRNA has been reported in human fetuses at 12 weeks gestation in the islets of Langerhans (Gray et al. 1985) and in mid-term fetuses in the pancreatic endocrine A-cells (Jacobsson 1989). At 20–23 weeks gestation, over-expression of the TTR gene in the intestine was reported in human trisomy 18 (Edward’s Syndrome) (Loughna et al. 1995). TTR mRNA was also detected at E9 in the rat foregut endoderm (Makover et al. 1989).
2.5
TTR Synthesis During Evolution (Adult Animals)
2.5.1
Liver
2.5.1.1
Albumin is the Oldest THDP in Vertebrates
For a comprehensive analysis, serum from adult individuals from about 150 species was analysed for the presence of THDPs. All species studied were found to have albumin, and in some species (e.g. fish, amphibians, reptiles and some mammals) albumin was the only THDP (e.g. Richardson et al. 1994; Schreiber and Richardson 1997). Therefore, it was concluded that albumin is the phylogenetically oldest THDP in adult vertebrates. 2.5.1.2
No Clear Phylogeny for TBG in Vertebrates
By contrast, TBG-like proteins were detected in serum from several eutherian, marsupial and monotreme species, but no clear phylogeny was apparent (Richardson et al. 1994). Furthermore, many of these TBG-like proteins were not unambiguously identified, and could feasibly include TBG, lipoproteins that bind 125I-T4, or other 125I-T4 binding proteins that migrate as globulins. 2.5.1.3
Hepatic TTR Synthesis in Adult Birds, Diprotodont Marsupials and Eutherians
Birds and eutherians had TTR in addition to albumin. An intriguing situation became apparent among the Australian marsupial species: some had albumin as their only THDP, while others had TTR in addition to albumin. Those that had TTR
34
S.J. Richardson
in their serum belonged to the Order Diprotodonta, while those without TTR in their serum belonged to the Order Polyprotodonta (Richardson et al. 1993, 1994; Fig. 2.1). As stated previously, this classification is not currently favoured by taxonomists, but we have used this classification because it fits exactly with the serum TTR data for the 67 species of adult Australian marsupials studied. Thus, it appears that hepatic TTR synthesis remains ‘turned on’ in the adult in the lineages leading to eutherians, birds and diprotodont marsupials, and is ‘turned off’ after development in the lineages leading to polyprotodont marsupials, reptiles, amphibians, fish and possibly monotremes. Although the hypothesis for hepatic TTR synthesis during development is related to the transient increased levels of THs in blood, there are two current hypotheses concerning possible selection pressures for maintaining hepatic TTR synthesis during adult life. 2.5.1.4
Hepatic TTR Synthesis and the Increase in Lipid Pool to Body Mass Ratio: Consider Marsupials
A study by Hulbert and Else (1989) compared many physiological parameters of an adult reptile and an adult eutherian of similar body mass. Amongst other data, they showed that the eutherian had larger sizes of internal organs (including liver, brain, kidney and heart, which are among the metabolically most active), and that these tissues contained about 50% more phospholipid than the corresponding tissues in the reptile. As THs are lipophilic and preferentially partition into the lipid phase rather than the aqueous phase (Dickson et al. 1987; Hillier 1970), the increase in the relative size of the lipid pool could have been a selection pressure for maintaining hepatic TTR synthesis during adult life of eutherians compared with reptiles (Richardson et al. 1994). As TTR has higher affinity for THs than albumin has, the presence of TTR in the blood would augment the pool of circulating THs, thereby counteracting the increased lipid pool (sink) into which THs could partition. Another example that supports this hypothesis is that of the Australian marsupials. The diprotodont marsupials have hepatic TTR synthesis as adults, but the polyprotodont marsupials do not. The digestive tracts of herbivorous (diprotodont) marsupials are longer than those of carnivorous (polyprotodont) marsupials (Hume 1982). The intestines have a substantial lipid content and are the extra-thyroidal tissue with the highest TH content (Nguyen et al. 1993), and it has been suggested that the THDPs may be responsible for the regulation of delivery of THs to the intestines (Distefano et al. 1993). Thus, the diprotodont marsupials with longer digestive tracts have TTR in their blood, while the polyprotodont marsupials with shorter intestines do not. 2.5.1.5
Hepatic TTR Synthesis and Homeothermy: Marsupials Fall between the Cracks
Most adult animals that synthesise TTR in their livers throughout life are homeothermic (maintain their body temperature at or near 37 C by metabolic means).
2 TTR Synthesis During Development and Evolution: What the Marsupials Revealed
35
TTR was found in serum from all studied species of birds and eutherians, which are known homeotherms. However, TTR was not detected in the serum from adult fish, amphibians, reptiles, which are ectotherms (body temperature is determined by behaviour and the environment) (see Richardson 2007; Fig. 2.1). As THs are involved in the regulation of oxygen consumption, basal metabolic rates and homeothermy, it is conceivable that there is a link between the increase in the size of the most metabolically active organs and increase in the TH distribution capacity in blood (TTR) and homeothermy. Thus, a selection pressure for maintaining hepatic TTR synthesis throughout life could have been to enable appropriate distribution of THs throughout the body to maintain homeothermy. Marsupials are ‘poor homeotherms’ and there has been no evidence that the presence of TTR in marsupial blood is correlated with better control of body temperature.
2.5.1.6
The TTR–RBP Complex: Marsupials Raise a Question
TTR binds many ligands, including naturally occurring compounds, pollutants and non-steroidal anti-inflammatory drugs (see chapter ‘TTR and Endocrine Disruptors’). The only protein ligand known to be bound by TTR is RBP, which itself binds retinol (Kanai et al. 1968). It was suggested that the TTR–RBP/retinol complex (80 kDa) or the retinol/RBP–TTR–RBP/retinol complex (100 kDa) prevented loss of RBP/retinol (21 kDa) through glomerular filtration of the kidneys (Raz and Goodman 1969). This hypothesis may hold true for eutherians, but it is not immediately convincing when considering adult marsupials. Diprotodonta have TTR in their blood while Polyprotodonta do not (Richardson et al. 1994). This raises the questions as to whether there is a difference in glomerular filtration size cut-off in diprotodont marsupials compared with that of polyprotodont marsupials, or if glomerular filtration has a lower molecular weight cut-off in marsupials than in eutherians, or if a plasma protein other than TTR binds to RBP in all marsupials or in Polyprotodonta.
2.5.2
Choroid Plexus
TTR synthesis was not detected in the choroid plexus from fish or amphibians, but was the major protein synthesised and secreted by the choroid plexus from reptiles, birds, monotremes, marsupials and eutherians (see Richardson 2005). It appears that the TTR gene in the choroid plexus was turned on once at the stage of the stemreptiles, the closest common ancestor to reptiles, birds and mammals, but not of amphibians and fish (see Fig. 2.1). The stem-reptiles were the first to develop traces of a cerebral neocortex (Kent 1987), resulting in an increase in brain volume. As THs are lipophilic and readily partition into cell membranes, the increase in brain volume may have been a selection pressure for ‘turning on’ the TTR gene in the choroid plexus. This resulted in TTR assisting movement of THs from the blood
36
S.J. Richardson
across the blood–CSF barrier into the brain, and also acting as a THDP in the CSF (Schreiber and Richardson 1997). It is most probable that the stem-reptiles had the TTR gene in their genomes, possibly expressed in the liver during development. A change in the specificity of transcription factors could have been all that was required to activate expression of the TTR gene in the choroid plexus. The major protein synthesised and secreted by the choroid plexus of juvenile and adult amphibians is the lipocalin prostaglandin D synthetase (PGDS) (Achen et al. 1992), also known as beta-trace (Beuckmann et al. 1999) and Cpl1 (Lepperdinger 2000). PGDS is a monomeric 20 kDa protein that belongs to the lipocalin superfamily. Lipocalins have a calyx (cup) structure and are specialized in binding small molecules (Godovac-Zimmermann 1988). This raises the question as to whether PGDS was the functional evolutionary precursor to TTR in the choroid plexus.
2.5.3
Other Tissues
The majority of data in this section is derived from the studies of eutherian mammals. Therefore, to obtain a more global picture, investigations in species from other classes of vertebrates in both juveniles and adults are required. In adult eutherian mammals, TTR synthesis has been reported in the placenta, RPE, CPE, intestine, pancreas and meninges (in addition to the liver and choroid plexus). In adult reptiles, TTR mRNA has been identified in the choroid plexus from adult animals of four species: stumpy-tailed lizards (Tiliqua rugosa) (Achen et al. 1993), red-eared slider turtle (Trachemys scripta), the common snapping turtle (Chelydra serpentine) (Richardson et al. 1997) and in whole eyes and choroid plexus of the salt-water crocodile (Crocodylus porosus) (Prapunpoj et al. 2002). One study of an adult fish species (Sparus aurata, sea bream) detected TTR mRNA by RT-PCR (i.e. higher levels of sensitivity compared to the above mentioned studies) in the liver, intestine, brain, skin, heart, skeletal muscle, kidney, testis, gills and pituitary (Santos and Power 1999). Thus, given the paucity of data from noneutherian species, a generalized picture of TTR synthesis in vertebrate’s tissues other than the liver and choroid plexus is not yet possible.
2.6
Evolution of TTR Structure and Function: Marsupials are a ‘Missing Link’
In earlier studies of 125I-T4 binding to TTRs from various species, it had been noted that chicken TTR appeared to have a lower affinity for T4 than human TTR did (S. Richardson, unpublished observations). However, the amino acids in the TH binding sites are identical in human and chicken TTRs (Duan et al. 1991). As the
2 TTR Synthesis During Development and Evolution: What the Marsupials Revealed
37
N-termini had been shown to be located in the vicinity of the opening to the THbinding channel of TTR (Hamilton et al. 1993), this raised the question as to whether the N-terminal regions of TTR might be affecting the entry of THs into the binding sites. The X-ray crystal structure of chicken TTR was determined (Sunde et al. 1996). It did not show diffraction for the N-terminal regions, implying that the four N-terminal regions were moving freely in solution. However, it did confirm that the TH binding sites were identical in chicken and human TTRs (Sunde et al. 1996). This was surprising, as a difference in binding affinity was expected to be due to a difference in ligand binding site. To further investigate the possibility that the N-terminal regions influenced TH affinity, TTRs were purified from several species of eutherians (short hydrophilic N-terminal regions), birds (long hydrophobic N-terminal regions) and marsupials (intermediate N-terminal regions). The literature revealed that, depending on the method used, Kd values for human TTR and T4 ranged from 0.3 to 128 nM (see Chang et al. 1999). Therefore, a precise, accurate and reproducible method for assaying Kd values of TTRs with THs was developed (Chang et al. 1999). As expected, eutherian TTRs bound T4 with higher affinity than T3. However, avian TTRs bound T3 with higher affinity than T4. Marsupial TTRs had intermediate affinities, but bound T4 with higher affinity than T3 (Chang et al. 1999). However, similar to avian TTRs, reptilian and amphibian TTRs were also found to bind T3 with higher affinity than T4 (Prapunpoj et al. 2002, 2000b; Yamauchi et al. 1998; Table 2.2). Piscine TTRs bind T3 with higher affinity than T4 (Santos and Power 1999; Yamauchi et al. 1999), but specific Kd values are yet to be determined. Thus, shorter hydrophilic N-terminal regions are correlated with higher
Table 2.2 Dissociation constants of T3 and T4 from TTRs from a variety of species Kd T3 (nM) Kd T3/Kd T4 Source of TTR Kd T4 (nM) Eutherians Human 13.6 56.6 4.2 Sheep 11.3 63.5 3.2 Rat 8.0 67.2 8.4 Marsupials Wombat 21.8 97.8 4.5 Possum 15.9 206.1 12.9 Wallaby 13.8 65.3 4.7 Birds Emu 37.4 18.9 0.51 Chicken 28.8 12.3 0.43 Pigeon 25.3 16.1 0.64 Reptile Crocodile 36.7 7.56 0.21 Amphibian Toad 508.0 248.0 0.49 Data are from Chang et al. 1999; Prapunpoj et al. 2000; Prapunpoj et al. 2002. From Richardson 2007
38
S.J. Richardson
affinity for T4 binding, and longer more hydrophobic N-terminal regions are correlated with higher affinity for T3 binding. Chimeric TTRs were synthesised, where N-terminal regions from one species were replaced with those from another species (e.g. human/crocodile; Xenopus/ crocodile). Kd values for T3 and T4 were determined (Prapunpoj et al. 2002, 2006). As expected, the N-termini altered the affinity and specificity of T3 and T4 binding to TTRs. More specifically, it appeared that the core of TTR had a major influence on determining the affinity of T3 and the N-terminal regions mainly affected the affinity of T4. (For further details, see chapter ‘Evolution of Transthyretin Gene Structure’.) These data supported the hypothesis that the character of the N-terminal regions of TTR affects the affinities for THs, and revealed that mammalian TTRs are the exception rather than the rule, in that they preferentially bind T4, while TTRs from fish, amphibians, reptiles and birds preferentially bind T3. Marsupial TTRs can be considered as a ‘missing link’ between avian/reptilian TTRs and eutherian TTRs in terms of structure and function. Marsupial TTR N-terminal regions are intermediate in structure (length and hydrophobicity) between those of avian/reptilian TTRs and eutherian TTRs, and provided one of the ‘steps’ in the step-wise change in the position of the intron 1/exon 2 splice site that caused the change in structure from longer and more hydrophobic to shorter and more hydrophilic (see chapter ‘Evolution of Transthyretin Gene Structure’). While marsupial TTRs bind T4 with higher affinity than T3 (similarly to other mammalian TTRs), they have lower affinity for T3 than eutherian, avian or reptilian TTRs and intermediate affinities for T4 between those of eutherian TTRs and avian and reptilian TTRs. This is consistent with the structure of the N-terminal regions of marsupial TTRs being intermediate between those of eutherian and avian/ reptilian TTRs, and the hypothesis that the N-terminal region affects affinity for T4.
2.7
Marsupial Models for Studying TTR Amyloid Formation
The evolutionary changes in TTR are clustered around the N-terminal regions, while the point mutations in human TTR that result in amyloidosis are evenly spread throughout the molecule (see Richardson 2007). In general, the amino acid residues that occur as point mutations in human TTR and result in amyloid formation are not found in other species. One notable exception is amino acid 68. In wild-type human TTR residue 68 is Ile, but if it is mutated to Leu, TTR amyloidosis results. However, Leu is the normal amino acid in this position in several marsupial TTRs (Schreiber and Richardson 1997). These marsupials are apparently without symptoms of amyloidosis. Elucidation of the 3D structure of a marsupial TTR with Leu68 could give us valuable insights into how Leu is accommodated at position 68 in a marsupial TTR, but not in a human TTR. A second example of a marsupial TTR that is of interest for the study of TTR amyloid formation is wallaby TTR. Human TTR is believed to dissociate from
2 TTR Synthesis During Development and Evolution: What the Marsupials Revealed
39
tetramers into dimers, and from dimers into monomers before forming amyloid fibrils. All amyloidogenic mutations in human TTR destabilise the tetramer (Altland et al. 2007). Under specific conditions that cause the human TTR dimers to dissociate into monomers (Altland et al. 1999), wallaby TTR dimers remain intact (see chapter ‘Histidine 31: The Achilles’ Heel of Human Transthyretin. Microheterogeneity is Not Enough to Understand the Molecular Causes of Amyloidogenicity’). Again, structural data on key residues in wallaby TTR (e.g. His31) could give insight into the mechanism of TTR amyloid formation.
2.8
Conclusions
1. Taking together the data for TTR synthesis in the liver and in the choroid plexus, during both development and evolution, we arrive at the following profile (Fig. 2.1): (a) TTR synthesis only in the liver, only during development: fish, amphibians Hypothesis: hepatic TTR synthesis is required during the developmental surge of THs in blood. (b)TTR synthesis in the liver during development and in the choroid plexus throughout life: reptiles, polyprotodont marsupials and probably monotremes Hypothesis: hepatic TTR synthesis is required during the developmental surge of THs in blood; and the increase in brain volume required TTRmediated transport of T4 across the choroid plexus and TTR as a THDP in the CSF. (c) TTR synthesis in the liver and in the choroid plexus throughout life: birds, diprotodont marsupials, eutherians Hypothesis: hepatic TTR synthesis is required during the developmental surge of THs in blood; increased lipid volume to body mass ratio and/or homeothermy required an additional THDP in blood; and the increase in brain volume required TTR-mediated transport of T4 across the choroid plexus and TTR as a THDP in the CSF. The complex patterns of tissue-specific TTR synthesis imply that TTR synthesis is tightly regulated during development and during evolution. It also implies a multi-factorial set of selection pressures governing its synthesis. 2. Marsupial TTRs are intermediate in structure and in function, between those of reptilian/avian TTRs and eutherian TTRs. They provide evidence of a step-wise shift in the evolution of TTR structure and function. TTR changed from distributing T3 in fish, amphibians, reptiles and birds to distributing T4 in mammals. A possibility for the selection pressure leading to
40
S.J. Richardson
this could be an additional level of regulation of TH gene expression by TH. Instead of the ‘active’ form of the hormone being distributed around the body and brain (i.e. T3), in mammals, TTR distributes the precursor form (i.e. T4). This could require tissue-specific or cell-specific regulation of activation by deiodinases from T3 to T4. This could give tighter control over regulation of TH-responsive gene expression. 3. Marsupials should be considered as models for studying TTR amyloid formation. Why Leu68 can be tolerated in marsupial TTRs but causes amyloid formation in human TTR is highly intriguing and should be investigated. Furthermore, features of wallaby TTR that render it more stable than human TTR under specific conditions should be elucidated.
References Achen, M. G., et al. (1993) Transthyretin gene expression in choroid plexus first evolved in reptiles. American Journal of Physiology 265:R982–R989 Achen, M. G., et al. (1992) Protein synthesis at the blood-brain barrier. The major protein secreted by amphibian choroid plexus is a lipocalin. Journal of Biological Chemistry 267:23170–23174 Alberts, B., et al. (2002) Molecular Biology of the Cell. Garland Science, New York Altland, K., et al. (2007) Genetic microheterogeneity of human transthyretin detected by IEF. Electrophoresis 28:2053–2064 Altland, K., et al. (1999) Electrically neutral microheterogeneity of human plasma transthyretin (prealbumin) detected by isoelectric focusing in urea gradients. Electrophoresis 20:1349–1364 Beuckmann, C. T., et al. (1999) Binding of biliverdin, bilirubin, and thyroid hormones to lipocalintype prostaglandin D synthase. Biochemistry 38:8006–8013 Blay, P., et al. (1993) Transthyretin expression in the rat brain: effect of thyroid functional state and role in thyroxine transport. Brain Research 632:114–120 Bridges, C. D., et al. (1984) Visual cycle in the mammalian eye. Retinoid-binding proteins and the distribution of 11-cis retinoids. Vision Research 24:1581–1594 Cavallaro, T., et al. (1990) The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye. Investigative Ophthalmology and Visual Science 31:497–501 Chang, L., et al. (1999) Evolution of thyroid hormone binding by transthyretins in birds and mammals. European Journal of Biochemistry 259:534–542 Chanoine, J. P., et al. (1992) Role of transthyretin in the transport of thyroxine from the blood to the choroid plexus, the cerebrospinal fluid, and the brain. Endocrinology 130:933–938 Dickson, P. W., et al., (1985) High prealbumin and transferrin messenger RNA levels in the choroid plexus of rat brain. Biochemical and Biophysical Research Communications 127:890–895 Dickson, P. W., et al. (1987) Thyroxine transport in choroid plexus. Journal of Biological Chemistry 262:13907–13915 Distefano, J. J., et al., (1993) Transfer kinetics of 3,5,30 -triiodothyronine and thyroxine from rat blood to large and small intestines, liver, and kidneys in vivo. Endocrinology 132:1735–1744 Duan, W., et al., (1991) Isolation, characterization, cDNA cloning and gene expression of an avian transthyretin. Implications for the evolution of structure and function of transthyretin in vertebrates. European Journal of Biochemistry 200:679–687 Fisher, D. A., Polk, D. H. (1989) Development of the thyroid. Bailliere’s Clinical Endocrinology and Metabolism 3:627–657
2 TTR Synthesis During Development and Evolution: What the Marsupials Revealed
41
Fung, W. P., et al., (1988) Structure and expression of the rat transthyretin (prealbumin) gene. Journal of Biological Chemistry 263:480–488 Funkenstein, B., et al., (1999) Cloning of putative piscine (Sparus aurata) transthyretin: developmental expression and tissue distribution. Molecular and Cellular Endocrinology 157:67–73 Godovac-Zimmermann, J. (1988) The structural motif of beta-lactoglobulin and retinol-binding protein: a basic framework for binding and transport of small hydrophobic molecules? Trends in Biochemical Sciences 13:64–66 Gray, H. D., et al., (1985) Sites of prealbumin production in the human fetus using the indirect immunoperoxidase technique. Virchows Archive A: Pathological Anatomy and Histopathology 406:463–473 Hamilton, J. A., et al., (1993) The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30 ! Met variant to 1.7-A resolution. Journal of Biological Chemistry 268:2416–2424 Hillier, A. P. (1970). The binding of thyroid hormones to phospholipid membranes. Journal of Physiology 211:585–597 Hulbert, A. J., Else, P. L. (1989) Evolution of mammalian endothermic metabolism – mitochondrial activity and cell composition. American Journal of Physiology 256:R63–R69 Hume, I. D. (1982) Digestive Physiology and Nutrition of Marsupials. Cambridge University Press, Cambridge Jacobsson, B. (1989) In situ localization of transthyretin-mRNA in the adult human liver, choroid plexus and pancreatic islets and in endocrine tumours of the pancreas and gut. Histochemistry 91:299–304 Kanai, M., et al., (1968) Retinol-binding protein: the transport protein for vitamin A in human plasma. Journal of Clinical Investigation 47:2025–2044 Kato, M., et al., (1985) Plasma and cellular retinoid-binding proteins and transthyretin (prealbumin) are all localized in the islets of Langerhans in the rat. Proceedings of the National Academy of Sciences of the United States of America 82:2488–2492 Kawaji, T., et al., (2005) Transthyretin synthesis in rabbit ciliary pigment epithelium. Experimental Eye Research 81:306–312 Kent, G. C. (1987) Comparative anatomy of the vertebrates. Time Mirror/Mosby College, St Louis. Lemkine, G. F., et al. (2005) Adult neural stem cell cycling in vivo requires thyroid hormone and its alpha receptor. The FASEB Journal 19:863–865 Lepperdinger, G. (2000) Amphibian choroid plexus lipocalin, Cpl1. Biochimica et Biophysica Acta 1482:119–126 Loughna, S., et al., (1995) Molecular analysis of the expression of transthyretin in intestine and liver from trisomy 18 fetuses. Human Genetics 95:89–95 Makover, A., et al., (1989) An in situ-hybridization study of the localization of retinol-binding protein and transthyretin messenger RNAs during fetal development in the rat. Differentiation 40:17–25 McKinnon, B., et al., (2005) Synthesis of thyroid hormone binding proteins transthyretin and albumin by human trophoblast. Journal of Clinical Endocrinology and Metabolism 90:6714–6720 Mendel, C. M., et al., (1989) Thyroxine transport and distribution in Nagase Analbuminemic rats. Journal of Clinical Investigation 83:143–148 Mendel, C. M., et al., (1987) Thyroid hormone binding proteins in plasma facilitate uniform distribution of thyroxine within tissues – A perfused rat liver study. Endocrinology 120:1742– 1749 Meredith, R. W., et al., (2007) A phylogeny and time scale for marsupial evolution based on sequences for five nuclear genes. Journal of Mammalian Evolution 15:1–36 Mizuno, R., et al., (1992) Temporal expression of the transthyretin gene in the developing rat eye. Investigative Ophthalmology and Visual Science 33:341–349
42
S.J. Richardson
Nguyen, T. T., et al., (1993) Steady-state organ distribution and metabolism of thyroxine and 3,5,30 -triiodothyronine in intestines, liver, kidneys, blood, and residual carcass of the rat invivo. Endocrinology 133:2973–2983 Ong, D. E., et al., (1994) Synthesis and secretion of retinol-binding protein and transthyretin by cultured retinal pigment epithelium. Biochemistry 33:1835–1842 Prapunpoj, P., et al., (2006) Change in structure of the N-terminal region of transthyretin produces change in affinity of transthyretin to T4 and T3. FEBS Journal 273:4013–4023 Prapunpoj, P., et al., (2000a) The evolution of the thyroid hormone distributor protein transthyretin in the order insectivora, class mammalia. Molecular Biology and Evolution 17:1199–1209 Prapunpoj, P., et al., (2002) Crocodile transthyretin: structure, function, and evolution. American Journal of Physiology – Regulatory Integrative and Comparative Physiology 283:R885–R896 Prapunpoj, P., et al., (2000b) Evolution of structure, ontogeny of gene expression, and function of Xenopus laevis transthyretin. American Journal of Physiology – Regulatory Integrative and Comparative Physiology 279:R2026–R2041 Raz, A., Goodman, D. S. (1969) The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complex. Journal of Biological Chemistry 244:3230–3237 Refai, E., et al., (2005) Transthyretin constitutes a functional component in pancreatic beta-cell stimulus-secretion coupling. Proceedings of the National Academy of Sciences of the United States of America 102:17020–17025 Richardson, S. J. (2005) Expression of transthyretin in the choroid plexus: Relationship to brain homeostasis of thyroid hormones. In: W. Zheng, A. Chodobski (eds.), The Blood-Cerebrospinal Fluid Barrier. CRC Press, Boca Raton, pp. 275–304 Richardson, S. J. (2007) Cell and molecular biology of transthyretin and thyroid hormones. International Review of Cytology 258:137–193 Richardson, S. J., et al., (2002) Developmental profile of thyroid hormone distributor proteins in a marsupial, the tammar wallaby Macropus eugenii. General and Comparative Endocrinology 125:92–103 Richardson, S. J., et al., (1993) The expression of the transthyretin gene in liver evolved during the radiation of diprotodont marsupials in Australia. General and Comparative Endocrinology 90:177–182 Richardson, S. J., et al., (1994) Evolution of marsupial and other vertebrate thyroxine-binding plasma proteins. American Journal of Physiology 266:R1359–R1370 Richardson, S. J., et al., (1997) Abundant synthesis of transthyretin in the brain, but not in the liver, of turtles. Comparative Biochemistry and Physiology B – Biochemistry and Molecular Biology 117:421–429 Richardson, S. J., et al., (2007) Cell division and apoptosis in the adult neural stem cell niche are differentially affected in transthyretin null mice. Neuroscience Letters 421:234–238 Richardson, S. J., et al., (2005) Developmentally regulated thyroid hormone distributor proteins in marsupials, a reptile, and fish. American Journal of Physiology – Regulatory Integrative and Comparative Physiology 288:R1264–R1272 Sandler, B., et al., (2004) Thyroxine-thyroid hormone receptor interactions. Journal of Biological Chemistry 279:55801–55808 Santos, C. R. A., Power, D. M. (1999) Identification of transthyretin in fish (Sparus aurata): cDNA cloning and characterisation. Endocrinology 140:2430–2433 Saunders, N. R., et al., (1989) Monodelphis domestica (grey short-tailed opossum): an accessible model for studies of early neocortical development. Anatomy and Embryology (Berlin) 180:227–236 Saunders, N. R., et al., (1999) Barrier mechanisms in the brain, II. Immature brain. Clinical and Experimental Pharmacology and Physiology 26:85–91 Schreiber, G. (1987) Synthesis, processing, and secretion of plasma proteins by the liver and other organs and their regulation. In: F. W. Putnam (ed.), The Plasma Proteins. Academic Press, New York, pp. 293–363
2 TTR Synthesis During Development and Evolution: What the Marsupials Revealed
43
Schreiber, G., et al., (1990) Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus. American Journal of Physiology 258:R338–R345 Schreiber, G., Richardson, S. J. (1997) The evolution of gene expression, structure and function of transthyretin. Comparative Biochemistry and Physiology. Part B, Biochemistry and Molecular Biology 116:137–160 Setchell, P. J. (1974) Development of thermoregulation and thyroid function in marsupial Macropus eugenii (Desmarest). Comparative Biochemistry and Physiology 47:1115–1121 Sklan, D., Ross, A. C. (1987) Synthesis of retinol-binding protein and transthyretin in yolk sac and fetus in the rat. Journal of Nutrition 117:436–442 Soprano, D. R., et al., (1986) Retinol-binding protein and transthyretin mRNA levels in visceral yolk sac and liver during fetal development in the rat. Proceedings of the National Academy of Sciences of the United States of America 83:7330–7334 Southwell, B. R., et al., (1993) Thyroxine transport to the brain: role of protein synthesis by the choroid plexus. Endocrinology 133:2116–2126 Southwell, B. R., et al., (1991) Ontogenesis of transthyretin gene expression in chicken choroid plexus and liver. Comparative Biochemistry and Physiology B: Comparative Biochemistry 100:329–338 Stauder, A. J., et al., (1986) Synthesis of transthyretin (pre-albumin) mRNA in choroid plexus epithelial cells, localized by in situ hybridization in rat brain. Journal of Histochemistry and Cytochemistry 34:949–952 Sunde, M., et al., (1996) The crystal structure of transthyretin from chicken. European Journal of Biochemistry 236:491–499 Talent, J. (1984) Australian biogeography past and present: determinants and implications. In: J. J. Veevers (ed.), Phanerozoic Earth History of Australia. Oxford University Press (Clarendon), London, pp. 57–93 Thomas, T., et al., (1990) Plasma protein synthesis and secretion in the visceral yolk sac of the fetal rat: gene expression, protein synthesis and secretion. Placenta 11:413–430 Tu, G. F., et al., (1990) Expression of the genes for transthyretin, cystatin C and beta A4 amyloid precursor protein in sheep choroid plexus during development. Brain Research Developmental Brain Research 55:203–208 Tyndale-Biscoe, H. (1973). Life of Marsupials. Arnold, London. Tyndale-Biscoe, H. C., Janssens, P. A. (1988) The Delevoping Marsupial: Models for Biomedical Research. Springer-Verlag, Berlin van Rheede, T., et al., (2006) The platypus is in its place: nuclear genes and indels confirm the sister group relation of monotremes and Therians. Molecular Biology and Evolution 23:587–597 Woodburne, M. O., Zinsmeister, W. J. (1982) Fossil Land Mammal from Antarctica. Science 218:284–286 Yamauchi, K., et al., (1999). Purification and characterization of thyroid-hormone-binding protein from masu salmon serum – A homolog of higher-vertebrate transthyretin. European Journal of Biochemistry 265:944–949 Yamauchi, K., et al., (1998) Structural characteristics of bullfrog (Rana catesbeiana) transthyretin and its cDNA – comparison of its pattern of expression during metamorphosis with that of lipocalin. European Journal of Biochemistry 256:287–296 Yamauchi, K., et al., (1993) Purification and characterization of a 3,5,30 -L-triiodothyroninespecific binding protein from bullfrog tadpole plasma: a homolog of mammalian transthyretin. Endocrinology 132, 2254–2261.
Chapter 3
Evolution of Transthyretin Gene Structure Porntip Prapunpoj
Abstract Transthyretin (TTR) is one of the three major thyroid hormone (TH)binding proteins in plasma and cerebrospinal fluid (CSF) of vertebrates. Binding of TTR to THs is necessary to counteract the loss of these hormones from the vascular and interstitial compartments, resulting from high lipid solubility and from the tendency to partition into and accumulate in the cell membranes. TTR and the other two components of the TH-binding protein system (albumin and thyroxine-binding globulin) function as a network. The loss of one of the proteins could be compensated by increased binding to the remaining plasma proteins. The gene structure of TTR at genomic and mRNA levels from many animals have been characterized over the 20 years since 1985. The structure of the TTR gene from three vertebrate species, that is, human, mouse, and rat, has been characterized, and the entire TTR genomic sequences are highly conserved among these species. They have two intronic open reading frames (ORFs) but neither is productively expressed as an independent polypeptide. The proximal and distal promoters with several regulatory elements necessary for transcription and tissue-specific expression of the TTR gene are located at the 50 -flanking region of the transcription initiation site. The polypeptide coding region of TTR has been studied for a variety of species from fish to human. TTR cDNA from up to 24 vertebrates have been isolated and analyzed to date. The nucleotide sequence and primary structure of TTR are highly conserved, in particular among eutherian, marsupial, bird, reptile, amphibian and fish species. All positions in the central channel, in particular, those involved in the binding interaction with THs have not been altered since at least 400 million years ago. However, mutations of TTR mostly occur in the 50 -terminal region of the TTR gene, which corresponds to the N-terminal segment of TTR polypeptide, during evolution of vertebrates. Shortening and change in hydropathy of the N-terminal regions of TTR occurred and have been demonstrated to influence the binding affinities to THs. The molecular mechanism underlying these phenomena is a series of single
P. Prapunpoj Department of Biochemistry, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90112, Thailand e-mail:
[email protected]
S.J. Richardson and V. Cody (eds.), Recent Advances in Transthyretin Evolution, Structure and Biological Functions, DOI: 10.1007/978‐3‐642‐00646‐3_3, # Springer‐Verlag Berlin Heidelberg 2009
45
46
P. Prapunpoj
base mutations that leads to a stepwise progressive movement of the 30 splice site, but not the 50 splice site, of the TTR intron 1. It is apparent that a rare molecular mechanism of positive Neo-Darwinian evolution has occurred during the evolution of TTR gene. Keywords cDNA, Evolution, Gene, Structure, Transthyretin
3.1 3.1.1
Genomic Structure of the Transthyretin Gene General
The transthyretin (TTR) gene is located on different chromosomes in different species. While the TTR genes from human and rat are located on chromosome 18 (Wallace et al. 1985; Remmers et al. 1993), those from mouse are located at the C6-D1 region of chromosome 4 (Qiu et al. 1992) and those from Sus scrofa and Bos taurus are on chromosome 6 (Arachibald et al. 1996) and 24 (Larsen et al. 1996), respectively. The TTR genes are varied in length spanning from 6.9 kb (in human) to 7.3 kb (in rat), and are composed of four exons and three introns. Until now, the genomic structure of the TTR gene from only three vertebrate species, that is, human, mouse and rat, has been characterized by nucleotide sequences of the 50 and 30 flanking regions, intron–exon borders, and part of introns being sequenced. The entire sequences of all exons, the 50 proximal region, and the flanking region of the exon–intron borders are highly conserved between human and rodent TTR genes (Tsuzuki et al. 1985; Wakasugi et al. 1985, 1986). The 50 -flanking region of the human and mouse TTR genes and the 30 end region of the first intron of the mouse TTR gene contain sequences homologous to the glucocorticoid receptor (GCR)binding site sequences (Sasaki et al. 1985; Tsuzuki et al. 1985). Moreover, the latter TTR gene also contains an enhancer sequence that is present in the immunoglobulin kappa-chain joining-constant kappa intron (Wakasugi et al. 1986).
3.1.2
Genomic Structure of Human TTR
Each human TTR monomer is encoded by a single-copy gene (Sparkes et al. 1987) that was located by Southern hybridization to the long arm of chromosome 18 (Wallace et al. 1985), in particular at the 18p11.1-q12.3 region, and most likely at the cen-q12.3 (Jinno et al. 1986). The TTR gene spans about 6.9–7.0 kilobases and contains four exons and three introns (Sasaki et al. 1985; Tsuzuki et al. 1985). Exon 1 encodes 23 amino acid residues, which comprises 20 residues of a signal peptide and the first three residues of the mature protein; exons 2, 3, and 4 encode for 44, 45, and 35 amino acid residues, respectively, of the mature protein. The 50 -untranslated region (50 -UTR) (26 bases) and the 30 -untranslated region (30 -UTR) (139 bases) are located in exon 1 and exon 4, respectively. There are three introns of 934, 2,090,
3 Evolution of Transthyretin Gene Structure
47
and 3,308 bp, and the GT/AG splicing consensus sequence was identified at all exon/intron borders of the gene (Sasaki et al. 1985). Two independent ORFs, ORF1 and ORF2, with putative regulatory sequences for transcription in the same transcription direction as that of TTR locate in the first and the third intron of the TTR gene (Tsuzuki et al. 1985). The nucleotide sequence of ORF1 is conserved among vertebrate species and codes for polypeptides of 60 and 37 amino acid residues. ORF2 also has two putative initiation codons and codes for a polypeptide of 49 amino acid residues (Tsuzuki et al. 1985). The transcriptional process under these TTR intronic ORFs occurs in liver, pancreas, and brain. However, these transcripts were produced as part of larger transcripts rather than as gene-specific mRNAs (Soares et al. 2003). Two copies of the Alu sequence with opposite directions, which are possibly involved in TTR gene regulation, were found in introns 2 and 3. Several regulatory signals including the Goldberg–Hogness sequence, CAAT boxlike sequence (GTCAAT), two glucocorticoid responsive elements (GRE), and liver-specific nuclear factors HNF-1, 3, 4, and C/E BP locate in the 50 -flanking region of human TTR gene (Sasaki et al. 1985, 1989). The cis-elements that are required for developmental tissue-specificity and for level of expression were also demonstrated at 0.6 to 6.0 kb of the gene (Nagata et al. 1995). The 30 -UTR of the human TTR gene contains polyadenylation signal located at 123 bp downstream from the coding region or at 23 bp upstream from the polyadenylation site (Tsuzuki et al. 1985). In addition, three enhancer core sequences were found in introns and 30 -UTR (Sasaki et al. 1985).
3.1.3
Genomic Structure of TTR from Rodents
The chromosomal structures of the TTR genes from other vertebrates that have been characterized till now are from mouse (Wakasugi et al. 1986) and rat (Fung et al. 1988). These rodent TTR genes are single copies, and the nucleotide sequences of the genes are highly conserved in comparison to human TTR. The genes contain four exons, three introns, TATA-box, and CAAT-box sequences, and the highly conserved regions are in the exons, 50 -flanking region, and 30 end region of intron 1, where only one ORF rather than two as identified in human TTR is present (Wakasugi et al. 1986). Introns of the mouse TTR gene are 0.9, 3.4, and 3.6 kb in length, but have low homology (up to 49% homology) to the corresponding human TTR introns. Two GCR-binding sites and one JkCk enhancer, which are found in immunoglobulin kappa chain gene, are located in the 30 end region of intron 1, similar to that found in the human TTR gene. In addition, two mouse mammary tumor virus (MMTV) GCR-binding site sequences are in the 50 -flanking region (Wakasugi et al. 1986). The proximal promoter (108 to 150 nucleotides) and the distal enhancer element (1.6 to 2.15 kb) of mouse TTR gene possess several binding sites for nuclear factors (Costa et al. 1986). Of the three binding sites present in the enhancer, two are responsible for the cell-specificity and the third is required for the general activation mechanism (Costa et al. 1988). Several nuclear
48
P. Prapunpoj
factors have been identified so far, including the activation protein one (AP-1), HNF-1 (binding site is 130 to 116 bp), HNF-3 (strong binding site is 106 to 94 bp while weak binding site is 140 to 131 bp), HNF-4 (binding site is 151 to 140 bp), HNF-6 (binding site is 106 to 94 bp), and CCAAT/enhancer binding protein (C/EBP; binding sites are 195 to 177 bp and 135 to 112 bp) (Costa et al. 1989, 1990; Grayson et al. 1989; Samadani and Costa 1996; Samadani et al. 1996). Cooperation between these factors to the TTR promoter and enhancer regions is required for the tissue-specific expression of the gene (Costa and Grayson 1991), such as nuclear factors NHF-1, 3, and 4 and C/EBP are required for TTR gene expression in the hepatocytes (Costa and Grayson 1991). The rat TTR gene spans to 7.3 kb (Fung et al. 1988). The nucleotide sequence of the proximal 50 -flanking region (position 51 to 89 bp), which corresponds to the binding sites for hepatocyte nuclear factors in mouse TTR (Costa et al. 1986), is highly conserved in comparison to human (93% identity) and mouse (97% identity) TTR genes. However, the homology significantly decreases with the nucleotide sequence further upstream from this region (Fung et al. 1988). The rat TTR gene has dual promoters, similar to those human and mouse TTR genes (Motojima and Goto 1989, 1990). A major proximal promoter is mainly used in liver and a minor distal promoter is mainly used in kidney and significantly in brain. Both the TATA-box like sequence (TATATAA sequence; at 30 to 24 bp) and the CAAT-box like sequence (GTCAAT; at 101 to 96 bp) are in the upstream region of the proximal promoter; however, neither is in the distal promoter. An additional transcriptional start site for the specific expression of rat TTR gene in the brain was located at least 65 bp upstream of the normal start site (Motojima and Goto 1989). The AATAAT sequence is present upstream of the region and this region is expressed only in the brain tissue.
3.2
Evolution of the TTR Gene Structure and the Stepwise Shift of the Splicing Mechanism
In the evolution of the TTR gene structure, two types of mutation patterns can be distinguished. The first type consists of random mutations found throughout the polypeptide chain of the human TTR subunit, and more than 80 positions of this mutation type are related to the medical disorder called amyloidosis (see details in chapters on TTR amyloid mutations). The second type consists of mutations occurring near the N-terminal region of the TTR subunit, which lead to changes in length and hydropathy of the N-terminal regions during evolution. Up to date, the primary structures of TTRs from many vertebrate species have been characterized. Although some were obtained directly from the amino acid sequencing, most were derived from nucleotide sequencing of the TTR cDNAs. Up to 24 vertebrate species of TTR cDNAs have been isolated and characterized. These include eutherians (human, hedgehog, shrew, rat, mouse, pig, cow, sheep, and rabbit), metatherians (wallaby, kangaroo, dunnart, opossum, and sugar glider),
3 Evolution of Transthyretin Gene Structure
49
bird (chicken), reptiles (crocodile and lizard), amphibians (bullfrog and xenopus), and fishes (sea bream, pacific bluefin tuna, and two genera of lamprey, Petromyzon marinus and Lampetra appendix). Messenger RNA of the vertebrate TTR subunit is generally composed of a 50 -UTR, a coding region, and a 30 -UTR preceding the poly (A) tail, similar to other mRNAs of eukaryotes. The nucleotide sequence in the coding region of these TTR genes is highly conserved, in particular, among eutherians, marsupials, birds, reptiles, and amphibians. This coding region corresponds to TTR presegment, 18–20 amino acid residues, and the functional subunit, which is varied in length depending on animal species, that is, from 125 amino acid residues in hedgehog TTR to 136 amino acid residues in lamprey TTR (Fig. 3.1). Alignment of the TTR primary structures, either obtained directly from amino acid sequencing or derived from the nucleotide sequence of TTR cDNA, from 28 vertebrates including mammals (small eutherians, insectivores, marsupials), birds, reptilians, amphibians, and fish shows that residues in all positions in the central channel of TTR including those involved in the binding interaction with thyroid hormones (THs) (Blake and Oatley 1977; Blake 1981; Wojtczak et al. 1996) are conserved and have not evolved since primitive fish (Fig. 3.1). Homology of the amino acid sequences is high, in particular, among eutherians, marsupials, birds, and reptiles (Table 3.1). On the contrary, most mutations of TTR that occurred during evolution are located only in the 50 -terminal region of the TTR gene that corresponds to the first ten amino acids (based on the amino acid numbering of human TTR) from the N-terminal region of the TTR subunit. A systematic change of the N-terminal region of the TTR subunit from longer and relatively hydrophobic to shorter and more hydrophilic is observed in the evolution of TTRs from eutherians from their common ancestors. Analysis and systemic comparisons between nucleotide sequences of TTR cDNAs and genomic DNAs isolated from eutherian, marsupial, and birds revealed that the shortening of the TTR polypeptide chain at the N-terminus occurred at the border between exon 1 and exon 2 (Aldred et al. 1997). Comparing the nucleotide sequences of genomic DNA and cDNA at the border between exon 1 and exon 2 showed that the position of the 30 splice site of exon 1 and the 50 splice site of intron 1 of all studied TTRs remained unchanged. The consensus recognition sequences for splicing at the 50 end of the intron are typical but well agreed with that found in other vertebrate genes (Moore et al. 1993), that is, the nucleotides U or C rather than A is preferred for the consensus sequence in the exon 1 region flanking the splice site. However, all changes occurred in the region of 30 end of intron 1 and the 50 end of exon 2. Position of the 30 splice site of the TTR intron 1 shifted to the 30 direction in successive steps during evolution of eutherians from their ancestral TTR genes similar to that in fish, leading to a successive shortening of the 50 end of exon 2 (Fig. 3.2). The mechanism underlying this splice site shift possibly occurred by a series of single base mutations that converted codons for amino acids into a new splice recognition site. According to the fact that the splice site recognition sequence at the 30 end of introns is relatively short (Moore et al. 1993), codons for amino acids, in particular, glutamine, CAA, and histidine, CAC or CAU, can be converted into the 30 splice site recognition sequence CAG by a single base change,
P. Prapunpoj
50
-------
Presegment-----
Mature Protein
------>
-------------disordered---------------
Human Hedgehog Shrew Rhesus Monkey 1 Rhesus Monkey 2 Pi g Sheep Bovine Rabbit Rat Mouse Tammar Wallaby Grey Kangaroo Brush-tail Possum Sugar Glider Wombat Stripe-faced Dunnart Grey Opossum Virginia Opossum Chicken Pigeon Emu Ostrich Crocodile Lizard Bullfrog Xenopus Sea Bream Lamprey
MASHRLLLLC LAGLVFVSEA GPT ******F*** ******M*** *** ***R****** *****L*T** *** *** *** ***Y****** ********** **A ***F****** ********** S*A ***F**F*** ********** *SV **V ***L**F*** ****I*A*** **G ***L**F*** ********** **A **F*S***** ****A****T AAV **F*S***** ****A****T AAV V **F*S***** ****L***** **V A*E **F*S***** ****L*L*** **V **F*S****G **S*L***D* A*V A*V **F*ST**VF ******L*** A*L A*L A*L A*L **F*SM**VF ******LT** A*L *G*SS***V* ***M*YLT** A*L **YYNT*A*L TIFIFSGAFH RAQ ***FKSF** **L*AI**** A*P *LQPLHC**L ASAVLCNTAP T** *--RF*C**V *VASSSLLCR ADD
-20
-1 +1 3
-10 -strand ----E-----
Human Hedgehog Shrew P ig Sheep Bovine Rabbit Rat Mouse Tammar Wallaby Grey Kangaroo Sugar Glider Stripe-faced Dunnart Grey Opossum Chicken Crocodile Lizard Bullfrog Xenopus Sea Bream Lamprey
V V V V V V G G H A D D H K S H E S -
- -
-
-
-
-
H H P A V A I T S T S S S S T S K H
H H X H H H H H H H H H H H H H H E
- -
EEEFVEGIYK D*K****V** D*K*****I* D*K** ** *** *DK****L** *DK****L** S*K****V** D *K * T * * V * R D*K****V*R DDK*G**L** DDK*G**L** DDK*G**L** DDQ*G**L** D*K*G**L** **Q****V*R D*K******R D*Q**Q*L** **Q******* D*Q*T**V** *QQ*PA*V*R DKD*T**T**
VEIDTKSYWK **L******* **L***T*** **L******* **L******* **L******* **L******* **L** ***** **L******* **F**I**** **F**I**** **F**I**** **F**V**** **F**F***N **F**S**** **F**S**** **F**S**** L*FA**RF*S I*FA**AF*G **F***A**T *RFE*QQ**T
ALGISPFHEH T********Y ******S**Y ** * ****** Y S********Y S********F *********Y *********Y T********F ***V*****Y ***V*****Y ***V*****Y TF*******Y ***V*****Y G**L*****Y ***L*****Y ***V*****Y K**LT****Y K**L*****Y NQ*ST****V KT**T****A
70
80
90
AE V* V* ** ** ** ** ** *D *D *D *D *D *D *D *D *D VD VD ** **
+4
-strand -----A----
-strand -----B----
PLMVKVLDAV ********** ********** ********** ********** ********** ********** ********** ********** ********** ********** ********** ********** **** ********** ******* ********S* ********** ******* ********** ***** ******* ******* ********** ********** ********** ********** *****I**** *****AI*S*
RGSPAINVAV *****V**** Q****V**** * * *****V**G* *****A**G* *****A**G* *****VD*S* *****VD*** *****VD*** **R**V**D* **R**V**D*
-strand ------C------
-strand D
HVFRKAADDT WEPFASGK K**K****E* ******** R**K****E* ********
TS ESGELHGLTT ** ********** ** *F********
K**K****G* K**K****E* K**K****E* ***K****E* K**K*T**GS K**K*TSEGS K**K*TEEQ* K**K*TEEQ*
** ** ** ** *A *A *N *N
*****L** ******** ******** ******** ******** ******** **L**A** **L**A**
*F******** D********* ********** KT******** ********** ********** DN**I*E*** DN**I*E***
**R**V**D* K**K*TEKQ* **L*****
*N DN**I*E**S
*****V**D* K**K*TEEQ* **L***** *****V**N* K**K*SEEQ* *****T**
*N NN**I*E**S *N DY**I*E**N
*****A**** K**K****G* *QD**T**
*T *F**I*E***
*****A***I **R**TSI** **I**AKLP* **I**A*LL* K*T**GS**L Q*K**AG*KL
K**K*TS*GD K*SKMSEEGD K**KQNE*KS N****TNSGK K*SQ*T**GG S*MK*QD*AS
*T *N ** *T *D *G
*F**V*E**S *F**I*E*** SD**I*N*A* SD**I*N*** AT****N*I* KT**S*H*IS
30
40
50
60
20
10 -strand -----G----
-strand -----F----
-- -helix-
GTGESKC *Q*** ***Q*** *VD**** *ID**** *A***** *A***** *A**P** ***D*** *A***** *A***** EGEH*** ESEH*** *GEH**X *GED*** *GDDX*X *AED*** *AED*** *AEDX*X *SVD*** *SVD*** *SVD**X *SVD**X *SID*** *SID*** *EAD*** *EAD*** *GSDTR* *GVKDS*
*QE**A** *KE**N** *DLIS**T **QIT*** *TQI*T*V *KEV*T*V
-strand ----H---
VVFTANDS ******** ******** ** ** ** ** ******** ******** ******** ******** ******** *******A *******A *******A *******A ***K***A ******** ******** ***S**** *******A *******A ***D*HPE ***M*HGA
GPRRYTIAAL *Q******** *K******** * R* H*** * ** *L*H****** ***H****** *H*S****** * H *H *** ** * *H*H****** *H*H****** *H*H*****Q *H*H*****Q *H*H*****Q *H*H****** *H*H****** *H*H****** *H*H****** *H*H**T*V* *H*Q****V* *HGH**L*L* *HKH*H*PM*
LSPYSYSTTA ********** ********** ********** ********** ********** ***F****** **** **** ** ********** *****F**** *****F**** *****F**** ***F*F**** ********** ***F****** ***F****** ***F****** *T***F**** *T***F*S** ***F**T*** ****FFA*G*
VVTNPKE L*SD*** L*SD*** L *SS***GAL L*SS*** L*SS**A **S**Q* **S**QN **S**QN I*S**T* I*S**T* I*S**T* **S***D **S***D **SD*Q* **SD*Q* **SD*** **SDV**AHV I*SE*HDDL **SSVH* I*VDG*GH
100
110
120
130
Fig. 3.1 Comparison of the amino acid sequences of vertebrate TTRs and derived amino acid sequences from 28 animal species (20 complete and 8 N-terminal sequences) are aligned. Those residues in other species with identical amino acids to those in human TTR are indicated by asterisks. First residues in the mature polypeptide are in bold. Features of secondary structure of human TTR are indicated above the sequences. The numbering of residues is based on human TTR: negative numbers, residues in the presegment; positive numbers, residues of the mature protein; a, b, g, d, e, z, Z, y; and i, positions of residues in noneutherian species. Residues in the core and the central channel of the human TTR subunit, according to Blake et al. (1974, 1978), are singly and doubly underlined, respectively. Gray shading, amino acids in the central channel those are completely conserved; arrows, positions of exon borders. Sources of TTR sequences: Human (Mita et al. 1984; Tsuzuki et al. 1985); Hedgehog and Shrew (Prapunpoj et al. 2000a); Rhesus monkey 1 and Rhesus monkey 2 (van Jaarsveld et al. 1973); Pig (Duan et al. 1995a); Sheep (Tu et al. 1989); Bovine (Schreiber et al. 1993); Rabbit (Sundelin et al. 1985); Rat (Dickson et al. 1985; Duan et al. 1989; Fung et al. 1988); Mouse (Wakasugi et al. 1985, 1986); Tammar Wallaby (Brack et al. 1995); Grey Kangaroo (Aldred et al. 1997); Brush-tail Possum, Sugar Glider, and Wombat (Richardson et al. 1994); Stripe-faced Dunnart and Grey Opossum (Duan et al. 1995b); Virginia Opossum (Richardson et al. 1996); Chicken (Duan et al. 1991); Pigeon, Emu, and Ostrich (Chang et al. 1999); Crocodile (Prapunpoj et al. 2002); Lizard (Achen et al. 1993); Bullfrog (Yamauchi et al. 1993); Xenopus (Prapunpoj et al. 2000b); Sea Bream (Santos and Power 1999); Lamprey: Petromyzon marinus (Manzon et al. 2007)
Sea bream 45 Xenopus 36 46 Lizard 38 51 56 Crocodile 40 51 58 80 Chicken 40 54 60 79 90 Opossum 45 48 58 72 73 74 Dunnart 41 48 59 72 74 75 82 Sugar 45 48 60 71 74 73 84 89 Glider Kangaroo 40 47 58 71 73 73 82 84 92 Wallaby 41 48 59 71 72 73 83 83 92 98 Mouse 42 47 57 70 75 75 74 75 74 72 72 Rat 44 49 61 68 74 75 73 73 74 71 72 93 Sheep 44 46 57 68 71 75 74 74 75 73 74 82 82 Shrew 42 44 53 68 71 71 69 68 70 67 68 78 79 83 Hedgehog 40 45 60 68 73 76 72 73 73 71 72 85 86 88 90 Human 42 45 53 67 71 74 71 71 72 69 70 81 82 85 85 87 Identity (%) of amino acid sequences were calculated using multiple sequence alignment of ClustalW program (Thompson et al. 1994). Accession number for the sequences: Human, AAA73473; Hedgehog, AAF70058; Shrew, O46375; Sheep, P12303; Rat, P02767; Mouse, P07309; Wallaby, P42204; Kangaroo, Q29616; Sugar Glider, P49142; Dunnart, P49143; Opossum, P49141; Chicken, P27731; Crocodile, O55245; Lizard, P30623; Xenopus, BAA77579; Sea Bream, AAC26108; Lamprey, ABI93605
Table 3.1 Comparison of amino acid sequences of TTRs from 17 vertebrate species Lamprey Sea bream Xenopus Lizard Crocodile Chicken Opossum Dunnart Sugar glider Kangaroo Wallaby Mouse Rat Sheep Shrew Hedgehog
52
P. Prapunpoj ---- Presegment----
Mature Protein------> ---------disordered---------------
Human Hedgehog Shrew Rat Mouse Tammar Wallaby Grey Kangaroo Sripe-faced Dunnart Grey Opossum Chicken Crocodile Lizard Xenopus Lamprey
MASHRLLLLC ******F*** ***R****** ***L**F*** ***L**F*** **F*S***** **F*S***** **F*S***** **F*S****G **F*ST**VF **F*SM**VF *G*SS***V* ***FKSF** *--RFLC**V
-20
-10
LAGLVFVSEA ******M*** *****L*T** ****I*A*** ********** ****A****T ****A****T ****L*L*** **S*L***D* ******L*** ******LT** ***M*YLT** **L*AI**** *VASSSLLCR
GPT *** *** **G **A AAV AAV **V A*V A*L A*L A*L A*P ADD
-1 +1 3
V V V G H A D H K S H E S
H H A I S S S S H
H H H H H H H H E
GTGESKC *Q*** ***Q*** *A***** *A***** EGEH*** ESEH*** *AED*** *AED*** *SVD*** *SID*** *SID*** *EAD*** *GVKDS*
- - - - - - - - - +4
10
-strand ----B---
-strand -----A---
PLMVKVLDAV ********** ********** ********** ********** ********** ********** ********S* ********** ********** ********** ********** ********** *****AI*S*
RGSPAINVAV *****V**** Q****V**** *****VD*** *****VD*** **R**V**D* **R**V**D* *****V**D* *****V**N* *****A**** *****A***I **R**TSI** **I**A*LL* Q*K**AG*KL
HVFRKAADDT K**K****E* R**K****E* K**K*T**GS K**K*TSEGS K**K*TEEQ* K**K*TEEQ* K**K*TEEQ* K**K*SEEQ* K**K****G* K**K*TS*GD K*SKMSEEGD N****TNSGK S*MK*QD*AS
20
30
40
Fig. 3.2 Comparison of intron 1 splice sites of TTRs from 14 vertebrate species The sequences of the first 40 amino acid residues including the presegment of TTR from 13 species are aligned with that of human TTR. An arrow indicates the position of the splice site at the exon 1/exon 2 border. Bold letters are the first amino acid at the N-terminus of the mature TTR polypeptide. Sources of splice site data: Human (Tsuzuki et al. 1985); Rat (Fung et al. 1988); Tammar Wallaby, Grey Kangaroo, Stripe-faced Dunnart, Grey Opossum, Chicken, and Lizard (Aldred et al. 1997); Hedgehog, Shrew, Mouse, Crocodile, Xenopus, and Lamprey (as referenced in Fig. 3.1)
that is, from A, C, or U to G. This conversion apparently has occurred at the 50 end of exon 2 of several TTR genes during evolution of eutherians. The histidine codon CAU in marsupials is possibly converted into the consensus recognition sequence CAG by a single base change from U to G, and, at least one other single base substitution, G to U or C, has occurred to inactivate the former 30 splice site recognition sequence operating in marsupial. A valine codon in position g apparently changed into the 30 splice site recognition sequence CAG, by either three base changes or deletion of the valine codon, during the evolution of the TTR gene in marsupial from its ancestor gene similar to that in bird and reptile. In addition, the conversion of the histidine codon CAU (in position e) or the histidine codon CAC (in position i) to the consensus sequence CAG occurred during evolution of bird and reptile TTR from the amphibian-like ancestor and that of amphibian from the fish-like ancestor TTR, respectively (Fig. 3.3b). These changes during evolution of the 50 end of exon 2 of the TTR gene resulted in a progressive movement of the 30 splice site, but not the 50 splice site of intron 1 (Fig. 3.3a), in the 30 direction and successive steps from fish to amphibian, reptilian and avian, marsupial and, finally, eutherian species, resulting in a progressive shortening of the 50 end of exon 2 and increase in hydrophilicity of the N-terminal region of the TTR subunit.
3.3
Influence of Changes in Gene Structure on Function of TTR
The binding affinities of THs to TTRs from several animal species were revealed (Chang et al.1999; Yamauchi et al. 1998 Prapunpoj et al. 2000b, 2002; Morgado et al. 2008). Affinity to T4 increased while that to T3 decreased during evolution of eutherians from their ancestors. The crystal structure of TTR tetramer revealed that
3 Evolution of Transthyretin Gene Structure
a
AG -8
-7
-6
-5
-4
-3
-2
-1
+1
2
53
guaagu g
3
Human
GGA CUG GUA UUU GUG UCU GAG GCU GGC CCU ACG Gly Leu Val Phe Val Ser Glu Ala Gly Pro Thr
Hedgehog
GGA CUG GUA UUU AUG UCU GAA GCU GGC CCU ACG Gly Leu Val Phe Met Ser Glu Ala Gly Pro Thr
**********gau**uau**aaucc*agu*cca*gucuccu*u*uaccucagcug*aguag*gggu
Shrew
GGA CUG GUG CUC GUC ACC GAG GCA GGC CCA ACG Gly Leu Val Leu Val Thr Glu Ala Gly Pro Thr
*********aaau*cugugaagucc*u*c***cc*uuuccugacuag*cga*ccag**gugacu**
gugaguguuucugugacaucccauuccuacauuuaagauucacgcuaaaugaaguagaagugacuc
Rat
GGA CUG AUA UUU GCG UCU GAA GCU GGC CCU GGG Gly Leu Ile Phe Ala Ser Glu Ala Gly Pro Gly
*******g*c******guga**caga*auggcagguagac*uuagau**agg***gccucccu*ca
Mouse
GGA CUG GUA UUU GUG UCU GAA GCU GGC CCC GCG Gly Leu Val Phe Val Ser Glu Ala Gly Pro Ala
*******a*c******gcgau*caga*auggcaguuagac*uuagau**a****a**ugccuu**u
Wallaby
GGC CUG GCG UUU GUG UCU GAG ACU GCA GCU GUG GLY Leu Ala Phe Val Ser Glu Thr Ala Ala Val
**a***u*ggu*acugaaagua**c*u*uug*gguuagc*u**ucau*ucc*uagu*g*caagg*a
Kangaroo
GGC CUG GCG UUU GUG UCU GAG ACU GCA GCU GUG Gly Leu Ala Phe Val Ser Glu Thr Ala Ala Val
**a***u*ggu*acuga*aguag*c*u*uug*gguuagc*ucuca**uucau***g**caa*guaa
Dunnart
GGC CUG GUG UUC CUG UCU GAG GCU GGA CCU GUG Gly Leu Val Phe Leu Ser Glu Ala Gly Pro Val
******u*ggu*acuga*aguag***u*cug*ggu*agccucuca**uccau***u**caa*guaa
Opossum
AGC CUG CUG UUU GUG UCU GAU GCU GCU CCU GUG Ser Leu Leu Phe Val Ser Asp Ala Ala Pro Val
******u*ggu*ccuga*aaguca*u**uuug*gguugacucuca**u**aucccuagcagacaag
Chicken
GGA CUG GUA UUU CUC UCC GAA GCU GCA CCA CUG Gly Leu Val Phe Leu Ser Glu Ala Ala Pro Leu
******c***uaaa
Crocodile
GGA CUG GUA UUU CUG ACU GAA GCU GCC CCA CUG Gly Leu Val Phe Leu Thr Glu Ala Ala Pro Leu
**a**c*c*****cauuuagggggcaga*uu*ga*g**c*guaaaau*uaau*aa**u*agc*uaa
Lizard
GGA AUG GUG UAC CUC ACU GAA GCU GCA CCA CUG Gly Met Val Tyr Leu Thr Glu Ala Ala Pro Leu
**a**ca**g*ac**g**aua**g*ggcua*c*agga*aaa*aaugc*g**cucacac*uga*gca
Xenopus
CUA CUG GCA UUU GUC UCA GAG GCU GCA CCA CCG Leu Leu Ala Phe Val Ser Glu Ala Ala Pro Pro
******a*g*ug*g*gu*c*uguaa*aacuca*gcuuuccuuuuaauug*agcacua*g*cuga*g
Lamprey
GCA UCC AGC UCG CUA CUC UGC AGG GCU GAC GAU Ala Ser Ser Ser Leu Leu Cys Arg Ala Asp Asp
**a****caca*caucgucau***cgucg
b
cncuga u u a
c
polypyrimidine tract -
Human
accacaaagaauaaauccuuucacucugaucaauuuuguuaa
-
-
-
cuu cuc acg ugu
-
-
cuu cuc
cag u uac
-
-
G 4
5
6
7
8
9
10
acc cag
↓GGC ACC GGU GAA UCC AAG UGU Gly Thr Gly Glu Ser Lys Cys
Hedgehog
*aaga**ga**a*****a***g*****ugc********c*g*
*** g** *uu ***
**c ***
**u
g** ***
↓--- --- GGU CAA UCC AAG UGU Gly Gln Ser Lys Cys
Shrew
cuag**cu*c*a*g*auaga*guuaaga*cuugccaau**ug
u*g acu u*u ca*
u*g **u
cuu
ug* ***
↓GGC ACU GGU CAG UCC AAG UGU Gly Thr Gly Gln Ser Lys Cys
Rat
***gg******c**gc**a**u*******c*c*c**cac*g*
*a* *** u*u ***
**c ***
**u
g** ***
↓GGU GCU GGA GAA UCC AAG UGU Gly Ala Gly Glu Ser Lys Cys
Mouse
***gg******c**gc*gg**u*******c*c****cac*g*
*a* u** u*u ***
**c ***
*gu
g** ***
↓GGU GCU GGA GAA UCC AAA UGU Gly Ala Gly Glu Ser Lys Cys
Wallaby
g*acuugccu**cuca*u*cag*u*ucc*a**ccccac*g*g
a** u** ugu **c
*** *ca
**g
↓CAC CAU GAA GGU GAG CAU UCC AAG UGC His His Glu Gly Glu His Ser Lys Cys
Kangaroo
ggacuuggcu**cuca*u*cag*u*ucc*a**ccccac*g*g
a** u** ugu **c
*** *ca
c*g
↓CAC CAU GAA AGU GAG CAU UCC AAG UGC His His Glu Ser Glu His Ser Lys Cys
Dunnart
uaacuugccc*gcuca*u**agcuaucc*au*ccccgc*g*g
u** u** ugu **c
*** *ca
c*g
↓GCC CAU GGA GCU GAG GAU UCC AAA UGC Ala His Gly Ala Glu Asp Ser Lys Cys
Opossum
**ucaugccug*cuca*u*cag*ugucc*a**uccccc*g*g
*** u** ugu **c
*** *ca
c*g
↓AUC CAU GGA GCU GAA GAU UCC AAA UGC Ile His Gly Ala Glu Asp Ser Lys Cys
Chicken
gag*agguuuu*gc*aggc*agugaacagcucc***acaacc
uc* *cu cgu *uc
gc* *ag
↓GUC UCC CAU Val Ser His
GGC UCU GUU GAU UCC AAA UGC Gly Ser Val Asp Ser Lys Cys
Crocodile
gauguggu*****gcc**agcgcg*u*ac*gc***ag*cau*
u** u** cu* cu*
ucc aag
↓GUU UCC CAU Val Ser His
GGU UCU AUU GAU UCC AAA UGC Gly Ser Ile Asp Ser Lys Cys
Lizard
uuu*ug*uc**g****ggg**uuag*a*gcauu****ccccc
*cc *c* cac cu*
a** aag
↓GUU UCA CAU Val Ser His
Xenopus
uaaua*u*au*accuaa***c**gca*c**u*ucca*cc*cu
u** g** u*a *ag
↓GGA CAU GCU Gly His Ala
Lamprey
*u*ggugcucgcu**cagccagcgcg**cg*cccacgcac*g
↓GAC CAC AAG AGC CAC GAA TCC CAC GAG GGA GGC GTC AAG GAC TCG TGC Asp His Lys Ser His Glu Ser His Glu Gly Gly Val Lys Asp Ser Cys
UCC CAU Ser His
GGC UCC AUU GAU UCC AAG UGU Gly Ser Ile Asp Ser Lys Cys GGA GAA GCC GAC UCC AAG UGU Gly Glu Ala Asp Ser Lys Cys
Fig. 3.3 Comparison of nucleotide and amino acid sequences of TTRs at the (a) exon 1/intron 1 border and (b) intron 1/exon 2 border. The 50 and 30 splice sites of intron 1 of TTR precursor mRNAs from 13 vertebrate species are aligned with those from human. The splice sites are indicated by arrows. The consensus recognition sequences for splicing (Moore et al. 1993) are indicated in bold above the position of the splice sites in human TTR precursor mRNA. Nucleotides identical with those in the consensus sequence for the 30 splice site branch point are underlined. Nucleotides in exons are in upper case; those in introns are in lower case. The amino acid residues at the N-terminus, determined by Edman degradation of the mature proteins or of the recombinant TTR, and their corresponding codons are represented in bold. For longer nucleotide sequences of intron 1, see Prapunpoj et al. (2002)
54
P. Prapunpoj
amino acid residues that are components in the binding cavity and involved in the binding with THs (Blake et al. 1974, 1978) are conserved. In addition, no amino acid residues of the N-terminal segment of TTR subunit is involved with or is a part of the binding sites. Instead, the N-terminal segment forms a radon-coil structure with high conformational flexibility (Hamilton et al. 1993; Wilce et al. 1995) on the surface of each TTR monomer, located at the entrance of the tunnel containing the TH-binding sites of the TTR tetramer. The direct involvement of these segments in the binding of THs had been, therefore, neglected. However, an indirect involvement has nevertheless been postulated. The influence on the binding of THs perhaps by interfering with the access of THs to the binding sites in the interior of the TTR molecule was demonstrated using a series of chimeric TTRs. By using the heterologous expression system of Pichia pastoris, a methylotrophic yeast, the recombinant native TTRs and the chimeric TTRs in which the N-terminal region was altered or truncated were successfully synthesized (Prapunpoj et al. 2002, 2006). Binding affinities to T4 and T3 of the recombinant TTRs including two native TTRs, that is, from human and saltwater crocodile (Crocodylus porosus), and three C. porosus chimeric TTRs, that is, one with the N-terminal sequence replaced by that of Xenopus laevis TTR (xeno/crocTTR), one with the N-terminal sequence replaced by that of human TTR (human/crocTTR), and the other with the N-terminal segment removed (truncated crocTTR), were determined using a highly reproducible and sensitive method (Chang et al. 1999). Changes in the affinities to T3 and T4 of C. porosus TTR were clearly observed when the nucleotide sequence at the 50 -terminal region of the TTR gene was either altered or truncated (Prapunpoj et al. 2006). The Kd values for T3 and T4 of the recombinant human TTR were 53.26 3.97 and 19.73 0.13 nM, respectively, while those of the recombinant C. porosus TTR were 33.03 0.42 and 55.69 7.69 nM, respectively (Prapunpoj et al. 2002). However, the affinity of human/ crocTTR for T4 (Kd was 22.75 1.89 nM) was higher than that of both human and C. porosus TTRs for T4, but the affinity to T3 (Kd was 5.40 0.25 nM) was similar for C. porosus TTR, which led to a Kd T3/T4 ratio of 0.24. In addition, the truncated crocTTR had a similar affinity for both T3 (Kd was 57.78 5.65 nM) and T4 (Kd was 59.72 3.38 nM), with a Kd T3/T4 ratio of 0.97. These led to the postulation that the N-terminal region has a role in determining the affinities of T3 and T4 to TTR. This hypothesis has been further confirmed by experiments with fish TTR. The affinity for T4 of the sea bream TTR decreased when the first six amino acid residues were removed (Morgado et al. 2008), suggesting a possibility that some residues in the N-terminal segment influence the binding to T4.
3.4
Conclusion
THs are involved in many regulatory aspects of metabolism in vertebrates. Because of its high lipid solubility, binding to TH-binding proteins is a necessity to prevent accumulation of THs in membranes and to ensure the appropriate extracellular and
3 Evolution of Transthyretin Gene Structure
55
intracellular distribution of the hormones. One of the most important and widely known functions of TTR, which acts in a network with other plasma TH-binding proteins, is to ensure an even distribution of THs (synthesized in and secreted from the thyroid gland) to target tissues throughout the body. Among vertebrates, the requirements of THs (in particular, the biologically active form, T3) are varied depending on many factors, including complexity of organs and a particular period of life, for example, during the developmental period, that requires higher concentrations of the hormones circulating in the blood. Differences in the action of THs are principally regulated via the conversion of the more biologically active T3 from the less active T4 by the deiodinases in the specific target tissues. This could also be achieved via influencing distribution of THs during transport in the blood-stream. Although the basic molecular structures of TTRs at both the genomic and the protein levels in all studied vertebrates are similar, for example, all TTR genes comprise four exons and three introns, TTR monomers are rich in b-pleated sheet structure and four monomers form the tetrameric protein. The affinities in binding to T3 and T4 differ quite dramatically during evolution of the vertebrates, that is, the affinity to T4 increased while the affinity to T3 decreased during the evolution of mammalian TTRs from common ancestoral TTRs. These changes in function are influenced by the N-terminal region of the TTR subunit that changed from longer and relatively hydrophobic to shorter and more hydrophilic during evolution. The stepwise shift of the 30 splice site of the TTR intron 1 in the 30 direction has been proven to be the underlying mechanism that led to the systemic change of the N-terminal region of each TTR subunit. The organization of the genome into exons and introns could speed evolution, as changes in one or a few bases occurring near splice sites could result in the deletion or addition of whole sequences of amino acids (Gilbert 1978). Therefore, with the splicing mechanism, novel or functionally improved proteins could be generated during evolution. The single base mutations near splicing sites that can lead to stepwise directional gradual changes in a protein have been demonstrated in TTR gene. It is most likely that during evolution, selection pressure has operated on the length and composition of the 50 end of exon 2 of the TTR gene, leading to the shorter and more hydrophilic N-termini during the evolution of eutherian TTRs from their ancestors. Such shifts could produce the stepwise changes in the functional properties of TTRs, in particular, the changing affinities observed for THs. This stepwise ‘‘improvement’’ of protein function could be the point of operation of selection pressure and it is an example of a molecular mechanism of positive Neo-Darwinian evolution.
References Achen MG, Duan W, Pettersson TM, Harms PJ, Richardson SJ, Lawrence MC, Wettenhall REH, Aldred AR, Schreiber G (1993) Transthyretin gene expression in choroid plexus first evolved in reptiles. Am J Physiol Regulat Integr Comp Physiol 265:R982–R989.
56
P. Prapunpoj
Aldred AR, Prapunpoj P, Schreiber G (1997) Evolution of shorter and more hydrophilic transthyretin N-termini by stepwise conversion of exon 2 into intron 1 sequences (shifting the 39 splice site of intron 1). Eur J Biochem 246:401–409. Arachibald AL, Couperwhite S, Jianq ZH (1996) The porcine TTR locus maps to chromosome 6q. Anim Genet 27:351–353. Blake CCF, Oatley SJ (1977) Protein-DNA and protein-hormone interactions in prealbumin: a model of the thyroid hormone nuclear receptor? Nature 268:115–120. Blake CCF, Geisow MJ, Oatley SJ, Re´rat B, Re´rat C (1978) Structure of prealbumin: secondary, ˚ . J Mol Biol tertiary and quaternary interactions determined by Fourier refinement at 1.8 A 121:339–356. Blake CC (1981) Prealbumin and the thyroid hormone nuclear receptor. Proc R Soc Lond B Biol Sci 211:413–431. Brack CM, Duan W, Hulbert AJ, Schreiber G (1995) Wallaby transthyretin. Comp Biochem Physiol 110B:523–529. Blake CCF, Geisow MJ, Swan ID, Rrat C, Rrat B (1974) Structure of human plasma prealbumin at 2.5 A resolution. A preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding. J Mol Biol 88:1–12. Chang L, Munro SLA, Richardson SJ, Schreiber G (1999) Evolution of thyroid hormone binding by transthyretins in birds and mammals. Eur J Biochem 259:534–542. Costa RH, Grayson DR (1991) Site-directed mutagenesis of hepatocyte nuclear factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal synergistic interactions with its enhancer region. Nucleic Acids Res 19:4139–4145. Costa RH, Lai E, Darnell JE (1986) Transcriptional control of the mouse prealbumin (transthyretin) gene: Both promoter sequences and a distal enhancer are cell specific. Mol Cell Biol 6:4697–4708. Costa RH, Lai E, Grayson DR, Darnell JE (1988) The cell-specific enhancer of the mouse transthyretin (prealbumin) gene binds a common factor at one site and a liver-specific factor (s) at two other sites. Mol Cell Biol 8(1):81–90. Costa RH, Grayson DR, Darnell JE (1989) Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and a1-antitrypsin genes. Mol Cell Biol 9:1415–1425. Costa RH, van Dyke TA, Yan C, Kuo F, Darnell JE (1990) Similarities in transthyretin gene expression and differences in transcription factors: live rand yolk sac compared to choroid plexus. Proc Natl Acad Sci USA 87:6589–6593. Dickson PW, Howlett GJ, Schreiber G (1985) Rat transthyretin (prealbumin): molecular cloning, nucleotide sequence, and gene expression in liver and brain. J Biol Chem 260:8214–8219. Duan W, Cole T, Schreiber G (1989) Cloning and nucleotide sequencing of transthyretin (prealbumin) cDNA from rat choroids plexus and liver. Nucleic Acids Res 17:3979. Duan W, Achen MG, Richardson SJ, Lawrence MC, Wettenhall REH, Jaworowski A, Schreiber G (1991) Isolation, characterization, cDNA cloning and gene expression of an avian transthyretin. Implications for the evolution of structure and function of transthyretin in vertebrates. Eur J Biochem 200:679–687. Duan W, Richardson SJ, Ko¨hrle J, Chang L, Southwell BR, Harms PJ, Brack CM, Pettersson TM, Schreiber G (1995a) Binding of thyroxine to pig transthyretin, its cDNA structure, and other properties. Eur J Biochem 230:977–896. Duan W, Richardson SJ, Babon JJ, Heyes RJ, Southwell BR, Harms PJ, Wettenhall REH, Dziegielewska KM, Selwood L, Bradley AJ, Brack CM, Schreiber G (1995b) Evolution transthyretin in marsupials. Eur J Biochem 227:396–406. Fung WP, Thomas T, Dickson PW, Aldred AR, Milland J, Dziadek M, Power B, Hudson P, Schreiber G (1988) Structure and expression of the rat transthyretin (prealbumin) gene. J Biol Chem 263:480–488. Gilbert W (1978) Why genes in pieces? Nature 27:501. Grayson DR, Costa RH, Darnell JE (1989) Regulation of hepatocyte-specific gene expression. Ann NY Acad Sci 557:243–256.
3 Evolution of Transthyretin Gene Structure
57
Hamilton JA, Steinrauf LK, Braden BC, Liepnieks JJ, Benson MD, Holmgren G, Sandgren O, Steen L (1993) The X-ray crystal structure refinements of normal human transthyretin and the ˚ resolution. J Biol Chem 268:2416–2424. amyloidogenic Val30! Met variant to 1.7 A Jinno Y, Matsumoto T, Kamei T, Kondoh T, Maeda S, Araki S, Shimada K, Nukawa N (1986) Localization of the human prealbumin gene to 18p11.1-q12.3 by gene dose effect study of southern blot hybridization. Jpn J Human Genet 31:243–248. Larsen NJ, Womack JE, Kirkpatrick BW (1996) Seven genes from human chromosome 18 map to chromosome 24 in the bovine. Cytogenet Cell Genet 73:184–188. Manzon RG, Neuls TM, Manzon LA (2007) Molecular cloning, tissue distribution, and developmental expression of lamprey transthyretins. Gen Comp Endocrinol 151:55–65. Mita S, Maeda S, Shimada K, Araki S (1984) Cloning and sequence analysis of cDNA for human prealbumin. Biochem Biophys Res Commun 124:558–564. Moore MJ, Query CC, Sharp PA (1993) Splicing of precursors to mRNA by the spliceosome. In: Gesteland RF, Atkins JF (eds) The RNA World. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, pp 303–357. Morgado I, Melo EP, Lundberg E, Estrela NL, Sauer-Eriksson AE, Power DM (2008) Hormone affinity and fibril formation of piscine transthyretin: The role of the N-terminal. Mol Cell Endocrinol 295(1–2):48–58. Motojima K, Goto S (1989) Brain-specific expression of transthyretin mRNA as revealed by cDNA cloning from brain. FEBS Lett 258:103–105. Motojima K, Goto S (1990) Dual promoters and tissue-specific expression of rat transthyretin gene. Biochem Biophys Res Commun 173:323–330. Nagata Y, Tashiro F, Yi S, Murakama T, Maeda S, Takahashi K (1995) A 6-kb upstream region of the human transthyretin gene can direct development, tissue-specific, and quantitatively normal expression in transgenic mouse. J Biochem 117:169–175. Prapunpoj P, Richardson SJ, Fumagalli L, Schreiber G (2000a) The evolution of the thyroid hormone distributor protein transthyretin in the order Insectivora, class Mammalia. Mol Biol Evol 17:1199–1209. Prapunpoj P, Yamauchi K, Nishiyama N, Richardson SJ, Schreiber G (2000b) Evolution of structure, ontogeny of gene expression, and function of Xenopus laevis transthyretin. Am J Physiol 279:R2026–R2041. Prapunpoj P, Richardson SJ, Schreiber G (2002) Crocodile transthyretin: structure, function, and evolution. Am J Physiol 283:R885–R896. Prapunpoj P, Leelawatwatana L, Schreiber G, Richardson SJ (2006) Change in structure of the Nterminal region of transthyretin produces change in affinity of transthyretin to T4 and T3. FEBS J 273:4013–4023. Qiu H, Shimada K, Cheng Z (1992) Chromosomal localization of the mouse prealbumin gene (Ttr) by in situ hybridization. Cytogenet Cell Genet 61:186–188. Remmers EF, Goldmuntz EA, Zha H, Crofford LJ, Cash JM, Mathern P, Du Y, Wilder RL (1993) Linkage map of seven polymorphic markers on rat chromosome 18. Mamm Genome 4:265–270. Richardson SJ, Bradley AJ, Duan W, Wettenhall REH, Harms PJ, Babon JJ, Southwell BR, Nicol S, Donnellan SC, Schreiber G (1994) Evolution of marsupial and other vertebrate thyroxinebinding plasma proteins. Am J Physiol Regulat Integr Comp Physiol 266:R1359–R1360. Richardson SJ, Wettenhall REH, Schreiber G (1996). Evolution of transthyretin gene expression in the liver of Didelphis virginiana and other American marsupials. Endocrinology 137:3507–3512. Samadani U, Costa RH (1996) The transcriptional activator hepatocyte nuclear factor 6 regulates liver gene expression. Mol Cell Biol 16:6273–6284. Samadani U, Qian X, Costa RH (1996) Indentification of a transthyretin enhancer site that selectively binds the hepatocyte nuclear factor-3 beta isoform. Gene Expr 6:23–33. Santos CRA, Power DM (1999) Identification of transthyretin in fish (Sparus aurata): cDNA cloning and characterisation. Endocrinology 140:2430–2433.
58
P. Prapunpoj
Sasaki H, Yoshioka N, Takagi Y, Sasaki Y (1985) Structure of the chromosomal gene for human serum prealbumin. Gene 37:191–197. Sasaki Y, Yoshioka K, Tanahashi H, Furuya H, Sasaki H (1989) Human transthyretin (prealbumin) gene and molecular genetics of familial amyloidotic polyneuropathy. Mol Biol Med 6:161–168. Schreiber G, Pettersson TM, Southwell BR, Aldred AR, Harms PJ, Richardson SJ, Wettenhall REH, Duan W, Nicol SC (1993) Transthyretin expression evolved more recently in liver than in brain. Comp Biochem Physiol 105B:317–325. Soares ML, Centola M, Chae J, Saraiva MJ, Kastner DL (2003) Human transthyretin intronic open reading frames are not independently expressed in vivo or part of functional transcripts. Biochim Biophys Acta 1626:65–74. Sparkes RS, Sasaki H, Mohandas T, Yoshioka K, Klisak I, Sakaki Y, Heinzmann C, Simon M (1987) Assignment of the prealbumin (PALB) gene (familial amyloidotic polyneuropathy) to human chromosome region 18q11.2-q12.1. Hum Genet 75:151–154. Sundelin J, Melhus H, Das S, Eriksson U, Link P, Tra¨gargh L, Peterson PA, Rask L (1985) The primary structure of rabbit and rat prealbumin and a comparison with the tertiary structure of human prealbumin. J Biol Chem 260:6481–6487. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680. Tsuzuki T, Mita S, Maeda S, Araki S, Shimada K (1985) Structure of the human prealbumin gene. J Biol Chem 260:12224–12227. Tu G-F, Cole T, Duan W, Schreiber G (1989) The nucleotide sequence of transthyretin cDNA isolated from a sheep choroid plexus cDNA library. Nucleic Acids Res 17:6384. van Jaarsveld PP, Edelhoch H, Goodman DS, Robbins J (1973) The interaction of human plasma retinol-binding protein and prealbumin. J Biol Chem 248:4698–4705. Wakasugi S, Maeda S, Shimada K, Nakashima H, Migita S (1985) Structure comparisons between mouse and human prealbumin. J Biochem (Tokyo) 98:1707–1714. Wakasugi S, Maeda S, Shimada K (1986) Structure and expression of the mouse prealbumin gene. J Biochem (Tokyo) 100:49–58. Wallace MR, Naylor SL, Kluve-Beckerman B, Long GL, McDonald L, Shows TB, Benson MD (1985) Localization of the human prealbumin gene to chromosome 18. Biochem Biophys Res Comm 129:753–758. Wilce JA, Craik DJ, Ede N, Jackson DC, Schreiber G (1995) 1H NMR studies of peptide fragments from the N-terminus of chicken and human transthyretin. Biochem Mol Biol Int 36:1153–1159. Wojtczak A, Cody V, Luft JR, Paugborn W (1996) Structure of human transthyretin complexed ˚ resolution. ˚ resolution and 30 , 50 -dinitro-N-acetyl-L-thyronine at 2.2 A with thyroxine at 2.0 A Acta Crystallogr D52:758–765. Yamauchi K, Kasahara T, Hayashi H, Horiuchi R (1993) Purification and characterization of a 3,5,30 -L-triiodothyronine-specific binding protein from bullfrog tadpole plasma: a homolog of mammalian transthyretin. Endocrinology 132:2254–2261. Yamauchi K, Takeuchi H, Overall M, Dziadek M, Munro SLA, Schreiber G (1998) Structural characteristics of bullfrog (Rana catesbeiana) transthyretin and its cDNA: comparison of its pattern of expression during metamorphosis with that of lipocalin. Eur J Biochem 256:287–296.
Chapter 4
Evolutionary Insights from Fish Transthyretin Deborah M. Power, Isabel Morgado, and Joa˜o C.R. Cardoso
Abstract Thyroid hormones (THs) synthesised and released by the thyroid follicles in fish circulate bound to TH distributor proteins (THDPs). Transthyretin (TTR) is a tetrameric THDP with a conserved structure in vertebrates and functions as a high affinity T4 binder in tetrapods and as a dual T3/T4 binder in fish. The difference in TH affinity appears to be linked to the longer N-terminal region in piscine TTR. Relatively few studies exist on gene regulation in fish, but those that do indicate that it may be similar to those described in mammals. Recently, a family of transthyretin-like proteins was identified and shown to correspond to the enzyme 5-hydroxyisourate hydrolase (HIUase) of purine metabolism in zebra fish. A combination of in silico and laboratory-based approaches indicate that TTR has a widespread distribution but is most abundant in liver, while HIUase expression seems to be mainly in the liver. Gene transcripts encoding TTR and HIUase genes are described in representatives of the orders Cypriniformes, Salmoniformes, Pleuronectiformes, Perciformes, Tetraodontiformes, Beloniformes, Gasterosteiformes, Gadiformes and Petromyzontiformes. The evolution of TTR and HIUase genes in fish is discussed. Keywords Evolution, Gene structure, Gene linkage, Regulation, Tissue distribution
Abbreviations RBP THs
Retinol binding protein Thyroid hormones
Deborah M. Power (*) Comparative and Molecular Endocrinology Group, Centre for Marine Sciences (CCMAR), Universidade do Algarve, Campus do Gambelas, 8005-139 Faro, Portugal e-mail: dpower @ualg.pt
S.J. Richardson and V. Cody (eds.), Recent Advances in Transthyretin Evolution, Structure and Biological Functions, DOI: 10.1007/978‐3‐642‐00646‐3_4, # Springer‐Verlag Berlin Heidelberg 2009
59
60
THDP T4 TBG TSH TTR TLP T3
4.1
Deborah M. Power et al.
Thyroid hormone distributor protein Thyroxine Thyroxine-binding globulin Thyroid stimulating hormone Transthyretin Transthyretin-like proteins Triiodothyronine
Introduction
Fish are the most successful group of extant vertebrates with an estimated 25,000 species, which may increase in number when molecular methods for classification are applied. Fish are part of the subphylum Vertebrata (possessing a cranium and vertebrae) and include the ‘ancient’ jawless Agnatha and modern jawed fish such as the cartilaginous Chondrichthyes (which includes sharks and rays) and the bony Osteichthyes (which includes ray-finned fish, Actinopterygii and lung fish). The fish are of considerable scientific interest because of their basal position in the evolution of vertebrates the existence of a variety of genome sizes and ploidy levels, the specific genome duplication proposed to have occurred in the teleost lineage (Ohno 1970; Jaillon et al. 2004; Taylor et al. 2003), their adaptation to a wide range of aquatic habitats throughout the World, their extreme biological diversity and the numerous examples of active speciation. In fact, fish have been crucial in establishing current models of vertebrate genome evolution (Jaillon et al. 2004; Ventakesh 2003). Despite their diversity and even taking into account the very limited number of species studied, there appears to have been a general conservation of an important regulatory network, the endocrine system. The thyroid system is no exception and most of the elements of this endocrine axis are conserved from fish to mammals. The present review will focus on one of the thyroid hormone distributor proteins (THDP), transthyretin (TTR), in fish. The recently identified family of genes encoding TTR-like proteins (TLP) will be touched upon in the context of TTR evolution in fish, as these recently identified proteins are dealt with in detail in other chapters of the present book. A number of reviews exist about TTR in vertebrates and provide an integrated picture of evolution and function of this protein across diverse classes of animals (Richardson 2007; Schreiber and Richardson 1997), and so this will only briefly be considered. The thyroid axis will be overviewed for readers unfamiliar with fish endocrinology and an update of the status of TTR in fish, which was first reviewed in 2000 will be given (Power et al. 2000). Some unpublished data will be introduced to highlight new and pertinent information about piscine TTR gene evolution and function.
4 Evolutionary Insights from Fish Transthyretin
4.2
61
Thyroid Axis
The thyroid hormones (THs), thyroxine (T4) and triiodothyronine (T3), are produced by thyroid follicles, which in most fish are not encapsulated in a gland but instead are scattered throughout the connective tissue of the lower jaw usually aggregated around the ventral aorta (reviewed by Bentley 1998; Leatherland 1994). The basic structural unit of the thyroid is the follicle, which is composed of a single layer of epithelial cells surrounding a central colloid-filled cavity. The thyroid appears to have the longest phylogenetic history of any endocrine gland and its basic follicular unit has been conserved in all vertebrates and homologous tissues have been identified in protochordates, including amphioxus (Cephalochordata) and ascidians (Urochordata) (Barrington 1962). The central components of the thyroid axis have largely been conserved across vertebrates, and in fish, thyroid function from TH biosynthesis to TH action seem to fit the mammalian model. Thyroid stimulating hormone (TSH) stimulates T4 secretion from the thyroid, which is converted in the periphery to T3 by deiodination. A family of selenoprotein enzymes, the deiodinases (I, II and III), activate and inactivate the THs in fish, including agnathans, chondrichthyes and teleosts (Orozco and Valverde-R 2005). THs bring about their action by binding to nuclear thyroid receptors (TRs) and activate or repress gene expression (Chin and Yen 1997; Zhang and Lazer 2000). The cytosolic TH-binding proteins and plasma membrane TH transporters identified in mammals still remain to be characterised in fish. In contrast to mammals, where plasma T4 largely exceeds T3 levels (50–100:1), plasma T3 levels in teleosts may exceed that of T4, suggesting a strong 50 -monodeiodination activity, and peripheral deiodination may be the primary control of teleost thyroid function (reviewed in Eales and Brown 1993; Power et al. 2008). In teleosts, as in mammals, more than 99% of the THs do not circulate in the free form (Eales and Shostak 1985; Weirich et al. 1987) but are bound to plasma proteins including lipoproteins (Babin 1992). In fish, TH transport by plasma proteins is poorly explored and so far only two of the three THDPs present in the blood of mammals have been reported, albumin (Richardson et al. 1994) and TTR (Kawakami et al. 2006; Santos and Power 1999; Yamauchi et al. 1999; Manzon et al. 2007).
4.3
Thyroid Hormones Distributor Proteins
The relative abundance and hormone binding properties of THDPs are not conserved in vertebrates. In a series of studies, reviewed by Richardson (2002), the presence of THDPs in serum samples from representatives of different vertebrates (mammals, birds, reptiles, amphibians and also fish, (Richardson et al. 2005)) was analysed. As albumin is the only THDP identified in all species studied, it is
62
Deborah M. Power et al.
proposed to be the evolutionarily oldest TH carrier protein. The same studies suggest an apparent absence of TTR in the plasma of adult amphibians, reptiles and fishes, although the presence of gene transcripts and protein is well established for the early stages of development (Funkenstein et al. 1999; Kawakami et al. 2006; Richardson et al. 2005; Santos and Power 1996, 1999; Yamauchi et al. 1993, 1998, 1999), which are characterised by a surge in TH blood levels (Hulbert 2000). The recent development of specific anti-sera for piscine TTR its presence by revealed by both western blot and ELISA blood of juvenile as a tetramer in juvenile (5 months), young adult (13 months) and adult (26 months) sea bream (Sparus aurata, Morgado et al. 2007b) and several other perciform species (authors’ observations). These data raise questions about why TTR was not detected in adult blood in the previous studies that used binding assays followed by native electrophoresis (Richardson et al. 2005). In the study by Morgado et al. (2007b), a specific ELISA was developed and revealed that the concentration of TTR in sea bream plasma is 4 mg ml1, which is 100 times lower than that in human plasma (0.3 mg ml1) (Ingenbleek et al 1972; Purkey et al. 2001; Sachs and Bernstein 1986), and may explain the failure to detect it in binding assays. In fact, it has been estimated that in humans the concentration of plasma TTR largely exceeds that of plasma THs (0.05-0.12 mg ml1), and less than 1% is estimated to be involved in TH transport (Robbins and Bartalena 1986). In this context, it has been proposed that the large excess of plasma TTR is associated with its second important function, to bind and transport all-trans-retinol complexed with retinol binding protein (RBP) and thus reduce glomerular filtration of retinol (Kanai et al. 1968; Monaco et al. 1995; Peterson 1971; Van Jaarsfeld et al. 1973). In the 1970s, RBP was isolated from the plasma of several fish species (Shidoji and Muto 1977) and rainbow trout (Oncorhynchus mykiss) and was shown to interact weakly with mammalian TTR (Berni et al. 1992). The subsequent cloning and isolation of TTR (Santos and Power 1996, 1999; Yamauchi et al. 1999; Kawakami et al. 2006; Manzon et al. 2007) and RBP (Bellovino et al. 2001; Sammar et al. 2001) from fish permitted binding studies with the piscine proteins, which revealed that TTR has a very low affinity for RBP (Folli et al. 2003). More recently, it has been clearly demonstrated that they do not form a complex (Zanotti et al. 2008). We hypothesise that the high circulating levels of plasma TTR and its tendency to form a TTR-RBP complex in mammals and birds (Heller 1976; Kopelman et al. 1976; Blaner 1989; Blomhoff et al. 1990), but not in fish, may indicate that the role of TTR in retinol transport may be an innovation in tetrapods. Further studies will be required to clarify when TTR emerged as an RBP binder in vertebrates and the evolutionary pressure that favoured the molecular modifications in the gene(s) which led to this function. Confirmation of whether RBP exists or not in lamprey (Petromyzon marinus, Lampetra appendix) and studies of its interaction with recently cloned lamprey TTR (Manzon et al. 2007) should contribute to resolve this issue. Nonetheless, preliminary analysis of the amino acids in TTR important for the stabilization of the TTR-RBP complex in humans (Folli et al. 2003)
4 Evolutionary Insights from Fish Transthyretin
63
reveals that they are more conserved in lamprey (5 out of 8 amino acids) than in sea bream (2 out of 8 amino acids).
4.4
Structure and Hormone Binding Characteristics
Cloning of sea bream TTR cDNA coupled with homology modelling using human (Hamilton et al. 1993) (PDB ID: 1tta), rat (Wojtczak et al. 2001) (PDB ID: 1gke) and chicken (Sunde et al. 1996) (PDB ID: 1tfp) TTR predicted that the overall topology of sea bream TTR is preserved, although its surface potential, especially at the TH binding site, is much more electronegative in chicken and sea bream (Power et al. 2000). Subsequent crystallographic studies confirmed the conserved structure of sea bream TTR with that of mammalian and avian TTRs (Folli et al. 2003; Eneqvist et al. 2004) and revealed that it is a tetramer that contains two high affinity sites to which L-T4 may bind. The TH binding site is highly conserved, although Ser 117 (human sequence) is substituted by Thr in sea bream TTR (Folli et al. 2003). The affinity of fish TTR for THs is ambiguous and initial qualitative binding studies indicated that T3 appeared to have greater affinity than T4 for sea bream TTR. However, the development of a specific binding assay using recombinant sea bream TTR revealed that it binds T4 and T3 with a similar affinity (9.8 0.97 and 10.6 1.7 nM, respectively; Morgado et al 2008). Interestingly, truncation of the N-terminal region of the protein modified its affinity for T4 but did not significantly affect its affinity for T3 (Morgado et al. 2008). The results of this study substantiate the idea that the N-terminus of TTR plays an important role in determining hormone affinity (Prapunpoj et al. 2006). Recent studies have revealed that in common with what is observed in other vertebrates (Brouwer et al. 1999; Cheek et al. 1999; Ishihara et al. 2003a, b; Lans et al. 1993; McKinney and Waller 1994; Rickenbacher et al. 1986; Yamauchi et al. 2000), piscine TTR has a high affinity for a number of pollutants commonly found in the environment (Morgado et al. 2007a). Interestingly, however, despite the relatively high overall sequence and structural conservation of vertebrate TTR, the binding profile of chemical contaminants varies, for example, diethylstilbestrol (DES) and pentachlorophenol are powerful inhibitors of [125I] T3 binding to chicken, bullfrog, Xenopus, Rana and Japanese quail TTR, but have poor affinity for piscine TTR (Ishihara et al. 2003a, b; Morgado et al. 2007a; Yamauchi et al. 2000). It will be of interest in the future to establish the structural basis of this differing affinity and such studies may help to better define tetramer/ligand interactions. Moreover, understanding the biological consequences for the organism of the high affinity of some pollutants for TTR represents a significant challenge because of the importance of THs at different stages of the life cycle. The tendency of pollutants to accumulate in aquatic ecosystems (from industrial residues, land run-offs and acid rains) and the consequent continuous exposure of aquatic organisms to such pollutants make studies in aquatic vertebrates such as fish pertinent.
64
4.5 4.5.1
Deborah M. Power et al.
Evolution TTR Tissue Distribution and Function
TTR has been identified in most vertebrate classes, including placental mammals, marsupials, birds, reptiles, amphibians and fish (Dickson et al. 1985; Duan et al. 1991, 1995; Larsson et al. 1985; Manzon et al. 2007; Mita et al. 1984; Prapunpoj et al. 2000a, 2002; Richardson et al. 1994, 1997; Santos and Power 1996, 1999; Tsuzuki et al. 1985; Yamauchi et al. 1993, 1999), and their overall amino acid sequence similarity is relatively high. TTR tissue expression and secretion is variable in the vertebrates in which it has been studied, and on the basis of the existing data, its specific expression in the liver or choroid plexus has been proposed to be class- and stage-dependent (reviewed in Richardson 2007). To explain life-stage-specific variations in the expression of TTR and other THDPs, it has been hypothesised that an augmented THDP network occurs at times of elevated TH in blood, such as, during development (Richardson et al. 2005). As mentioned earlier, fish are extremely diverse, and representatives from only a fraction of the superorders have been studied. However, considerably more examples from fish are required before a clear picture of the evolution of TTR, and its tissue-specific expression or life-stage-specific variations can be established. In Cyclostomata (e.g. lamprey), RT-PCR has revealed moderate TTR expression in the liver and heart and low expression in the brain gills, gut, kidney and blood of larvae (Manzon et al. 2007). Analysis of TTR was restricted to the liver and brain in adult fish, where the expression appeared to be much lower than that of the larval and juvenile stages. Analysis of TTR expression in other fish is restricted to a salmoniform (masu salmon, Oncorhynchus masu) and two perciformes (sea bream and Pacific bluefin tuna, Thunnus orientalis). In these species, TTR appears to be expressed during ontogeny (Funkenstein et al. 1999; Santos and Power 1996, 1999) and in juveniles, principally in the liver, although in the sea bream it is also detected at appreciable levels in the intestine and heart and to a lesser extent in the kidney, skin and brain (Power et al. 2000). Despite repeated attempts to identify TTR protein by immunohistochemistry (IHC) in the liver of juvenile and adult sea bream, sea bass (Dicentrarchus labrax) and Atlantic halibut (Hippoglossus hippoglossus), it has not been possible (unpublished observations). Western blot of adult sea bream liver extracts also revealed relatively low concentrations of TTR protein in spite of fairly constant circulating concentrations (4 mg ml1) and generally high hepatic transcript abundance. We hypothesise that such observations are consistent with the constitutive release of TTR (Morgado et al. 2007b). In addition, the detection of TTR in adult plasma suggests that it is very important as a THDP during development in fish. Relatively few physiological studies of TTR have been carried out on fish and its regulation and response to changing conditions remain largely unknown. In the sea bream injection of the sex steroid, estradiol-17 (5 mg g1 body weight) causes a reduction in hepatic TTR transcripts (Funkenstein et al. 2000), although it remains
4 Evolutionary Insights from Fish Transthyretin
65
to be established if this is a normal physiological response during reproduction. Food restriction for several weeks in sea bream (Power et al. 2000) causes downregulation of liver TTR mRNA expression, suggesting that fish may be similar to mammals in which TTR is a marker of malnutrition or stress (Ingenbleek et al. 1972; Ingenbleek and Young 1994, 2002; Ingenbleek and Berstein 1999; Beck and Rosenthal 2002; Brugler et al. 2002). When plasma T3 or T4 are increased in fish, there is a significant increase in the circulating levels of TTR, although hepatic transcription is unchanged (Morgado et al. 2007b). Further studies of hepatic gene regulation and protein turnover are required to elucidate the way in which TTR contributes to TH homeostasis and whole animal physiology in fish.
4.5.2
TTR and TLP Evolution in Fish
The integration of data about TTR gene sequence, protein structure and hormone affinity across vertebrates has led to a general evolutionary model. TTR is proposed to have changed from a T3 binder in ‘lower vertebrates’ to a T4 binder in eutherians as a result of changes in the length of the N-terminal region. In vertebrates, the TTR gene is composed of four coding exons, and the longer hydrophobic N-terminus in fish and the shorter hydrophilic region in mammals are a consequence of a shift in the intron1/exon2 splice site during evolution (Aldred et al. 1997; Prapunpoj et al. 2000a, b, 2002). In masu salmon and bluefin tuna, the affinity of TTR is greater for T3, and in sea bream, TTR has similar affinity for T3 and T4 and the N-terminus of the fish proteins is several amino acids longer than mammalian TTR (Kawakami et al. 2006; Morgado et al. 2008; Yamauchi et al. 1999). The affinity of lamprey TTR for THs has not yet been determined, but analysis of the 50 region of the genomic DNA is consistent with the proposed evolutionary model and the N-terminus is nine amino acids longer than mammalian TTR (Manzon et al. 2007). The increase in available sequence data for fish in recent years makes evolutionary studies relevant, although a more comprehensive analysis still requires the inclusion of sequences from far more species. A family of transthyretin-like proteins (TLPs) or transthyretin-related proteins (TRPs, Eneqvist et al 2003) has recently been identified in prokaryotes and eukaryotes and shown to be enzymes (Lee et al. 2005; Ramazzina et al. 2006). The enzyme 5-hydroxyisourate hydrolase (HIUase) of purine metabolism in zebra fish (Danio rerio, Q06S87) is a TLP, and duplication of this gene is proposed to have given rise to TTR in vertebrates (Zanotti et al. 2006). To conduct phylogenetic analysis of TTR and TLP in fish, extensive searches in Genebank (www.ncbi.nlm.nih.gov) and Ensembl (www. ensembl.org) (October 2008) were carried out and specific cDNA, ESTs and predicted genes were retrieved (Table 4.1). It was possible to identify gene transcripts encoding TTR and HIUase genes (TLP) in 18 species, which included representatives of the orders Cypriniformes, Salmoniformes, Pleuronectiformes, Perciformes, Tetraodontiformes, Beloniformes, Gasterosteiformes, Gadiformes and Petromyzontiformes. The ESTs encoding TTR were identified in a range of
66
Deborah M. Power et al.
Table 4.1 Accession numbers of the TTR and HIUase (TLPs) proteins, predicted genes and ESTs clones identified by searching public databases (available from NCBI and Ensembl) using the mature precursor sequences of published teleost TTR sequences with the tBlastn algorithm (sequences with e-value smaller than 105 were selected) Accession numbers Observations ACTINOPTERYGII (ray-finned fishes) Beloniformes Oryzias latipes (Medaka) TTR Not identified HIUase1 AM156132 BJ516106, BJ010835, BJ024650, DK059860, DK047918, DK070190, DK164988, DK141970, DK082087, DK145206, DK168247, DK170492, DK147440 BJ910632, DK261436, DK261403, DK242464, DK261679, DK242707, DK242998, DK261968, DK229688, DK248571 DC247390, DC256322 ENSORLG00000009326 HIUase2 ENSORLG00000000779 Gasterosteiformes Gasterosteus aculeatus (Three-spined stickleback) TTR Not identified HIUase1 DN731287, DW668813, DW668812 ENSGACG00000015936 HIUase2 ENSGACG00000008507 Perciformes Sparus aurata (Seabream) TTR CB184881, CB184737, CB184929 AAC26108 HIUase
AM950811, AM952219, AM952201, AM951997 Dicentrarchus labrax (Seabass) TTR CV186278 HIUase FM000902, FM000585 FM019182 Pleuronectiformes Platichthys flesus (Flounder) TTR DW985862 ABU54858 HIUase DV566090, EC378613 Psetta maxima (Turbot) TTR Not identified HIUase EY454781
Neurula Embryo
Liver
Fin Predicted Predicted
Brain Predicted Predicted
Liver and embryos Santos and Power (1999) Liver
Liver Liver Kidney
Liver Goetz et al. (unpublished) Liver
Liver (continued )
4 Evolutionary Insights from Fish Transthyretin Table 4.1 (continued) Accession numbers Tetraodontiformes Tetraodon nigroviridis (Green spotted pufferfish) TTR CR642656, CR635654, CR650478, CR649397, CR636486, CR651447, CR651621, CR652101, CR656042 ENSTNIG00000010473 HIUase SCAFFOLD_14581 Takifugu rubripes (Japanese pufferfish) TTR ENSTRUG00000006085 HIUase1 SCAFFOLD_2288 HIUase2 SCAFFOLD_9318 Cypriniformes Danio rerio (Zebra fish) TTR CN167258 EH532041, EH505861,EH515185, EH488817 AAI64894, XP_001919368 HIUase BC090440, BC097189 Q06S87 ENSDARG00000068644 Cyprinus carpio (Common carp) TTR CA966004, CA964904 CAD66520 HIUase Not identified Carassius auratus (Goldfish) TTR ABY40363 HIUase Not identified Gobiocypris rarus (Rare minnow) TTR ACE74244 HIUase EE394013 Gadiformes Gadus morhua (Cod) TTR ES240035, ES238908, ES239200, ES240301 HIUase ES471358 Salmoniformes Oncorhynchus mykiss (Rainbow trout) TTR BX886606, CX256523,BX878043, BX878043, CU073679, CX256522, CA377780 CX152238,CX148258,CX139266,CX138173, CX138172 CB497711 HIUase CU066583 BJ494178 Salmon salar (Atlantic salmon) TTR CK888905, BE518610, AM397609
67
Observations
Liver
Predicted Predicted Predicted Predicted Predicted
Liver Gut/Internal Organs Predicted Embryo Zanotti et al. (2006) Predicted Liver Apreda et al. (unpublished)
Wiens et al. (unpublished)
Li et al. (unpublished) Liver
Liver Liver
Multi-tissues Juvenile Steelhead Multi-tissues Embryo Liver (continued )
68 Table 4.1 (continued) Accession numbers CK887387 CK895595 CK990828 HIUase EG904021, EG904019 Thymallus thymallus (Grayling) TTR FF846145, FF846144 HIUase Not identified CEPHALASPIDOMORPHI (Lampreys) Petromyzontiformes Petromyzon marinus (Sea lamprey) TTR ABI93605 HIUase Not identified Lampetra appendix (American brook lamprey) TTR ABI93606 HIUase Not identified
Deborah M. Power et al.
Observations Kidney Swim bladder Multi-tissues Multi-tissues Multi-tissues
Manzon et al. (2007)
Manzon et al. (2007)
different piscine tissue libraries, which included liver, gut, kidney, swimbladder, whole juvenile and embryo. In contrast, HIUase cDNAs were principally identified in liver, although they were also identified in whole embryo and trunk kidney cDNA, suggesting this gene may have a more restricted tissue distribution than TTR, although gene expression studies are required to confirm the in silico results. An alignment of piscine TTR and HIUase amino acid sequences (Fig. 4.1) revealed that they are highly conserved. A novel zebra fish HIUase gene (HIUase2) was identified and duplicate HIUase genes were also found in stickleback (Gasterosteus aculeatus), Takifugu (Takifugu rubripes) and medaka (Oryzias latipes) genomes (Fig. 4.1). In common with the gene structure of teleost TTR, four coding exons were also identified for HIUase genes and sequence comparison suggests that in some species N-terminal splicing of the HIUase gene probably occurs and accounts for shorter transcripts lacking exon 1, which are similar in size to the mouse homologue. In the other teleosts for which sequence data exists, a single copy gene for HIUase was identified and the presence of a duplicate copy remains to be established. The teleost TTR and HIUase genes share conserved splice consensus regions and the signature motifs identified in prokaryotes and eukaryotes such as the N-terminal VKILDAV and C-terminal GHRHY in TTR and DGRCPG in TLPs are also present (Hennebry et al. 2006). The C-terminal TLP motif, YRGS, was present in nearly all piscine HIUase, with the exception of stickleback HIUase2 (ENSGACG00000008507, contig_1506) in which R has been substituted by T (YTGS) and in medaka HIUase2 (ENSORLG00000000779, chromosome 6) where the C-terminal YRGS motif is substituted by HRSN. Of particular note was the large number of cDNAs identified for HIUase in the medaka, which were the product of the HIUase1 gene. However, no EST transcripts
4 Evolutionary Insights from Fish Transthyretin
SP
TTR Mouse Seabass Seabream Flounder Takifugu* Tetraodon Goldfish* Carp Zebrafish Cod Trout Salmon Grayling* Lamprey SeaLamprey
69
MASLRLFLLCLAGLVFVSEAGPA--------GAGESKC MVK MLQP-LRCLLLTSAVLLCNATPT---PTEKHGGTDTRC TVK MLQP-LHCLLLASAVLLCNTAPT---PTDKHGGSDTRC MVK -IQP-VHCLLLASAVLLCNSSPT---PTEKHGGSDTKC TVK -----------------------------AHGGSDTKC TVK MLPL-LLSLLLVSAALPSHAAPV----LKSHGGSDTTC TVK -------------------SAPV-----GIHGGSDAHC TVK MAKA-VICVLLVSLFACCRSAPV-----GIHGGSDVHC TVK MAKE-VICVLLASLFALCRSAPV-----AFHGGSDAHC TVK MMRP-LLWLLLASISLPCDTAPV-----EKHGESDTTC MVK MDSS-LLCVLLATAVLLCSAAPV-----DRHGESDTHC MVK MDSS-LLCVLLAAAVLLCSAAPV-----DRHGESDTHC MVK ------------------------------------------K MTRFLCLLVLVASSSLLCSADDDHKSHESHEGGVKDSC MVKA -MRFLCLLVLVASSSLLCRADDDHKSHESHEGGVKDSC MVKA
AVR AVK AVK AVK AVK AVK AVK AVK AVK AVK AVK AVK AVK SVR SVQ
S AVD T AGS T AGS T AGS T AGP TAAGP T AGN T AGN T AGN L AAS V AGA V AGA V AGS K AAG K AAG
A A A A A A A A A A A T A K K
K K K K N T D D D K S S S S S
F-KKTSEGS S-QKAADGG S-QKTADGA F-QKAADGA Y-QRTADGG Y-KKAADGG Y-RQEQGGT Y-RQDQGGT F-RQDQGGT S-KKGTDGE S-RRVNGMT S-RRVNEMT S-RRVNGMT M-KKQEDAS M-KKQDDAS
--------------------------------MATESS TTH TAS L AQG ---------MSTFR-LQQLKGHISPENKITTMASLE-S TTH VAM V ASN -------------------------------MSTAEVS TTQ SSD V GAR -------------------------------MAGSA-S TTH TAT V GAN ---------------------------------MMESCT TTH SVD V AAR --------MAAAESSPLTTHVLNTGDGVPAAMAAAESS TTH TGD V AAR ---------MGANR-LQQLKGHILPENKITAMAGSP-S TTH TGM V GSN ---------MSVSR-LQKLKGHILSENKSTAMAGSP-S TTH TAL I ASN -------------------------------MAAAASS TTH TGD I AAK -------------------------------------- TTH TAM I ASN -------------------------------------------------------------------------------------------S TTH TGM I ASN -----------MNR-LQHIRGHIVSADKHINMSATLLS STH IAQ V GAN ------------------------------MSSASDIS STH TGD V AQR -----------MNR-LQHIRGHIVSADKY--MAATLPS TTH TAQ V GAN ---------MSADRRLHNLSNQIVAANPCGAMAQPG-S TTH TAM V GSN ---------MSTSR-LQHIKDHLLDEYTCAEMAAPY-S TTH TGM V GAH ------------------------------MSSTLPNS TTY TGD V GAR ------------MIKFLLFLAIAAATVISNAELAVPTAS SAH ISG S AGG
C T A T A A A A A A A A T T T T A A Q
R SRLEAPCQQ R YRQDPSSKT S HRLDSELVI S HRQDPLTSA S HRLEPPLMV S HRLDSDLMI S YRQDPSTNV S SRQVPSTND S HRLDSELMI H YRQDPSTNA S HRLDSKLMI N YRKDPSNDT V HRLDPVSSA S HRLEPRITV I YRLDPISSV L YKQDSSAAA S HRMDPSTSL S HRLDSLLVI LAFILLN--NG
EPFAS TH AN TQ AT TQ AN TQ AN TQ AN EK AS EK AS EK AS TH AI AQ AS AQ AS AQ AS KE AT KE AT
K AES V AT V AT V DT M AS T AT KV IT KV MT KV MT V ET V LT V LT V LT V GKT V GKT
ELHG EIHD EIHN ESHN EIHN EIHE EVHN EVHN EVHN EVHN EVHN EVHN EVHN ESHH ESHH
78 82 82 81 57 81 62 80 80 80 80 80 44 86 85
RTSY LD NT I AD SV T EA TT I AD SL T ED SV T ED TT T DD IN T DD SI T ED KT T ED SV - ED KT T ED TT I DD TV S ED TT T ED TT I SD TT T DD TV T DD GSQF QDN
RCPG RYPG RCPG RCPG RCSG RCPG RCPG RCPG RCPG RCPG CCPG RCPG RCPG RCPG RCPG RCPG RCPG RCPG RVDW
55 76 56 55 54 79 76 76 56 49 31 50 75 57 73 77 76 57 73
HIUase Mouse Medaka1 Medaka2 Stickleback1 Stickleback2 Seabass2 Seabream1 Flounder1 Turbot2 Takifugu1* Takifugu2* Tetraodon1* Zebrafish1 Zebrafish2 Minnow1 Cod1 Trout1 Salmon2 Celegans
ME QL TM SL SL NM SL TL NM SL NM SL NI SL NL NL NL NL TN
TTR Mouse Seabass Seabream Flounder Takifugu* Tetraodon Goldfish* Carp Zebrafish Cod Trout Salmon Grayling* Lamprey SeaLamprey
TTDEK TEQQ TEQQ TEQQ TEQK PEEA TEQE TEQE AEQE TDQQ SDQD SDQD SEQD GDKD SDKD
VE PA PA SA LP PP TP TP TP PA QS QS QA TE T TE T
ELD E D E D E D D D D D E D E D E D D D E D E D E D R D R E
KS KA KA KS KS KA KS KA LT KA KA KA KA QA QQ
KTL KNE TNQ KNE KNE MNE KAE KAE KTE KSQ KSQ KSQ KSQ TKA TKT
I P S P S P S P SVP N P R P R P R P S P T P T P T P I P I P
HEFAD TANDSGHRH T AA P TAVVSNPQNHEAAD EAHTEGHRH T A -P TAVVTD-H-HEVAE DAHPEGHRH T A P TAVVSSVHEHEAAD EAHAEGHRH T A P - TAVVTDTHQHEVTN EAHSEGHRH T A P TALVTDVQHHEVTN EAHAGGHRH T A P TALVSDVPHHQL-------------------------------------HQLAD EAHAEGHRH T A P TAVVVKAHEHQLAD EAHAEGHRH T A P TAVVVKAHDHEMAE EAHGEGHLH T A P TAVVS-THQHETAE EAHAEGHRH T A P TAVVMKAHEHETAE EAHAEGHRH T A P TAVVMKAHEHETAE EAHAEGHRH T A P TAVVINAHEHEAAE MAHGAGHKH H P P F A GTIVGDAEGH HEAAE MAHGAGHKH H P P F A GAIVVDGKGH
F H R H R R H H R H R H R R R H R R V
ER AQ AS AQ GS GS VQ AQ GS AK GP AQ GK QQ GK DR GQ GQ EP
KER QES YPYVE TITKETQ-K H P P YRGS ASL D S YPYVE TINDPGQ-K H P R YRGS ESRTQ S YPYVE SISEPEQ-S H A P HRSN QSMEE C YPYVE TINDPGK-KHH P R YRGS ESR Q SLHPYVE SISDHHQ-RIH P R IYTGS ETL Q S YPYVE TISEPDQ-RVH P R YRGS ESL E C YPYVE TINNPGQ-K H P R YRGS ASI D S YPYVE TINDPGL-K H P R YRGS ESL Q S HPYVE TISSPEQ-R H P R YRGS ERI E G YPYVE TINDPGQ-K H P P YRGS ESL HIS YPYVE R---------------------------ESM Q S YPYVE IINDPGQ-K H P R YRGS DAL E C YPYVE TITNTSQ-H H P R YRGS ESL Q S YPYVE TITDVDQ-RLH P R YRGS DAL E C YPYVE TITDPSQ-K H P C YRGS GCL EES YPYVE TIRNPVD-K H P R YRGS GSL E S YPYVE TITDHSQ-K H L C R YRGS ESL HNS YPYVE TITNPNE-R H P R YRGS TAKNVES YPYVE NIRNATQ-H H P T P G YRGS
147 151 151 149 126 150 94 149 149 148 149 149 113 156 155
HIUase Mouse Medaka1 Medaka2 Stickleback1 Stickleback2 Seabass2 Seabream1 Flounder1 Turbot2 Takifugu1* Takifugu2* Tetraodon1* Zebrafish1 Zebrafish2 Minnow Cod1 Trout1 Salmon1 Celegans
TPSQIKP T TKEL TA RREA TP TTQM TS AAREELGP T SRRA AA TKET TP TKEL TP SREA IS TPQA TSD PHPD LP TSQM TS TKEN IA SRDA TP KKES VA TTREL TP TRET TPA TTKA TP SPDFTLIP T
D E E D E E E D E E E D E E E D E E I
118 139 119 118 117 142 139 139 119 112 67 113 138 120 136 140 139 120 136
Fig. 4.1 Multiple sequence alignment of the teleost and lamprey TTR and HIUase mature precursors with mouse TTR and HIUase and C.elegans TLP. The order of teleost sequences in the alignment is in agreement with Table 4.1 and their common names are indicated: Medaka (Oryzias latipes), Stickleback (Gasterosteus aculeatus), Seabass (Dicentrarchus labrax), Seabream (Sparus aurata), Flounder (Platichthys flesus), Turbot (Psetta maxima), Takifugu (Takifugu rubripes), Tetraodon (Tetraodon nigroviridis), Goldfish (Carassius auratus), Carp (Cyprinus carpio), Zebra fish (Danio rerio), Minnow (Gobiocypris rarus), Cod (Gadus morhua), Trout (Oncorhynchus mykiss), Salmon (Salmon salar), Grayling (Thymallus thymallus), Lamprey
70
Deborah M. Power et al.
TAKIFUGU Scaffold_401
TTR ZEBRAFISH Chr24
TETRAODONT Scaffold_14628
ECT2
B4GALT6 TTR
RFC4 B4GALT6
B4GALT6
B4GALT6
TTR
TTR
TTR
0,1M
0,03M
3M
0,124M STICKLEBACK Scaffold_348
MEDAKA Chr3
HIUase ZEBRAFISH Chr 18
TCF25
MVD PDCD5
HIUase1
MTHFSD9 TCF25
TCF25 HIUase1
PDCD5
PDCD5
MTHFSD
MVD FOXF1
FOXF1
MTHFSD
HIUase1 0,029M
Chr6 Chr 25
RFWD3 HIUase2 0,1M 0,4M
MOUSE Chr 7 PCDC5
0.1M Scaffold_1056
0,2M
ZNF277P
MOUSE Chr 18
ECT2 RFC4
TNN12
ZNF277P TNN12
TNN13 CACNA2D4 LRTM2
TNN13 CACNA2D4
RFWD3 HIUase2 ZNF277P
HIUase2
HIUase 9M
LRTM2 RFWD3 0.4M
Fig. 4.2 Comparison of the TTR and HIUase (TLPs) gene environments in teleosts with the mouse homologue regions. Genes are presented by open boxes and chromosomes or genome fragments by vertical lines. Only common genes are represented and are named according to HUGO annotation. TTR and HIUase genes are in bold and underlined and their respective linked genes, B4GALT6 and PDCD5 are in bold. Homologue genes were identified based upon their sequence similarity using the BLAST programme and the linkage maps were constructed based on gene annotated available from Mapviewer (http://www.ncbi.nlm.nih.gov/mapview/) and Ensembl (www.ensembl.org) databases. The figure is not drawn to scale and the size of the genome regions analysed is indicated
< Fig. 4.1 (continued) (Lampetra appendix) and Sea lamprey (Petromyzon marinus). The HIUase duplicates identified in teleosts are designated as 1 (most similar to the published zebra fish HIUase sequence) and 2. Vertical arrows indicate the localisation of exon–intron splice sites and the double arrow the homologue region of the human signal peptide sequence (SP). The degree of amino acid conservation between TTR and HIUase is indicated by shading and an asterisk (*) indicates teleost sequences that are incomplete. Specific motifs previously identified by Hennebry et al. (2006) are within open boxes and the region where amino acids are proposed to have been lost at the 50 end of exon 2 is in a dashed box. The conserved exon–intron splice sites are indicated by open arrows and the closed arrow indicates the beginning of the homologue region of the mature human TTR protein. Accession numbers of the predicted genes, ESTs and peptides used to generate the alignment are indicated in Table 4.1. The Minnow TTR sequence was not included as it was very incomplete. The accession numbers for TTR and HIUase from mouse (Mus musculus) are NP_038725 and Q9CRB3, respectively, and transthyretin-like protein (TLP) for C. elegans is ZK697
4 Evolutionary Insights from Fish Transthyretin
71
for its paralogue or for the predicted stickleback HIUase2 gene were identified, suggesting that they may be low abundance or expressed in tissues for which few ESTs exist in the NCBI database. A further intriguing observation in the medaka and stickleback was the failure to identify a homologue of the teleost TTR gene despite the extensive number of Genebank sequences that exist for both model organisms (22,500 and 19,000, respectively, in the Unigene database, http://www. ncbi.nlm.nih.gov/), and it will be of interest to explore the significance of these observations. It is generally accepted that gene duplication has fuelled organismal complexity, and two major rounds of genome duplications (1R and 2R) are suggested to have occurred at the origin of vertebrates. Such events explain the general increase in gene number in vertebrate genomes and provide a plausible explanation as to how TTR emerged in the vertebrates. Despite the demonstrated sequence and structural conservation of TTR and HIUase (TLP) genes in vertebrates, comparison of the immediate gene environment fails to reveal homologous regions, suggesting that after gene duplication the future TTR gene was transposed to a different genome region (Fig. 4.2). However, some conservation of the flanking genes exist in teleosts and mammals and homologues of B4GALT6 map in close proximity to TTR and homologues of PDCD5 are linked to teleost HIUase1 and mouse HIUase, suggesting that the HIUase2 gene is the duplicated gene form of TLPs, which arose from a specific duplication event. The failure so far to identify a TTR paralogue in teleosts may indicate that it was either eliminated from the genome or arose as a consequence of partial genome duplication.
Acknowledgements Some of the work described was co-financed by POCI 2010 and European Social Funds attributed by the Portuguese National Science Foundation (FCT) to project POCTI/ CVT/38703/2001 and Pluriannual funding to CCMAR.
References Aldred A, Prapunpoj P, Schreiber G (1997) Evolution of shorter and more hydrophilic transthyretin N-termini by stepwise conversion of exon 2 into intron 1 sequences (shifting the 3’ splice site of intron 1). Eur J Biochem 246:401–409 Babin PJ (1992) Binding of thyroxine and 3,5,30 -triiodothyronine to trout plasma lipoproteins. Am J Physiol 262:E712–E720 Barrington EJ (1962) Hormones and vertebrate evolution. Experientia 18:201–210 Beck FK, Rosenthal TC (2002) Prealbumin: a marker for nutritional evaluation. Am Fam Phys 65:1575–1578 Bentley PJ (1998) Comparative Vertebrate Endocrinology, 3rd edn. Cambridge University Press, Cambridge Bellovino D, Morimoto T, Mengheri E, et al. (2001) Unique biochemical nature of carp retinolbinding protein: N-linked glycosylation and uncleavable NH2-terminal signal peptide. J Biol Chem 276:13949–13956
72
Deborah M. Power et al.
Berni R, Stoppini M, Zapponi MC (1992) The piscine plasma retinol-binding protein: purification, partial amino acid sequence and interaction with mammalian transthyretin. Eur J Biochem 204:99–106 Blaner WS (1989) Retinol binding protein: the serum transport protein for vitamin A. Endocr Rev 26:1241–1251 Blomhoff R, Green MH, Berg T, Norum KR (1990) Transport and storage of vitamin A. Science 250:399–404 Brouwer A, Longnecker MP, Birnbaum LS, et al. (1999) Characterization of potential endocrinerelated health effects at low-dose levels of exposure to PCBs. Environ Health Perspect 107 (Suppl 4):639–649 Brugler L, Stankovic A, Bernstein L, et al. (2002). The role of visceral protein markers in protein calorie malnutrition. Clin Chem Lab Med 40:1360–1369 Cheek AO, Kow K, Chen J, McLachlan JA (1999) Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin. Environ Health Perspect 107:273–278 Chin WW, Yen PN (1997) Molecular mechanisms of nuclear thyroid hormone action. In: Braverman LR (ed) Diseases of the Thyroid. Humana Press, pp. 1–15 Dickson PW, Howlett GJ, Schreiber G (1985) Rat transthyretin (prealbumin). Molecular cloning, nucleotide sequence, and gene expression in liver and brain. J Biol Chem 260:8214–8219 Duan W, Achen MG, Richardson SJ, et al. (1991) Isolation, characterization, cDNA cloning and gene expression of an avian transthyretin. Implications for the evolution of structure and function of transthyretin in vertebrates. Eur J Biochem 200:679–687 Duan W, Richardson SJ, Babon JJ, et al. (1995) Evolution of transthyretin in marsupials. Eur J Biochem 227:396–406 Eales J, Brown S (1993) Measurements and regulation of thyroidal status in teleost fish Rev. Fish Biol Fish 3:299–347 Eales JG, Shostak S (1985) Free T4 and T3 in relation to total hormone, free hormone indices, and protein in plasma of rainbow trout and arctic charr. Gen Comp Endocrinol 58:291–302 Eneqvist T, Lundberg E, Karlsson A, et al. (2004) High resolution crystal structures of piscine transthyretin reveal different binding modes for triiodothyronine and thyroxine. J Biol Chem 279:26411–26416 Eneqvist T, Lundberg E, Nilsson L, et al. (2003) The transthyretin-related protein family. Eur J Biochem 270:518–532 Folli C, Pasquato N, Ramazzina I, et al. (2003) Distinctive binding and structural properties of piscine transthyretin. FEBS Lett 555:279–284 Funkenstein B, Bowman CJ, Denslow ND, et al. (2000) Contrasting effects of estrogen on transthyretin and vitellogenin expression in males of the marine fish, Sparus aurata. Mol Cell Endocrinol 167:33–41 Funkenstein B, Perrot V, Brown CL (1999) Cloning of putative piscine (Sparus aurata) transthyretin: Developmental, expression and tissue distribution. Mol Cell Endocrinol 157:67–73 Hamilton JA, Steinrauf LK, Braden BC, et al. (1993) The X-ray crystal structure refinements of ˚ resolution. normal human transthyretin and the amyloidogenic Val-30 ! Met variant to 1.7 A J Biol Chem 268:2416–2424 Heller J (1976) Purification and evidence for the identity of chicken plasma and egg yolk retinolbinding protein-prealbumin complex. Dev Biol 51:1–9 Hennerbry SC, Wright HM, Likic VA, et al. (2006) Structural and functional evolution of transthyretin and transthyretin-like proteins. Proteins 64:1024–1045 Hulbert AJ (2000) Thyroid hormones and their effects: a new perspective. Biol Rev Camb Philos Soc 75:519–631 Ingenbleek Y, Bernstein L (1999) The stressful condition as a nutritionally dependent adaptive dichotomy. Nutrition 15:305–320 Ingenbleek Y, De Visscher M, De Nayer P (1972) Measurement of prealbumin as index of proteincalorie malnutrition. Lancet 2(7768):106–109
4 Evolutionary Insights from Fish Transthyretin
73
Ingenbleek Y, Young VR (1994) Transthyretin (prealbumin) in health and disease: nutritional implications. Ann Rev Nutr 14:495–533 Ingenbleek Y, Young VR (2002) Significance of transthyretin in protein metabolism. Clin Chem Lab Med 40:1281–1291 Ishihara A, Nishiyama N, Sugiyama SI, Yamauchi K (2003a) The effect of endocrine disrupting chemicals on thyroid hormone binding to Japanese quail transthyretin and thyroid hormone receptor. Gen Comp Endocrinol 134:36–43 Ishihara A, Sawatsubashi S, Yamauchi K (2003b) Endocrine disrupting chemicals: interference of thyroid hormone binding to transthyretins and to thyroid hormone receptors. Mol Cell Endocrinol 199:105–117 Jaillon O, Aury J-M, Brunet F, et al. (2004) Genome duplication in the teleost fish Tetraodon nigroviridis reveals the early vertebrate proto-karyotype. Nature 431:946–957 Kanai M, Raz A, Goodman DS (1968) Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest 47:2025–2044 Kawakami Y, Seoka M, Miyashita S, et al. (2006) Characterization of transthyretin in the Pacific bluefin tuna, Thunnus orientalis. Zoolog Sci 23:443–448 Kopelman M, Cogan U, Mokady S, Shinitzky M (1976) The interaction between retinol binding proteins and prealbumins studied by fluorescence polarization. Biochim Biophys Acta 439: 449–460 Lans MC, Klasson-Wehler E, Willemsen M, et al. (1993) Structure-dependent, competitive interaction of hydroxy-polychlorobiphenyls, -dibenzo-p-dioxins and -dibenzofurans with human transthyretin. Chem Biol Interact 88:7–21 Larsson M, Petterson T, Carlstrom A (1985) Thyroid-hormone binding in the serum of 15 vertebrate species: isolation of thyroxine binding globuline and prealbumin analogs. Gen Comp Endocrinol 58:360–375 Leatherland J (1994) Reflections on the thyroidology of fishes: from molecules to humankind. Guelph Ichthyology Rev 2:1–67 Lee Y, Lee do H, Kho CW, et al. (2005) Transthyretin-related proteins function to facilitate the hydrolysis of 5-hydroxyisourate, the end product of the uricase reaction. FEBS Lett 579:4769–4774 McKinney JD, Waller CL (1994) Polychlorinated biphenyls as hormonally active structural analogues. Environ Health Perspect 102:290–297 Manzon RG, Neuls TM, Manzon LA (2007) Molecular cloning, tissue distribution, and developmental expression of lamprey transthyretins. Gen Comp Endocrinol 151:55–65 Mita S, Maeda S, Shimada K, Araki S (1984) Cloning and sequence analysis of cDNA for human prealbumin. Biochem Biophys Res Com 124:558–564 Morgado I, Hamers T, Van der Ven L, Power DM (2007a) Disruption of thyroid hormone binding to sea bream recombinant transthyretin by ioxinyl and polybrominated diphenyl ethers. Chemosphere 69:155–163 Morgado I, Melo EP, Elisabeth Sauer-Eriksson A, et al. (2008) Piscine transthyretin hormone affinity and fibril formation: the role of the N-terminal. Mol Cell Endocrinol. 295:48–58 Morgado I, Santos CRA, Jacinto R, Power DM (2007b) Regulation of transthyretin by thyroid hormones in fish. Gen Comp Endocrinol 152:189–197 Monaco HL, Rizzi M, Coda A (1995) Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. Science 268:1039–1041 Ohno S (1970) Evolution by Gene Duplication. Springer, Berlin Orozco A, Valverde R-C (2005) Thyroid hormone deiodination in fish. Thyroid 15:799–813 Peterson PA (1971) Studies on the interaction between prealbumin, retinol-binding protein, and vitamin A. J Biol Chem 246:44–49 Power DM, Elias NP, Richardson SJ, et al. (2000) Evolution of the thyroid hormone-binding protein, transthyretin. Gen Comp Endocrinol 119:241–255 Power DM, Silva N, Campinho MA (2008) Metamorphosis. In: Finn RN, Kapoor BG (eds) Fish Larval Physiology. Science Publishers, USA
74
Deborah M. Power et al.
Prapunpoj P, Leelawatwatana L, Schreiber G, Richardson SJ (2006) Change in structure of the N-terminal region of transthyretin produces change in affinity of transthyretin to T4 and T3. FEBS J 273:4013–4023 Prapunpoj P, Richardson SJ, Schreiber G (2002) Crocodile transthyretin: structure, function, and evolution. Am J Physiol 283:R885–R896 Prapunpoj P, Richardson SJ, Fugamalli L, Schreiber G (2000a) The evolution of the thyroid hormone distributor protein transthyretin in the order Insectivora, class Mammalia. Mol Biol Evol 17:1199–1209 Prapunpoj P, Yamauchi K, Nishiyama N, et al. (2000b) Evolution of structure, ontogeny of gene expression, and function of Xenopus laevis transthyretin. Am J Physiol 279:R2026–R2041 Purkey HE, Dorrell MI, Kelly JW (2001) Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma. PNAS 98:5566–5571 Ramazzina I, Folli C, Secchi A, et al. (2006) Completing the uric acid degradation pathway through phylogenetic comparison of whole genomes. Nature Chem Biol 2:144–148 Richardson SJ (2002) The evolution of transthyretin synthesis in vertebrate liver, in primitive eukaryotes and in bacteria. Clin Chem Lab Med 40:1191–1199 Richardson SJ (2007) Cell and molecular biology of transthyretin and thyroid hormones. Int Rev Cytol 258:137–193 Richardson SJ, Bradley AJ, Duan W, et al. (1994) Evolution of marsupial and other vertebrate thyroxine-binding plasma proteins. Am J Physiol 266:R1359–R1370 Richardson SJ, Hunt JL, Aldred AR, et al. (1997) Abundant synthesis of transthyretin in the brain, but not in the liver, of turtles. Comp Biochem Physiol B 117:421–429 Richardson SJ, Monk JA, Shepherdley CA, et al. (2005) Developmentally regulated thyroid hormone distributor proteins in marsupials, a reptile, and fish. Am J Physiol 288:R1264– R1272 Rickenbacher U, McKinney JD, Oatley SJ, Blake CC (1986) Structurally specific binding of halogenated biphenyls to thyroxine transport protein. J Med Chem 29:641–648 Robbins J, Bartalena L (1986) Plasma transport of thyroid hormones. In: Thyroid Hormone Metabolism. Marcel Dekker, New York Sachs E, Bernstein LH (1986) Protein markers of nutrition status as related to sex and age. Clin Chem 32(2):339–341 Sammar M, Babin PJ, Durliat M, et al. (2001) Retinol binding protein in rainbow trout: molecular properties and mRNA expression in tissues. Gen Comp Endocrinol 123:51–61 Santos CRA, Power DM (1996) Piscine (Sparus aurata) transthyretin. Ann Endocrinol 57:58 Santos CRA, Power DM (1999) Identification of transthyretin in fish (Sparus aurata): cDNA cloning and characterisation. Endocrinol 140:2430–2433 Schreiber G, Richardson SJ (1997) The evolution of gene expression, structure and function of transthyretin. Comp Biochem Physiol B 116:137–160 Shidoji Y, Muto Y (1977) Vitamin A transport in plasma of the non-mammalian vertebrates: Isolation and partial characterisation of piscine retinol binding protein. J Lipid Res 18:679–691 Sunde M, Richardson SJ, Chang L, et al. (1996) The crystal structure of transthyretin from chicken. Eur J Biochem 236:491–499 Taylor JS, Braasch I, Frickey T, et al. (2003) Genome duplication, a trait shared by 22,000 species of ray-finned fish. Genome Res 13:382–390 Tsuzuki T, Mita S, Maeda S, et al. (1985) Sturcture of the human prealbumin gene. J Biol Chem 260:12224–12227 Van Jaarsveld PP, Edelhoch H, Goodman DS, Robbins J (1973) The interaction of human plasma retinol-binding protein and prealbumin. J Biol Chem 248:4698–4705 Venkatesh B (2003) Evolution and diversity of fish genomes. Curr Opin Genet Dev 13:588–592 Weirich RT, Schwartz HL, Oppenheimer JH (1987) An analysis of the interrelationship of nuclear and plasma triiodothyronine in the sea lamprey, lake trout, and rat: evolutionary considerations. Endocrinol 120:664–677
4 Evolutionary Insights from Fish Transthyretin
75
Wojtczak A, Cody V, Luft JR, Pangborn W (2001) Structure of rat transthyretin (rTTR) complex with thyroxine at 2.5 A resolution: first non-biased insight into thyroxine binding reveals different hormone orientation in two binding sites. Acta Crystallog D 57:1061–1070 Yamauchi K, Kasahara T, Hayashi H, Horiuchi R (1993) Purification and characterization of a 3,5,30 -L-triiodothyronine-specific binding protein from bullfrog tadpole plasma: a homolog of mammalian transthyretin. Endocrinol 132:2254–2261 Yamauchi K, Nakajima J-I, Hayashi H, et al. (1999) Purification and characterization of thyroidhormone-binding protein from masu salmon serum: A homolog of higher-vertebrate transthyretin. Eur J Biochem 265:944–949 Yamauchi K, Prapunpoj P, Richardson SJ (2000) Effect of diethylstilbestrol on thyroid hormone binding to amphibian transthyretins. Gen Comp Endocrinol 119:329–339 Yamauchi K, Takeuchi H, Overall M, et al. (1998) Structural characteristics of bullfrog (Rana catesbeiana) transthyretin and its cDNA: comparison of its pattern of expression during metamorphosis with that of lipocalin. Eur J Biochem 256:287–296 Zanotti G, Cendron L, Ramazzina I, et al. (2006) Structure of zebra fish HIUase: insights into evolution of an enzyme to a hormone transporter. J Mol Biol 363:1–9 Zanotti G, Folli C, Cendron L, et al. (2008) Structural and mutational analyses of proteinprotein interaction between transthyretin and retinol-binding protein. FEBS Journal 275(23): 5841–5854 Zhang J, Lazar MA (2000) The mechanism of action of thyroid hormones. Ann Rev Physiol 62:439–466
Chapter 5
The Salmonella sp. TLP: A Periplasmic 5-Hydroxyisourate Hydrolase Sarah Hennebry
Abstract The primary, secondary, tertiary and quaternary structures of TTRs have been highly conserved during the evolution of vertebrates. This suggests that the TTR gene must have evolved prior to the divergence of vertebrates from invertebrates. Open reading frames predicted to encode a TTR homolog, transthyretin-like protein (TLP) were identified in all kingdoms. The Salmonella dublin TLP was selected as a model by which to characterise the structure, function and evolutionary relationships between TTR and TLP. The X-ray crystal structure of the S. dublin ˚ . As the first X-ray crystal structure of a TLP determined, TLP was solved to 2.5 A the results revealed the remarkable conservation of the TLP/TTR fold. The only significant differences in the structures of S. dublin TLP with TTRs were localised to the dimer–dimer interface and indicated that thyroid hormones could not be bound by TLP. Studies by others had indicated that cytoplasmic TLPs functioned in purine metabolism by hydrolysing 5-hydroxyisourate (5-HIU). It was demonstrated that a periplasmic TLP, the S. dublin TLP also hydrolysed 5-HIU. Three residues at the dimer–dimer interface of S. dublin TLP were shown to be essential for chemical catalysis and are 100% conserved in all TLP sequences but absent in TTRs. Therefore it was proposed that following the duplication of the TLP gene in early protochordate evolution, loss of these catalytic residues resulted in the formation of a deep, negatively charged channel which runs through the centre of the TTR tetramer. The results thus demonstrate the remarkable evolution of the TLP/TTR protein from a hydrolytic enzyme to a thyroid hormone distributor protein. Keywords 5-Hydroxyisourate, Periplasm, TLP
S. Hennebry Human Neurotransmitters Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
S.J. Richardson and V. Cody (eds.), Recent Advances in Transthyretin Evolution, Structure and Biological Functions, DOI: 10.1007/978‐3‐642‐00646‐3_5, # Springer-Verlag Berlin Heidelberg 2009
77
78
5.1
S. Hennebry
Introduction
Studies investigating the evolution of the structure of TTR have highlighted the significant conservation of the primary, secondary, tertiary and quaternary structures of vertebrate TTRs. Alignments of the TTR subunit sequences from the organisms in which it has been identified, revealed significant sequence homology (for a review, see Power et al. (2000) and previous chapter). The most evolutionarily distant TTR sequences, those from human and sea bream, share 48% identity (67% similarity). Within the group of eutherian TTR sequences, the identity is higher, with 82% sequence identity (92% similarity) between human and rat TTR sequences. The significantly higher degree of sequence similarity among TTR sequences compared to sequence identity, suggests that the overall chemical properties of the protein have been conserved throughout its evolution (Power et al. 2000). In the previous chapter, the X-ray crystal structures of TTR from human, rat, chicken and fish were compared. The secondary, tertiary and quaternary structures of these proteins were shown to be highly conserved. Given the homology of TTR structures throughout vertebrate evolution, it was postulated that the TTR gene arose prior to the divergence of vertebrates from invertebrates. In 2000, Prapunpoj et al. (2000) announced the identification of open reading frames (ORFs) in the recently sequenced genomes of invertebrate organisms. These ORFs were predicted to encode a putative TTR homolog which was named the transthyretin-like protein (TLP). At the time, little was known about TLP other than the fact that it shared approximately 60% sequence similarity with TTR. To further characterise the distribution of TLP genes in nature, a more extensive mining of the available databases was required. Determination of the sequence characteristics of TLP and in particular, the shared sequence characteristics of TLP and TTR was also required to elucidate the evolutionary relationship, if any, between TLP and TTR. This chapter focuses on the initial characterisation of TLP structure and function using bioinformatic tools, and the subsequent in vitro characterisation of a bacterial TLP, the Salmonella sp. TLP.
5.2 5.2.1
The Identification of Non-Vertebrate TTR Homologs The Relative Distributions of TTR and TLP Genes
At the time of the first discovery of TLP ORFs, in 2000, very few genomes had been completely sequenced. The last decade has seen a considerable shift in the manner and speed with which protein phylogenies could be determined as a result of large-scale sequencing of genomes from a wide variety of organisms. Genome sequence data have increased exponentially and have enabled the completion of a more thorough analysis of the distribution of TLP genes by examining the number of organisms with TLP genes (Eneqvist et al. 2003; Hennebry et al. 2006a).
5 The Salmonella sp. TLP: A Periplasmic 5-Hydroxyisourate Hydrolase
79
Phylogenetic analyses have also been used to provide a powerful insight into the evolution of these two protein families (Eneqvist et al. 2003; Hennebry et al. 2006a). The results of the bioinformatic analyses have provided an important ‘first step’ in our understanding of TLP and have influenced the direction of subsequent research. To date, in excess of 200 individual TLP sequences have been identified using a combination of BLAST and HMM searches (Hennebry et al. 2006a). TLP genes are found in all kingdoms. In contrast, TTR genes are only found in vertebrate genomes. This finding has led to the hypothesis that the TTR gene may have evolved from the duplication of the TLP gene in early vertebrate evolution (Hennebry et al. 2006a).
5.2.2
Motifs Characterising TLP and TTR Sequences
In order to better define the sequence characteristics of TLP and TTR and to distinguish between the two protein families, the sequences were probed for isolated signature motifs (Hennebry et al. 2006a). The high level of similarity between TTR sequences was such that a single motif was found to span the entire protein. Therefore, a set of TTR-specific motifs was unattainable. However, five motifs were identified among TLP sequences (A–E) and were found in the arrangement (E), B, D, C, A along the length of the protein sequence (Fig. 5.1a(i)). Motif A, which corresponds to the region of greatest similarity between TLP sequences, was found at the C-terminal region of the sequences and included a consensus YRGS tetrapeptide which was 100% conserved in all TLP sequences. Motif B is the second strongest motif and was found in the N-terminal region of the protein. Motifs C and D were found in the middle of the TLP sequences. Motif E was only found in TLPs from plant species and from two alphaproteobacteria: Bradyrhizobium japonicum and Magnetospirillum magnetotacticum. Motif E is homologous to the proteins of COG 3195 (Cluster of Orthologous Groups), a group of bacterial proteins where the entire protein is made up of this single domain. Motif E has been subsequently identified as a unique protein, OHCU decarboxylase whose function relative to TLP will be discussed further in chapter ‘Clinical Implications of TTR Amyloidosis’. Three motifs were identified to be in common between TLP and TTR sequences: A’, B’ and C’ (Fig. 5.1a(ii)). Motif A’ is equivalent to Motif A of the TLP-only set: at the C-termini of the proteins. Motif A’ is the most highly conserved among the set of TLP + TTR sequences. Motif B’ in the TLP + TTR set completely overlapped with the Motif B in the TLP only set, and extended for three and five residues further toward the N- and C-termini, respectively. Motif C’ found in the TLP + TTR set was shorter (15 vs. 21 residues) but partially overlapped Motif C in the TLP only set. The absence of a Motif D’ in the TLP + TTR set implied that Motif D is specific for TLP sequences and is the region with the least similarity between TTR and TLP sequences (Fig. 5.1a(ii)).
80
S. Hennebry
Fig. 5.1 Motifs identified in TLP sequences and in the set of TLP + TTR sequences. (a) Motifs identified in (i) TLP sequences and (ii) TTR + TLP sequences. (i) In the set of TLP sequences, five motifs were identified (A–E). The motifs are found in the order (E), B, D, C, A, with A being the most highly conserved. Motif E (not shown) is only found in the TLPs from plants and the a-proteobacteria Magnetospirillum magnetotacticum and Bradyrhizobium japonicum. (ii) In the set of TTR + TLP sequences, three motifs were identified. Motif A’ is equivalent to Motif A from the TLP motif set. Motif B’ is similar but extended in the N- and C-terminal regions to Motif B. Motif C’ is shorter than Motif C and its location is shifted towards the N-terminus. Motif D is specific to the TLP set of proteins. Motifs logos were generated using the MEME program (Bailey and Elkan 1994). (c) The motifs identified in the TLPs correlate to regions of structural significance. (i) TheSalmonella dublin sequence is shown with the predicted secondary structure indicated above the sequence. Motifs identified in common between TLPs and TTRs are indicated below the alignment of the S. dublin TLP sequence with that of human TTR. The experimentally determined secondary structure of human TTR is indicated above its sequence. The alignments indicate that the primary and secondary structures of TLPs and TTRs are highly conserved. (ii) The motifs identified in common between TLPs and TTRs were superimposed on the tertiary structure of sea bream TTR (Folli et al. 2003). Motif A’ lines the hydrophobic core. Motif B’ forms the dimer–dimer interface and the entrance to the hydrophobic core. Motif C’ forms the monomer– monomer interface. The program SWISS-PDB viewer was used to generate the figure (from Hennebry et al. 2006a)
5.2.3
Structural Significance of Motifs
In order to determine whether the conserved sequence motifs corresponded to regions of structural significance, a homology model of the Salmonella dublin TLP was constructed (Hennebry et al. 2006a). The S. dublin TLP was selected for this analysis as it was among the first TLP sequences identified (Prapunpoj et al. 2000). In addition, the predicted amino acid sequences from Salmonella sp. were identical, and so the S. dublin TLP would represent TLPs from this genus. The sequence motifs which were determined to be common to both TLP and TTR sequences were aligned with the predicted and experimentally determined secondary structures of TLP and TTR respectively (Fig. 5.1b(i)). Motif A’ corresponded to b-strand Gloop-strand H region of TTR. Motif B’ corresponded to b-strand A-loop-strand B region of TTR. Motif C’ corresponded to b-strand E-turn-a-helix of TTR. The equivalent regions of the S. dublin TLP were predicted to share the same secondary structure features as TTRs (Hennebry et al. 2006a). These results suggested that the
5 The Salmonella sp. TLP: A Periplasmic 5-Hydroxyisourate Hydrolase
81
conserved motifs might correspond to important structural features of the TTR tetramer. The motifs were then superimposed onto the crystal structure coordinates of sea bream TTR (pdb identifier: 1OO2; Folli et al. 2003) (Fig. 5.1b(ii)). The residues comprising Motif A’ (the most highly conserved motif) were found to line the dimer–dimer interface of the protein and were also potentially involved in monomer–monomer interactions. The residues comprising Motif B’ were also found to cluster at the dimer–dimer interface of the protein, this time forming the entrance to the ligand binding channel of TTR. Residues comprising Motif C’ were also found to have a structural role, potentially in monomer–monomer interactions. The finding that the sequence motifs conserved between TLP and TTR corresponded to structurally important regions of the TTR tetramer lent further weight to the prediction that TLP shares similar secondary and tertiary structures to TTR. The identification of the motifs specific to TLP and to the set of TLP + TTR revealed that the regions of greatest similarity between the proteins are in the Nand C-terminal regions and that these correspond to the b-strands (strands A, B, G and H) forming the entrance to and lining the dimer–dimer interface of the TTR tetramer. However, a close examination of the differences between the TLPspecific motifs and TLP + TTR motifs revealed important information regarding the likely ligand(s) of TLPs. The ligands of TTR (thyroid hormones and related compounds) bind deep within the central channel of the protein, formed by the dimer–dimer interface. Important residues involved in this ligand binding include: Lys15, Glu54 and Thr119. An inspection of the dimer–dimer interface in the molecular models generated for the S. dublin TLP suggested a structurally distinct binding channel. The presence of conserved histidine, arginine and tyrosine residues in all TLP sequences at the equivalent regions of Lys15, Glu54 and Thr119 in all TTR sequences suggested that the central channel would be considerably smaller and more positively charged in TLP. These observations suggested that if the dimer–dimer interface is the ligand binding site of TLP, the ligands bound are likely to be smaller than thyroid hormones and carry different distribution of charges.
5.2.4
Variations in the Predicted Subcellular Localisation of TLPs
Whilst all TLP sequences identified have been shown to contain Motifs A–D, further variations were observed in the N-terminal regions of these sequences. Careful inspection of the N-terminal regions of TLP from various organisms revealed that many TLP sequences contained likely subcellular localisation sequences or secretion peptides. On this basis, TLP sequences can be divided into four groups: (1) cytoplasmic TLPs (the majority of TLP sequences); (2) periplasmic TLPs (a small group of gram-negative bacterial TLP sequences mainly from the group Enterobacteriaceae); (3) peroxisomal TLPs (most metazoan TLP sequences and plant TLP sequences); and (4) extracellular TLPs (nematode TLP sequences). As noted, plant and metazoan TLPs are represented by both cytoplasmic and
82
S. Hennebry
peroxisomal sequences. This is due to splice variation of the TLP gene in these organisms which results in the loss of the peroxisomal targeting sequence (Hennebry et al. 2006a). It is postulated that TLPs from plants and metazoan organisms are localised to both the cytoplasm and the peroxisome. In most instances, only one TLP gene was identified per haploid genome. However, several bacteria were found to possess two or three non-identical TLP genes. In these cases, the second or third TLP gene was found to encode a protein with a periplasmic localisation sequence. The functional significance of the dual localisation of TLPs in some bacteria and in plants and metazoans will be discussed later in this chapter.
5.3 5.3.1
Structural Characterisation of the S. dublin TLP Synthesis and Characterisation of Recombinant S. dublin TLP
Given that bioinformatic analysis of the S. dublin TLP suggested shared similar structural characteristics with TTR, this protein was selected for further structural and functional studies. Recombinant S. dublin TLP was synthesised using an E. coli expression system (see Hennebry et al. 2006a). Given the close evolutionary distance between E. coli and Salmonella, the periplasmic localisation signals utilised by both bacteria are identical. Thus, the N-terminal periplasmic localisation signal of the S. dublin TLP was left intact so that secretion of the recombinant protein to the periplasm could be tested in E. coli. Recombinant S. dublin TLP was successfully purified from the periplasm of host E. coli (Hennebry et al. 2006a). N-terminal sequencing of the recombinant protein confirmed that the N-terminal signal peptide had been cleaved upon translocation of the protein into the periplasm (Hennebry et al. 2006a). This indicated that it was likely that in vivo the S. dublin TLP was localised to the periplasm. Recombinant S. dublin TLP was subjected to gel filtration and comparison of its subunit molecular mass (as determined by ionising mass spectrometry) with its apparent native molecular weight suggested that the protein formed homotetramers, similarly to TTR.
5.3.2
The X-Ray Crystal Structure of the S. dublin TLP
The three-dimensional structures of TTR from various organisms have been well characterised (refer to relevant chapter in this book). The first X-ray crystal structure of a TTR to be solved was that of human TTR, in 1978 (Blake et al. 1978). The Protein Database (http://www.pdb.org) contains multiple crystal structure coordinates for human TTR (including multiple amyloidogenic forms
5 The Salmonella sp. TLP: A Periplasmic 5-Hydroxyisourate Hydrolase
83
and with various ligands bound to both wild-type and mutant human TTRs). The crystal structures of TTR from rat (Wojtczak 1997), chicken (Sunde et al. 1996) and sea bream (Folli et al. 2003; Eneqvist et al. 2004) have also been solved. All of these structures demonstrate the remarkable conservation of the prealbumin-like fold (as described by SCOP, http://scop.mrc-lmb.cam.ac.uk) which consists of an eightstranded b-sandwich (strands A–H) with each sheet adopting a Greek-key topology. A two-turn a-helix usually exists between strands E and F in TTR. The two TTR dimers associate via non-polar interactions between the loops joining stands G and H with the loops joining strands A and B, making the TTR tetramer a ‘dimer of dimers’. ˚ (Hennebry The X-ray crystal structure of the S. dublin TLP was solved to 2.5 A et al. 2006b) (Fig. 5.2). Comparison of the structure of S. dublin TLP with that of TTRs from various organisms has enabled a greater understanding of the structural evolution of these paralogous proteins. In the months following the publication of the S. dublin TLP, the X-ray crystal structures of the TLPs from E. coli, B. subtilis and Danio rerio (Lundberg et al. 2006; Jung et al. 2006; Zanotti et al. 2006) were solved. The structures of these proteins will be discussed in the subsequent chapters of this book. The overall structure of the S. dublin TLP strongly resembled the archetypal TTR fold (Blake and Oatley 1977; Blake et al. 1978): a prealbumin-like fold (as defined by the SCOP database: http://scop.mrc-lmb.cam.ac.uk) consisting of an eight-stranded b-sandwich with each sheet adopting a greek-key topology (Hennebry et al. 2006b). A two-turn a-helix was found between strands E and F. The asymmetric unit consisted of two protein molecules (a TLP dimer; Fig. 5.2a) which dimerise via intermolecular hydrogen bonds between H-strands to form an eight-stranded b-sheet. A similar interaction has been found in all TTR crystal structures published to date. Application of tight non-crystallographic symmetry (NCS) restraints during refinement yielded identical molecules in the asymmetric unit. Therefore, the S. dublin TLP, similarly to TTR, was determined to be a tetrameric ‘dimer of dimers’ (see Fig. 5.2b). The two dimers were found to associate via non-polar interactions between the loops joining strands G and H with loops joining strands A and B. This was consistent with the observation from gel filtration analyses, that the TLP formed tetramers in solution (Hennebry et al. 2006a).
5.3.3
Comparison of the Structure of S. dublin TLP with TTRs from Human, Chicken, rat and Seabream
5.3.3.1
Comparison of the Overall Fold of S. dublin TLP with TTR
The structure of S. dublin TLP was overlayed with structures of TTRs from human (1F41), chicken (1TFP), rat (1KGI) and seabream (1SNO) (Hornberg et al. 2000; Sunde et al. 1996; Muziol et al. 2001; Eneqvist et al. 2004). The human, rat and fish ˚ . Chicken TTR and TTR tetramers superimposed to within an RMSD of 1.0 A
84
S. Hennebry
˚ crystal structure of the S. dublin TLP. (a) Dimeric structure within the Fig. 5.2 The 2.5 A asymmetric unit of the crystal, showing the interaction between the b-strands H of each monomer. Secondary structure elements are labelled. The C and N termini are marked with an asterisk (*). (b) The homotetrameric structure generated by crystal symmetry, in an orthogonal orientation to (a). Approximate positions of predicted ligand binding sites at the dimer–dimer interface (shown as a dotted line) are indicated by black circles. Figure generated using PyMol (Delano 2002) (from Hennebry et al. 2006b)
5 The Salmonella sp. TLP: A Periplasmic 5-Hydroxyisourate Hydrolase
85
˚ (Fig. 5.3). S. dublin TLP showed larger variation, with RMSD values up to 4.0 A The structural deviation observed between the S. dublin TLP and the TTR subunits was of the same order of magnitude to that within the set of TTR subunits. The total ˚ ) was contacting surface area between molecules within the tetramer (5,275 A ˚ ˚ ˚ ) and 6–14% less than that of fish (5,625 A), human (5,810 A), chicken (5,828 A ˚ rat (6,133 A) TTR structures. 5.3.3.2
Comparison of the Putative Active Site of S. dublin TLP with the Thyroid Hormone Binding Site of Human TTR
One of the striking features of the quaternary structure of TTR is the central channel of the protein into which the thyroid hormones and other ligands (with the exception of retinol-binding protein) bind. This central channel traverses the entire tetramer. Whilst the overall structure of S. dublin TLP and human TTR were highly homologous, examination of the dimer–dimer interface of the TLP revealed significant differences compared to human TTR. The conserved residues His6, His95 and Tyr108 at the dimer–dimer interface of S. dublin TLP and other TLPs were shown to dramatically alter the physicochemical properties of this region of the protein in comparison to human and other TTRs. Figure 5.4 shows a comparison of the dimer– dimer interface of S. dublin TLP with the equivalent region in human TTR. The Tyr108 residue in S. dublin TLP has a profound effect on the size and shape of the dimer–dimer interface compared with human TTR, dramatically reducing the depth of the central channel. The equivalent residue in human TTR is a conserved threonine (Thr119). Residue Leu99 of S. dublin TLP also adopts a conformation which plugs the base of the pocket, compared to the equivalent residue Leu110 in human TTR. Thus, the residues Leu99 and Tyr108 in the S. dublin TLP contribute to a groove-like dimer–dimer interface. This contrasts with the dimer–dimer interface of the TTR molecule, which forms a deep and funnel-shaped central channel which runs through the middle of the tetramer. Other residues at the dimer–dimer interface of S. dublin TLP which differ considerably to the equivalent interface of TTR, are several positively charged residues (Fig. 5.4), His6, Arg44 and His95. These residues are also 100% conserved among TLP sequences and contribute to a significantly more positively charged dimer–dimer interface of S. dublin TLP compared to the more negatively charged channel of human TTR (Fig. 5.4a(i) and 5.4a(ii)). The comparison of the structures of TTRs and TLPs indicates that following the duplication of the TLP gene in early vertebrate evolution, specific amino acid changes at the dimer–dimer interface of the TLP tetramer resulted in increased negative charge and an ‘opening’ of the central channel of the protein. None of the charged residues identified at the dimer-dimer interfaces of TLPs are conserved in TTR sequences. One exception is the recently identified TTR from the lamprey, Petromyzon marinus (Manzon et al. 2007). This is the only TTR sequence to have a histidine residue at the position equivalent to His95 in S. dublin TLP (which is a conserved histidine in all TLPs). Therefore, it is likely that changes to the dimer– dimer interface of TLP occurred firstly at His6, Arg44 or Tyr108 residues and lastly at His95.
86
S. Hennebry
Fig. 5.3 Structural comparison of the S. dublin TLP with TTR. (a) Stereo diagram showing a superimposition of the S. dublin tetramer (magenta) with human (1F41, Hornberg et al. (2000), cyan), rat (1KGI, Muziol et al. (2001), yellow), chicken (1TFP, Sunde et al. (1996), orange) and fish (1SNO, Eneqvist et al. (2004), green) TTRs. Tetramers were superimposed using the A chain only. (b) Stereo diagram showing a superimposition of monomers of S. dublin TLP (magenta) with human (1F41, cyan), rat (1KGI, yellow), chicken (1TFP, orange) and fish (1SNO, green) TTRs. Bound thyroxine ligand in the human structure is shown as sticks. Regions of plastic deformation are labelled. Residues at the dimer–dimer interface of S. dublin TLP are shown as red sticks (from Hennebry et al. 2006b)
5 The Salmonella sp. TLP: A Periplasmic 5-Hydroxyisourate Hydrolase
87
Fig. 5.4 Comparison of the dimer–dimer interfaces of human TTR and S. dublin TLP. (a) (i) Residues that make up the ligand binding pocket of (i) human TTR are shown. Thyroxine is shown in stick representation, in yellow. The residues Lys15, Glu54 and Thr119 are labelled and form important interactions with thyroxine. Some elements of secondary structure are not shown, for clarity. (ii) The dimer–dimer interface of S. dublin TLP is shown (at the equivalent position to human TTR shown in part (i)). Hydrogen bonds are shown as broken cyan lines. Some elements of secondary structure are not shown, for clarity. Residues known to be important to catalysis in S. dublin TLP are indicated with an asterisk. Residues His6, His95 and Tyr108 of S. dublin TLP are equivalent upon structural alignment to Lys15, Thr106 and Thr119 of TTR, respectively. (b). Surface characteristics and interactions at the ligand binding sites of (i) human TTR and (ii) S. dublin TLP. Positively charged residues are in blue, negatively charged residues are in red. (i) The electrostatic surface potential surface of human TTR (1F41; Hornberg et al. 2000), shown with thyroxine ligand inside the hormone-binding pocket, is negatively charged. (ii) The equivalent region in the S. dublin TLP is positively charged. Figure generated using PyMol (Delano 2002) (from Hennebry et al. 2006b)
5.3.3.3
Comparison of the X-Ray Crystal Structure of S. dublin TLP to TLP Structures from E. coli, B. subtilis and D. rerio
The X-ray crystal structures of the TLP from E. coli (Lundberg et al. 2006), B. subtilis (Jung et al. 2006) and D. rerio (Zanotti et al. 2006) were published shortly after the structure of the S. dublin TLP was published. A comparison of the TLPs from the three species of bacteria with the vertebrate TLP (zebrafish) shows
88
S. Hennebry
little structural divergence. Major differences between the S. dublin TLP and D. rerio TLP were found in the flexible portions of strand B and C that protrude towards the solvent and in the conformation of the loop connecting strands D and E (Zanotti et al. 2006). Greater differences were observed between the structures of TLPs from B. subtilis and D. rerio: the B-C loop was significantly shorter in B. subtilis TLP whilst the loop connecting the short a-helix to strand F was extended. The dimer–dimer interfaces of TLP from prokaryotes and eukaryotes were nearly identical. The location and orientation of the residues present in this region were well maintained, including the highly conserved residues His6, Arg44, His95 and Tyr108 (S. dublin TLP numbering). The only significant difference was found in the C-terminal serine residue (from the YRGS tetrapeptide), which assumed different orientations in the structures from S. dublin, E. coli and B. subtilis compared with D. rario. It is therefore clear that the dimer–dimer interface of TLP has been incredibly well conserved throughout evolution. This suggests that the dimer–dimer interface might be the ligand binding site of TLP.
5.4 5.4.1
The In Vitro Function of the S. dublin TLP Binding of Thyroid Hormones by the S. dublin TLP
Even before the publication of the X-ray crystal structure of a TLP, homology modelling of the likely structures of these proteins led to the hypothesis that it was unlikely that thyroid hormones were the natural ligands of TLPs. Homology modelling of the S. dublin TLP (Sect. 5.2.3) suggested that the shape and charge of the dimer–dimer interface of this protein might preclude the binding of thyroid hormones. To confirm this, experiments characterising the binding of thyroid hormones to the S. dublin TLP were performed using the method published by Chang et al. (1999). The binding of radiolabelled tri-iodothyronine (T3) and tetraiodothyronine (T4) by the S. dublin TLP could not be detected. The resultant scatchard plots suggested low levels of non-specific interactions between the protein and thyroid hormones, indicating that the affinity of the thyroid hormones for TLP was too low to be of physiological significance. This finding supported the hypothesis that it was likely that the dimer–dimer interface of TLP would be too shallow to accommodate bulky compounds bound by TTRs.
5.4.2
Examining the Role of the S. dublin TLP in Purine Metabolism
In order to gain clues as to the likely function of TLP, the genomic context of TLP genes from bacteria was examined. In bacteria, genes encoding proteins which act in a shared metabolic pathway are often found grouped on the chromosome in an
5 The Salmonella sp. TLP: A Periplasmic 5-Hydroxyisourate Hydrolase
89
operon. Genes encoding cytoplasmic TLP sequences were frequently found in a specific genomic context: a purine metabolism operon. Specifically, the cytoplasmic TLP genes were frequently found neighbouring the gene encoding the enzyme uricase. Indeed, a role for TLP in purine metabolism was proposed in 2001. In an effort to develop a greater understanding of purine metabolism in the gram-positive bacterium, Bacillus subtilis, Schultz et al. (2001) generated a series of insertion mutants. One of these mutations was made in the TLP gene which is located immediately downstream of the gene encoding uricase. The bacteria harbouring this mutation were characterised by a reduced rate of proliferation (compared to wild-type) on media containing uric acid as the principal source of nitrogen (Schultz et al. 2001). In gram negative bacteria, the TLP gene was also found in purine metabolism operons. However, the purine metabolism-associated genomic context of the TLP gene was only found for the TLP genes encoding cytoplasmic proteins. There was no consistent genomic context identified for TLP genes encoding periplasmic proteins. For example, the S. dublin TLP gene is immediately downstream of genes (CopR and CopS) encoding a two-component sensor-histidine kinase system for bacterial resistance to copper. Therefore it was unclear whether the S. dublin TLP would share similar functions to TLPs from other bacteria. Purines are significantly smaller compounds that thyroid hormones, whilst sharing similar chemical characteristics. Therefore, the binding of uric acid and allantoin to S. dublin TLP was assessed, using fluorescence quenching. The static quenching of the intrinsic fluorescence of tryptophans results from conformational changes in proteins upon ligand binding (Engelborghs 2001). No such conformational static quenching of the intrinsic fluorescence of the tryptophan residues of S. dublin TLP could be detected following titration with uric acid or allantoin (Hennebry et al. 2006a). These results, however, could not be taken as conclusive evidence of the lack of binding of the compounds by the TLP. Rather, the lack of quenching merely indicated a lack of significant conformational change to the protein in regions containing a tryptophan residue.
5.4.3
Hydrolysis of 5-HIU by the the S. dublin TLP
It had long been reported that that the enzyme uricase oxidises the purine uric acid directly into allantoin (e.g. Howell and Wyngaarden 1960). The enzyme reaction has since been demonstrated to be more complex. Tipton’s group showed in 1997 that uricase oxidises uric acid to a metastable compound, 5-hydroxyisourate (5-HIU) (Kahn et al. 1997). This intermediate decomposes into racemic allantoin nonenzymatically via another unstable intermediate, 2-oxo-4-hydroxy-4-carboxy5-ureidoimadolazine (OHCU) (Fig. 5.5a). The decomposition of 5-HIU was shown to occur over 30 min at pH 7, in vitro (Sarma et al. 1999). In biological systems, only (S)-allantoin is found and the enzyme which degrades this purine, allantoinase, specifically binds the (S) form of the compound (Lee and Roush 1964).
90
S. Hennebry
Fig. 5.5 The hydrolysis of 5-HIU by S. dublin TLP. (a) The uricase degradation pathway showing the role of three enzymes (uricase, TLP and OHCU decarboxylase) in converting uricase to allantoin. (b) Hydrolysis of 5-HIU by wild-type S. dublin TLP and by His6Ala, His95Ala and Tyr108Phe mutant S. dublin TLPs. 0.05 units ml 1 uricase was equilibrated in 50 mM potassium phosphate buffer (pH 7.8) for 3 min. The reaction was commenced with the addition of 50 mM uric acid. The appearance of 5-HIU was monitored spectrophotometrically at 312 nm. The amount of 5-HIU peaked after approximately 3 min and began spontaneous decomposition if left unperturbed. Addition of 0.04 mM wild-type S. dublin TLP resulted in rapid hydrolysis of 5-HIU (10 mmol min 1 mg 1 TLP). Addition of equimolar amounts of His95Ala or Tyr108Phe mutants S. dublin TLPs resulted in reduced hydrolysis (1.2 mmol min 1 mg 1 TLP; activity reduced by 90%). The His6Ala mutation abolished hydrolytic activity (from Hennebry et al. 2006b)
The implication, as hypothesised by Kahn and Tipton (1998), was the involvement of at least two additional enzymes in the degradation of uric acid to allantoin: to increase the rate of decomposition and to facilitate the generation of stereo-specific allantoin. The significance of this hypothesis in the context of a possible function of TLP was not fully appreciated until recently, when it was revealed that the TLP from the gram positive bacterium, B. subtilis, hydrolysed one intermediate in the uric acid degradation pathway, 5-HIU to OHCU (Lee et al. 2005). Importantly, the same researchers established that human TTR did not possess this hydrolytic activity. Ramazzina et al. (2006) have more recently shown that mouse TLP hydrolyses 5-HIU and that the COG3195 protein was responsible for the decarboxylation of
5 The Salmonella sp. TLP: A Periplasmic 5-Hydroxyisourate Hydrolase
91
OHCU to S-allantoin (Fig. 5.5). Thus, the pathway of the conversion of uric acid to S-allantoin via the three enzymes, uricase, TLP (5-HIUase) and OHCU decarboxylase was revealed (Fig. 5.5a). The TLP from B. subtilis was predicted to be cytosolic and its gene was located in a purine metabolism operon. However, it was not clear whether a periplasmic TLP, such as the S. dublin TLP, would also hydrolyse 5-HIU. The recombinant S. dublin TLP was tested for its ability to hydrolyse 5-HIU, using the method published by Lee et al. (2005). One mg of recombinant S. dublin TLP was shown to hydrolyse 10 mol min 1 of 5-HIU (Hennebry et al. 2006b).
5.4.4
Characterisation of the Active Site of S. dublin TLP
In the previous section the ligand binding channel of human TTR was compared with the equivalent region of the crystal structure of S. dublin TLP. Several residues at the dimer–dimer interface of the S. dublin TLP (Fig. 5.4b) were 100% conserved across all TLP sequences but not found in any TTR sequences. Examination of the likely arrangement of these residues indicated a potential catalytic site where 5-HIU might be hydrolysed (Fig. 5.4b). With this in mind, residues which could theoretically perform a role in chemical catalysis were selected for site-directed mutagenesis to see what affect this would have on the hydrolytic activity of TLP. These residues were His6, His95 and Tyr108 (Fig. 5.4b). The mutations His6Ala, His95Ala and Tyr108Phe were introduced into the S. dublin TLP sequence (Hennebry et al. 2006b). The S. dublin TLP His6Ala, His95Ala and Tyr108Phe proteins were synthesised, purified and shown to form homotetramers, in order to rule out the potential global structural importance of the mutated residues. The hydrolytic activity of each mutated S. dublin TLPs was compared with that of wild-type S. dublin TLP. All of these mutations had significant effects on the hydrolytic activity of the protein (Fig. 5.5b). The His6Ala mutation abolished hydrolytic activity which was reduced to a negligible rate of 0.1 mol min 1 mg 1 of protein. The His95Ala and Tyr108Phe S. dublin TLPs had activities of 1.2 mol min 1 mg 1 of protein: a reduction of 90%.The His10Ala mutation completely abolished enzyme activity. The His99Ala and Tyr119Phe mutations reduced activity by more than 90% (Hennebry et al. 2006b).
5.5
Perspectives
We determined that the S. dublin TLP is most likely a periplasmic protein. The periplasm is a layer of peptidoglycan found between the inner and outer membranes of gram-negative bacteria. In these bacteria, the periplasm has a variety of important roles. Several groups of enzymes with specialised functions reside in the
92
S. Hennebry
periplasm. For example, hydrolytic enzymes which can degrade foreign DNA or peptides are important part of the bacteria’s defence system. Some periplasmic enzymes, for example, superoxide dismutase and catalase detoxify oxidising compounds (free radicals) from the external environment. Proteins involved in chemotaxis and nutrient acquisition are localised to the periplasm as are numerous transport proteins which dock to membrane-bound proteins to elicit transport of their substrate into the cytoplasm (for a review, see Oliver 1996). In all bacteria studied to date, the proteins involved in purine metabolism are located in the cytosol (for a review, see Vogels and van der Drift (1976)). Therefore, a role for the S. dublin TLP in purine metabolism is unclear. In addition, Salmonellae lack the upstream enzymes required for generation of 5-HIU: no homologs of xanthine dehydrogenase, uricase or OHCU-decarboxylase have been identified in the genomes of Salmonella species. Nonetheless, import proteins and enzymes for the degradation of downstream compounds, such as allantoin are encoded in the Salmonellae genomes. If 5-HIU is the true ligand of the S. dublin TLP, then the source of 5-HIU must be the external environment, as is the case for allantoin. In vivo, 5-HIU is short-lived and is produced by the non-enzymatic oxidation of uric acid (Santos et al. 1999). 5-HIU is highly reactive and capable of reacting with free radicals, causing lipid oxidation (Santos et al. 1999). It has therefore been proposed that together, TLP and OHCU decarboxylase rapidly detoxify 5-HIU, yielding the relatively inert allantoin (Hennebry et al. 2006a; Ramazzina et al. 2006). In the case of S. dublin, an enteric bacterium, possible sources of oxidised uric acid (i.e. 5-HIU) include the gut of its host: the guts of reptilian and avian Salmonella hosts are particularly high in uric acid (Wright 1995); mammalian hosts secrete uric acid into their guts in response to bacterial infection (Vorbach et al. 2003). The data presented here demonstrate the rapid kinetics by which recombinant S. dublin TLP hydrolyses 5-HIU, a reactive compound known to generate damaging oxidative radicals. Therefore, it is possible that the role of periplasmic TLP in enteric bacteria such as S. dublin is to rapidly detoxify 5-HIU from the external environment. The investigation of the structure and function of the S. dublin TLP represented the first step in furthering our understanding of the non-vertebrate evolution of the TTR molecule. The conservation of catalytic residues at the TLP dimer-dimer interface, which have been demonstrated to be essential for enzymatic activity, indicates that is likely that all TLPs share 5-HIU hydrolytic activity. Furthermore, the distribution of TLPs in all kingdoms, but the representation of TTRs in vertebrates alone, clearly suggests that the transthyretin-like fold originally functioned in purine metabolism. Following the duplication of TLP gene, amino acid substitutions to residues at the dimer-dimer interface dramatically altered the protein’s function whilst its overall structure was unchanged. Thus, the evolution of TLP represents a remarkable case of the divergent evolution from a hydrolytic enzyme (TLP) to a thyroid hormone distributor (TTR).
5 The Salmonella sp. TLP: A Periplasmic 5-Hydroxyisourate Hydrolase
93
References Bailey, T.L., Elkan, C. (1994) Fitting a Mixture Model by Expectation Maximisation to Discover Motifs in Biopolymers. AAAI Press, Menlo Park, CA Blake, C.C.F., Oatley, S.J. (1977) Protein–DNA and protein–hormone interactions in prealbumin: A model of the thyroid hormone nuclear receptor? Nature 268, 115–120 Blake, C.C.F., Geisow, M.J., Oately, S.J. (1978) Structure of prealbumin: Secondary, tertiary and ˚ . J. Mol. Biol. 121, 339–356 quaternary interactions determined by Fourier refinement at 1.8 A Chang, L., Munro, S.L.A., Richardson, S.J., Schreiber, G. (1999) Evolution of thyroid hormone binding by transthyretins in birds and mammals. Eur. J. Biochem. 259, 534–542 DeLano W.L. (2002) The PyMol User’s Manual. Delano Scientific, San Carlos, CA, USA Eneqvist, T., Lundberg, E., Nilsson, L., Abagyan, R., Sauer-Eriksson, A.E. (2003) The transthyretinrelated protein family. Eur. J. Biochem. 270, 518–532 Eneqvist, T., Lundberg, E., Karlsson, A., Huang, S., Santos, C.R.A., Power, D.M., Sauer-Eriksson, A.E. (2004) High-resolution crystal structures of piscine transthyretin reveal different binding modes for triiodothyronine and thyroxine. J. Biol. Chem. 279, 26411–26416 Engelborghs, Y. (2001) The analysis of time resolved protein fluorescence in multi-tryptophan proteins. Spectrochim. Acta A Mol. Biomol. Spectrosc. 57, 2255–2270 Folli, C., Pasquato, N., Ramazzina, I., Battistutta, R., Zanotti, G., Berni, R. (2003) Distinctive binding and structural properties of piscine transthyretin. FEBS Lett. 555, 279–284 Hennebry, S.C., Wright, H.M., Likic´, V.A., Richardson, S.J. (2006a) Structural and functional evolution of transthyretin and transthyretin-like proteins. Proteins 64, 1024–1045 Hennebry, S.C., Law, R.H., Richardson, S.J., Buckle, A.M., Whisstock, J.C. (2006b) The crystal structure of the transthyretin-like protein from Salmonella dublin, a prokaryote 5-hydroxyisourate hydrolase. J. Mol. Biol. 359, 1389–1399 Hornberg, A., Eneqvist, T., Olofsson, A., Lundgren, A., Sauer-Eriksson, A.E. (2000) A comparative analysis of 23 structures of the amyloidogeneic protein transthyretin. J. Mol. Biol. 032, 649–669 Howell, R.R., Wyngaarden, J.B. (1960) On the mechanism of peroxidation of uric acids by hemoproteins. J. Biol. Chem. 235, 3544–3550 Jung, D.-K., Lee, Y., Park, S.G., Park, B.C., Kim, G.-H., Rhee, S. (2006) Structural and functional analysis of PucM, a hydrolase in the ureide pathway and a member of the transthyretin-related protein family. Proc. Nat. Acad. Sci. U.S.A. 103, 9790–9795 Kahn, K., Serfozo, P., Tipton, P.A. (1997) Identification of the true product of the urate oxidase reaction. J. Am. Chem. Soc. 119, 5435–5442 Kahn, K., Tipton, P.A. (1998) Spectroscopic characterisation of intermediates of the urate oxidase reaction. Biochemistry 37, 11651–11569 Lee, K.W., Roush, A.H. (1964) Allantoinase assays and their application to yeast and soybean allantoinases. Arch. Biochem. Biophys. 108, 460–467 Lee, Y., Lee, D.H., Kho, C.W., Lee, A.Y., Jang, M., Cho, S., Lee, C.H., et al. (2005) Transthyretinrelated proteins function to facilitate the hydrolysis of 5-hydroxyisourate, the end product of the uricase reaction. FEBS Lett. 579, 4769–4774 Lundberg, E., Backstrom, S., Sauer, U.H., Sauer-Eriksson, E. (2006) The transthyretin-related protein: structural investigation of a novel protein family. J. Struct. Biol. 155, 445–457 Manzon, R.G., Neuls, T.M., Manzon, L.A. (2007) Molecular cloning, tissue distribution, and developmental expression of lamprey transthyretins. Gen. Comp. Endocrinol. 151, 55–65 Muziol, T., Cody, V., and Wojtczak, A. (2001) Comparison of binding interaction of dibromoflavonoids with transthyretin. Acta Biochim. Pol. 48, 885–892 Oliver, D.B. (1996) The periplasm. In: Neidhart, F.C., Curtiss, R. III, Ingraham, I.L., Lin, E.C.C., Low, K.B., Magasanik, B., Reznikoff, W.S., Riley, M., Schaecter, M., Umbarger, M.E. (eds.) Escherichia coli and Salmonella: Cellular and molecular biology. ASM Press, Washington. pp 88–103
94
S. Hennebry
Power, D.M., Elias, N.P., Richardson, S.J., Mendes, J., Soares, C.M., Santos, C.R.A. (2000) Evolution of the thyroid hormone-binding protein, transthyretin. Gen. Comp. Endocrinol. 119, 241–255 Prapunpoj, P., Yamauchi, K., Nishiyama, N., Richardson, S.J., Schreiber, G. (2000) Evolution of structure, ontogeny of gene expression, and function of Xenopus laevis transthyretin. Am. J. Physiol. Reg. Integr. Comp. Physiol. 279, R2026–R2041 Ramazzina, I., Folli, C., Secchi, A., Berni, R., Percudani, R. (2006) Completing the uric acid degradation pathway through phylogenetic comparison of whole genomes. Nat. Chem. Biol. 3, 144–148 Sarma, A.D., Serfozo, P., Kahn, K., Tipton, P. (1999) Identification and purification of hydroxyisourate hydrolase, a novel ureide-metabolising enzyme. J. Biol. Chem. 274, 33863–33865 Santos, C.X.C., Anjos, E.I., Augusto, O. (1999) Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation. Arch. Biochem. Biophys. 372, 285–294 Schultz, A.C., Nygaard, P., Saxild, H.H. (2001) Functional analysis of 14 genes that constitute the purine catabolic pathway in Bacillus subtilis and evidence for a novel regulon controlled by the PucR Transcription activator. J. Bacteriol. 183, 3293–3302 Sunde, M., Richardson, S.J., Chang, L., Pettersson, T.M., Schreiber, G., Blake, C.C. (1996) The crystal structure of transthyretin from chicken. Eur. J. Biochem. 236, 491–499 Vogels, G.D., van der Drift